Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3000620	p-c3	g/l (g/l)	8387	14252	0.05%
3000620	s-c3	g/l (g/l)	6428	10369	0.00%
3000620	p-c3	— (—)	667	771	100.00%	Distribution not available
3000620	s-c3	— (—)	403	476	100.00%	Distribution not available
3000620	s-c3	g/l_______ (g/l)	172	228	0.00%
3000620	pf-c3	g/l (g/l)	128	143	0.00%
3000620	s-komplementtic3	g/l_______ (g/l)	71	95	0.00%
3000620	s-komplementtic3	g/l (g/l)	67	68	0.00%
3000620	pf-c3	— (—)	31	33	100.00%	Distribution not available
3000620	p-c3	G/L (g/l)	16	16	0.00%	Distribution not available
3000620	pf-komplementtic3	g/l (g/l)	10	12	0.00%	Distribution not available
3000620	p-c3	g/l_______ (g/l)	8	9	0.00%	Distribution not available
3000620	s-c3h	g/l (g/l)	7	7	0.00%	Distribution not available
3000620	pf-komplementtic3	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Septicaemia

1493

4643

3.06

321.43

1.9

1.6

1.17

1.18

g/l

0.58

1423

4435

Diseases of the musculoskeletal system and connective tissue

1584

2500

3.27

320.94

2.1

1.2

1.17

1.19

g/l

1.30

1525

2393

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3369

10811

2.13

320.75

2.0

1.7

1.20

1.19

g/l

2.30

3226

10368

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

507

787

7.40

319.79

2.0

1.4

1.31

1.18

g/l

11.34

481

757

Cardiovascular diseases (excluding rheumatic etc)

2250

5136

2.59

316.89

2.2

1.8

1.21

1.16

g/l

10.36

2167

4931

Explicit Sepsis, including avohilmo

1618

5278

2.90

315.60

1.9

1.6

1.17

1.19

g/l

1.72

1546

5047

Neurological diseases, wide definition

879

881

5.19

312.12

2.0

1.2

1.19

1.16

g/l

1.51

841

840

Explicit Sepsis

1583

5171

2.91

311.07

1.9

1.6

1.17

1.19

g/l

1.60

1512

4942

Headache

2401

6711

2.87

307.65

1.9

1.6

1.20

1.18

g/l

2.75

2296

6444

Asthma (mode)

2623

4860

2.93

307.65

1.7

1.23

1.18

g/l

12.53

2518

4668

Other systemic involvement of connective tissue

2720

3068

10.79

307.65

2.8

1.2

1.15

1.21

g/l

12.67

2647

2903

Other bacterial diseases

3414

9441

2.48

307.65

1.9

1.7

1.21

1.19

g/l

3.23

3270

9052

Reimbursement for rheumatic diseases

3681

7731

5.22

307.65

3.0

1.3

1.16

1.20

g/l

12.84

3566

7379

Implicit bacterial Sepsis, including avohilmo

1820

4630

3.44

307.65

1.9

1.5

1.17

1.20

g/l

2.71

1727

4425

Unspecified kidney failure

551

874

6.98

307.65

1.6

1.5

1.15

1.17

g/l

0.43

532

829

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3038

9407

2.24

307.65

1.9

1.7

1.18

1.20

g/l

2.15

2902

9032

L04AA Selective immunosuppressants

1436

3106

5.18

307.65

3.7

1.6

1.13

1.21

g/l

13.79

1397

2966

Seropositive rheumatoid arthritis

1028

2194

4.98

307.65

2.1

1.2

1.16

1.20

g/l

3.37

992

2085

Renal failure

2601

4519

5.34

307.65

1.8

1.6

1.17

1.19

g/l

1.63

2506

4282

Bacterial infection, other or unspecified

2088

5776

3.20

307.65

1.9

1.6

1.21

1.19

g/l

3.04

1985

5524

Systemic sclerosis (FG)

310

171

26.60

307.65

2.4

1.2

1.09

1.20

g/l

3.69

299

158

Adverse effects, not elsewhere classified

1230

2920

4.67

307.65

1.7

1.8

1.21

1.18

g/l

1.93

1137

2805

Condition for Implicit Sepsis (Organ dysfunction codes)

2936

8878

2.36

307.65

1.9

1.7

1.18

1.20

g/l

2.45

2805

8521

Bacterial Sepsis

1891

4828

3.41

307.65

2.0

1.5

1.16

1.20

g/l

3.58

1794

4614

ILD, hospital admissions

806

1608

5.55

307.65

1.9

1.5

1.19

1.18

g/l

0.51

784

1529

Systemic lupus erythematosus

876

351

62.04

307.65

7.6

1.2

1.04

1.23

g/l

19.63

852

331

Azathioprine

899

1443

6.97

307.65

4.3

1.4

1.13

1.17

g/l

2.97

874

1385

Asthma-related infections

2217

8946

2.51

307.65

1.7

1.8

1.23

1.18

g/l

14.97

2122

8562

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4340

9766

3.14

307.65

2.0

1.6

1.17

1.20

g/l

5.68

4151

9367

Other and unspecified effects of external causes

1408

4205

3.60

307.65

1.8

1.20

1.18

g/l

1.80

1309

4053

Tramadol

2707

6892

2.44

307.65

1.8

1.7

1.23

1.17

g/l

16.06

2593

6603

Implicit Sepsis

2794

7981

2.68

307.65

1.9

1.6

1.18

1.20

g/l

2.30

2662

7659

Bacterial infection, other or unspecified, including avohilmo

2252

6369

3.03

307.65

1.9

1.6

1.21

1.18

g/l

3.26

2143

6100

Oral corticosteroids

5587

7629

4.58

307.65

2.3

1.4

1.20

1.18

g/l

3.76

5337

7307

Renal tubulo-interstitial diseases

3582

9588

2.86

307.65

1.9

1.7

1.19

g/l

0.07

3452

9176

Asthma, unspecified (mode), excluding more controls

1836

4265

3.20

307.65

1.6

1.7

1.23

1.18

g/l

8.21

1770

4095

Oedema, not elsewhere classified

1506

3499

4.49

307.65

1.8

1.6

1.21

1.18

g/l

1.82

1429

3341

Fever of other and unknown origin

2735

5953

4.23

307.65

2.2

1.6

1.22

1.18

g/l

6.32

2631

5709

Finngen Rheumatological endpoints

4300

6537

3.93

307.65

2.5

1.3

1.17

1.20

g/l

4.06

4141

6245

Urticaria

1547

4610

3.61

307.65

1.9

1.8

1.19

g/l

0.27

1465

4430

Implicit Sepsis, including avohilmo

2951

8684

2.51

307.65

1.9

1.7

1.18

1.20

g/l

2.35

2817

8335

Autoimmune diseases excluding thyroid diseases

4839

7142

3.87

307.65

2.4

1.3

1.16

1.20

g/l

11.17

4659

6837

Pneumonias (Asthma/COPD co-morbidities)

3455

10778

2.15

307.65

2.0

1.7

1.20

1.19

g/l

2.23

3310

10337

Autoimmune diseases

4198

7200

3.07

307.65

2.2

1.3

1.17

1.20

g/l

5.30

4038

6892

Dialysis, with operation codes

816

1286

7.27

307.65

1.9

1.6

1.09

1.19

g/l

10.83

779

1220

Influenza and pneumonia

3629

10652

2.16

307.65

2.0

1.7

1.20

1.18

g/l

2.55

3476

10219

Other necrotizing vasculopathies (FG)

499

435

14.04

307.65

2.2

1.2

1.23

1.19

g/l

1.46

479

408

SLE, ICD10

853

393

58.12

307.65

7.7

1.3

1.04

1.21

g/l

19.26

829

373

ILD medications

5749

6871

4.79

307.65

2.3

1.3

1.19

1.18

g/l

0.51

5516

6575

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

723

308

18.70

307.65

2.0

1.2

1.20

1.18

g/l

0.44

704

287

Asthma, excluding more controls

2608

4489

3.09

307.65

1.7

1.23

1.18

g/l

11.12

2506

4310

Pneumonia, organism unspecified

3145

9959

2.23

307.65

1.9

1.7

1.20

1.19

g/l

1.95

3018

9548

Autoimmune diseases related-to ILD

4481

9752

4.09

307.65

2.8

1.3

1.17

1.19

g/l

4.58

4327

9306

Other soft tissue disorders, not elsewhere classified

3435

7945

2.54

307.65

1.9

1.8

1.20

1.18

g/l

5.51

3293

7610

Rheumatoid arthritis

1433

3120

4.34

307.65

2.1

1.6

1.17

1.18

g/l

0.66

1379

2985

Used for control exclusion in common control thyroid runs

3788

6622

2.99

307.65

2.2

1.3

1.17

1.20

g/l

4.74

3650

6338

Other bacterial diseases, including avohilmo

3640

9829

2.39

307.65

1.9

1.7

1.21

1.18

g/l

6.27

3496

9423

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3138

7661

2.47

307.65

2.0

1.7

1.20

1.18

g/l

4.33

3006

7355

Systemic lupus erythematosus, unspecified

779

347

67.13

307.65

7.8

1.3

1.04

1.21

g/l

20.23

756

331

Interstitial lung disease endpoints

812

1626

5.52

307.65

1.9

1.5

1.19

1.18

g/l

0.54

790

1547

Certain disorders involving the immune mechanism

1061

2547

4.60

307.65

1.9

1.7

1.20

g/l

0.15

1014

2441

All chronic kidney diseases

2978

5367

4.78

307.65

2.3

1.6

1.18

1.19

g/l

0.48

2874

5117

Dermatitis

2713

9127

3.06

307.65

1.9

1.7

1.19

g/l

0.24

2612

8728

Coagulation defects, purpura and other haemorrhagic conditions

1000

2638

4.12

307.65

2.7

1.7

1.14

1.19

g/l

4.24

952

2515

Other specific joint derangements/joint disorders

3077

6103

3.29

307.65

1.8

1.7

1.19

1.18

g/l

0.95

2947

5855

Dermatitis and eczema

4049

10535

2.35

307.65

1.8

1.7

1.19

g/l

0.08

3896

10079

Nephropathy related operations

766

1394

6.26

307.65

2.0

1.5

1.09

1.20

g/l

12.93

732

1325

SLE (Finngen)

876

258

84.96

307.65

7.6

1.3

1.04

1.24

g/l

15.29

852

244

Implicit viral Sepsis, including avohilmo

1249

3815

3.45

307.65

2.2

1.6

1.17

1.19

g/l

1.62

1185

3648

Diseases of arteries, arterioles and capillaries

2318

6573

2.69

307.65

1.7

1.6

1.15

1.20

g/l

11.67

2231

6281

Other specified/unspecified systemic involvement of connective tissue

971

564

28.48

307.65

3.7

1.2

1.09

1.22

g/l

15.54

948

533

Glomerular disorders in diseases classified elsewhere

934

1242

8.98

307.65

3.6

1.5

1.16

1.19

g/l

1.64

896

1179

Examination and observation for other reasons

1974

4074

2.83

307.65

1.8

1.6

1.19

1.20

g/l

0.62

1894

3934

Rheumatoid arthritis, including avohilmo

1647

5257

3.33

307.65

2.1

1.6

1.18

1.20

g/l

1.97

1585

5000

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2354

8408

2.53

307.65

1.8

1.7

1.18

1.19

g/l

0.97

2252

8045

Implicit bacterial Sepsis

1669

4239

3.56

307.65

1.9

1.5

1.17

1.19

g/l

2.39

1579

4043

Other necrotizing vasculopathies

604

642

11.56

307.65

2.8

1.2

1.22

1.21

g/l

0.29

581

609

Other and unspecified urticaria

1038

2823

4.00

307.65

1.9

1.8

1.18

1.19

g/l

0.49

975

2706

Polyarthropathies

3177

5419

3.99

307.65

1.9

1.7

1.20

1.18

g/l

2.28

3063

5195

Care involving dialysis

547

836

7.60

307.65

2.0

1.6

1.07

1.20

g/l

12.48

526

787

3138

7661

2.47

307.65

2.0

1.7

1.20

1.18

g/l

4.33

3006

7355

Anaemias

1104

1283

5.90

307.65

2.4

1.9

1.16

1.12

g/l

3.55

1063

1233

Dyspnoea

3197

10342

2.30

307.65

1.9

1.7

1.21

1.18

g/l

3.65

3067

9912

Cutaneous lupus erythematosus

418

251

29.28

307.65

4.3

1.6

1.10

1.22

g/l

6.70

411

239

Asthma (only as main-diagnosis)

2534

4799

3.06

307.65

1.6

1.7

1.23

1.18

g/l

11.68

2430

4609

Diseases of the skin and subcutaneous tissue

3142

6393

2.54

307.65

1.8

1.6

1.19

g/l

0.27

3017

6132

Other joint disorders

2822

6194

2.44

307.65

1.9

1.7

1.18

g/l

0.06

2703

5943

SLE, strict definition

853

393

58.12

307.65

7.7

1.3

1.04

1.21

g/l

19.26

829

373

Other specified/unspecified arthritis

1412

3075

4.98

307.65

1.9

1.6

1.20

1.19

g/l

1.11

1367

2947

Sicca syndrome [Sjögren]

1148

862

19.15

307.65

2.8

1.3

1.14

1.23

g/l

11.76

1129

823

Other arthritis (FG)

1592

3120

5.53

307.65

1.9

1.3

1.20

g/l

0.12

1541

2979

Second line medication for Crohn's disease

3320

8447

4.26

307.65

2.7

1.5

1.17

1.20

g/l

4.47

3209

8087

Other and unspecified vasculitis limited to skin

372

233

25.91

307.65

1.9

1.6

1.23

1.20

g/l

0.65

362

224

All pneumoniae

3474

10798

2.15

307.65

2.0

1.7

1.20

1.19

g/l

2.59

3329

10355

Systemic sclerosis

310

227

19.91

307.65

2.4

1.2

1.09

1.23

g/l

7.51

299

213

Asthma

2669

4799

2.97

307.65

1.7

1.23

1.18

g/l

12.05

2565

4609

Asthma, hospital admission 2, infections

2217

8946

2.51

307.65

1.7

1.8

1.23

1.18

g/l

14.97

2122

8562

Other systemic involvement of connective tissue (FG)

2674

2345

13.69

307.65

2.8

1.2

1.15

1.20

g/l

8.59

2602

2229

Other disorders of skin and subcutaneous tissue

2890

9275

2.75

307.65

2.2

1.6

1.18

1.19

g/l

2.28

2771

8872

Urticaria and erythema

1856

5658

3.52

307.65

2.0

1.8

1.19

g/l

0.35

1763

5428

Raynaud syndrome

819

1204

8.33

307.65

1.9

1.06

1.20

g/l

27.17

797

1141

Chronic kidney disease

1941

3053

6.79

307.65

1.9

1.5

1.16

1.18

g/l

2.08

1870

2892

Autoimmune diseases excluding thyroid diseases, strict definition

4683

6919

3.88

307.65

2.4

1.3

1.16

1.20

g/l

11.61

4512

6625

Heart failure, not strict

2719

6595

2.89

307.65

1.9

1.6

1.20

g/l

0.47

2610

6315

ILD, hospital admissions 1, main diag only

743

1435

5.77

307.65

1.9

1.5

1.20

1.18

g/l

0.76

723

1363

Other interstitial pulmonary diseases

812

1614

5.57

307.65

1.9

1.5

1.19

1.18

g/l

0.54

790

1536

Pain in joint

2555

4404

3.75

307.65

1.8

1.7

1.20

1.17

g/l

2.74

2445

4227

L04AX Other immunosuppressants

3261

8183

4.33

307.65

2.7

1.5

1.17

1.20

g/l

4.41

3152

7832

ILD medications: immunosuppressive drugs

4184

6293

6.62

307.65

2.7

1.3

1.17

1.19

g/l

3.81

4040

6022

Other and unspecified dermatitis

2429

7768

3.31

307.65

1.9

1.7

1.19

g/l

0.29

2339

7434

All kidney diseases

4080

9940

2.87

307.65

2.1

1.6

1.20

1.19

g/l

0.93

3937

9502

Abnormalities of breathing

3194

7444

2.53

307.65

1.9

1.7

1.22

1.18

g/l

7.63

3058

7150

Infections, IBD-co-morbidities

581

521

8.30

307.65

2.0

1.2

1.16

1.17

g/l

0.16

553

491

Asthma (only as main-diagnosis), excluding more controls

2486

4489

3.18

307.65

1.7

1.23

1.18

g/l

10.80

2385

4310

Malaise and fatigue

1738

4892

2.90

307.65

1.8

1.6

1.20

1.18

g/l

1.53

1658

4680

Pain in limb

2873

7822

2.41

307.65

1.9

1.8

1.21

1.18

g/l

6.04

2752

7491

Systemic connective tissue disorders

3855

3998

11.98

307.65

3.2

1.2

1.14

1.21

g/l

21.63

3739

3787

ILD medications: azathioprine

899

1277

7.89

307.65

4.3

1.3

1.13

1.19

g/l

4.39

874

1225

Cardiovascular diseases

2202

4167

2.91

307.65

2.1

1.8

1.18

1.16

g/l

2.40

2124

3997

General symptoms and signs

3894

7072

2.86

307.65

1.9

1.6

1.20

1.18

g/l

3.00

3736

6790

Acute renal failure

1211

2226

5.99

307.65

1.9

1.5

1.17

1.18

g/l

0.94

1166

2113

Vasculitis limited to skin, not elsewhere classified

396

268

23.27

307.65

1.9

1.6

1.23

1.20

g/l

0.70

386

257

First line medication for Crohn's disease

5170

7049

4.16

307.65

2.3

1.3

1.19

1.18

g/l

1.11

4949

6762

Asthma, unspecified (mode)

1861

4551

3.06

307.65

1.6

1.7

1.23

1.18

g/l

8.34

1794

4371

Glomerular diseases

1416

2130

7.80

307.65

3.1

1.6

1.16

1.20

g/l

2.25

1364

2029

Glomerulonephritis

715

1106

7.57

307.65

2.9

1.6

1.17

1.18

g/l

0.43

690

1047

Interstitial lung disease

812

1626

5.52

307.65

1.9

1.5

1.19

1.18

g/l

0.54

790

1547

Other respiratory diseases principally affecting the interstitium

932

1939

5.28

307.65

1.9

1.5

1.19

1.18

g/l

0.77

905

1849

Other peripheral vascular diseases

724

943

9.34

307.65

1.9

1.8

1.06

1.19

g/l

21.61

706

896

Inflammatory bowel disease treatment related agents

5694

7898

4.24

307.65

2.3

1.4

1.20

1.18

g/l

2.89

5458

7570

ILD, hospital admission 2, with pulmonary infections

560

889

7.05

307.65

1.9

1.4

1.20

1.18

g/l

0.40

542

846

Arthropathies

2927

6216

2.45

307.65

1.9

1.7

1.19

1.18

g/l

0.53

2810

5965

ILD medications: prednisolone, methylprednisolone, prednisone

5593

6738

4.91

307.65

2.3

1.3

1.19

g/l

0.61

5361

6445

Systemic sclerosis, icd10

310

289

15.65

304.89

2.4

1.7

1.09

1.21

g/l

6.17

299

276

Other heart diseases

1675

3897

2.90

301.73

2.1

1.7

1.20

1.16

g/l

5.24

1607

3745

Hypertensive diseases (excluding secondary)

1802

3841

2.83

300.68

2.2

1.7

1.24

1.16

g/l

18.01

1735

3681

Immunodeficiencies

414

561

9.12

299.77

2.2

1.6

1.18

1.20

g/l

0.62

388

532

Other septicaemia, including avohilmo

1352

4277

3.10

299.47

1.8

1.6

1.17

1.18

g/l

0.52

1292

4079

Aplastic and other anaemias

1623

5520

2.80

298.53

1.9

1.6

1.14

1.19

g/l

6.96

1541

5272

Other septicaemia

1324

4177

3.12

297.42

1.8

1.6

1.17

1.18

g/l

0.45

1266

3984

1743

6786

2.66

293.14

1.7

1.8

1.24

1.17

g/l

14.35

1671

6494

Abnormal findings on diagnostic imaging of lung

1659

5986

2.73

293.09

1.8

1.6

1.18

1.19

g/l

1.01

1584

5719

Viral Sepsis

893

2427

3.92

285.72

2.3

1.6

1.17

1.19

g/l

1.12

847

2314

Implicit viral Sepsis

889

2423

3.91

283.25

2.3

1.6

1.17

1.19

g/l

0.98

843

2310

Any gastric operation

2382

5068

2.42

282.45

1.9

1.6

1.20

1.17

g/l

2.72

2268

4898

GASTRO-related operations

2382

5068

2.42

282.45

1.9

1.6

1.20

1.17

g/l

2.72

2268

4898

Any reimbursement code in KELA

1830

3410

2.77

281.77

2.2

1.4

1.19

1.17

g/l

2.32

1753

3281

Pain, not elsewhere classified

1061

3245

3.43

281.62

1.8

1.6

1.21

1.18

g/l

2.33

1020

3109

Asthma (diagnoses ohter than nonallergic)

2960

11720

2.10

281.09

1.6

1.8

1.23

1.18

g/l

15.74

2836

11229

Certain infectious and parasitic diseases

2954

6936

2.19

278.86

2.0

1.6

1.19

1.18

g/l

0.53

2832

6661

Other and unspecified anaemias

1483

5147

2.82

277.19

1.9

1.6

1.15

1.19

g/l

5.23

1411

4904

Other anaemias

1491

5181

2.81

276.26

1.9

1.6

1.15

1.19

g/l

5.37

1419

4938

L04AD Calcineurin inhibitors

645

1429

5.07

275.96

3.0

1.6

1.12

1.19

g/l

6.48

617

1360

Pain in throat and chest

2658

7258

2.22

273.70

1.9

1.7

1.20

1.18

g/l

2.20

2556

6967

Fibromyalgia

571

1157

5.51

271.02

1.9

1.24

1.19

g/l

3.21

546

1095

Other diseases of pleura

1498

4857

2.79

270.26

2.1

1.5

1.15

1.19

g/l

5.45

1430

4623

Heart failure and antihypertensive medication

865

1399

4.23

270.03

1.9

1.6

1.18

1.16

g/l

1.11

827

1345

Other pulmonary diagnosis

2276

4851

2.41

268.20

1.9

1.7

1.20

1.18

g/l

2.31

2185

4661

Nephrotic syndrome

304

326

12.09

266.95

2.4

1.3

1.19

1.21

g/l

0.33

295

308

ILD, hospital admissions 3, with pneumonia sepsis

459

770

6.64

266.52

1.9

1.4

1.20

1.17

g/l

1.15

445

733

Excluding asthma or asthma-COPD overlap

2271

4851

2.40

266.35

1.9

1.7

1.20

1.18

g/l

2.18

2179

4661

Symptoms and signs involving the circulatory and respiratory systems

3064

7455

2.11

264.87

2.0

1.7

1.20

1.18

g/l

3.50

2937

7160

Secondary hypertension

412

615

7.28

261.73

3.0

1.6

1.13

1.18

g/l

1.96

392

584

COPD differential diagnosis

2258

4862

2.39

260.34

1.9

1.7

1.20

1.18

g/l

2.28

2165

4670

ILD differential diagnosis

2257

4860

2.38

260.16

1.9

1.7

1.20

1.18

g/l

2.29

2164

4668

Extracorporeal dialysis

414

650

7.47

259.71

2.0

1.5

1.06

1.19

g/l

10.46

395

620

Antihypertensive medication - note that there are other indications

2015

4326

2.51

259.67

2.2

1.7

1.20

1.15

g/l

10.29

1943

4154

Abnormal findings on examination of blood, without diagnosis

1608

5774

2.62

258.99

1.8

1.6

1.24

1.18

g/l

9.06

1538

5528

Heart failure,strict

1574

4176

2.73

258.46

1.8

1.5

1.17

1.20

g/l

2.71

1508

3992

Ulcer of lower limb, not elsewhere classified

639

1467

4.71

258.22

1.8

1.5

1.20

1.19

g/l

0.19

609

1393

Opioids

3018

7631

2.09

257.56

1.8

1.21

1.17

g/l

10.47

2881

7321

Codeine

2869

7540

2.11

252.54

1.8

1.22

1.17

g/l

14.48

2737

7230

Purpura and other haemorrhagic conditions

686

1699

4.41

252.30

2.6

1.6

1.14

1.19

g/l

3.09

649

1612

Other disorders of lacrimal gland

1437

5567

2.71

249.69

2.3

1.7

1.18

1.20

g/l

1.92

1388

5305

Disorders of thyroid, IBD co-morbidities

525

623

6.00

247.96

1.9

1.2

1.20

1.16

g/l

1.93

498

593

Other heart diseases, wide

2956

8967

2.05

247.56

1.9

1.7

1.20

1.19

g/l

0.88

2838

8594

Sulfasalazine

954

2960

3.37

247.15

1.6

1.4

1.20

1.18

g/l

0.61

908

2837

Medical observation and evaluation for suspected diseases and conditions

1941

4084

2.49

246.82

2.0

1.6

1.19

1.20

g/l

0.96

1875

3942

Symptoms and signs involving the skin and subcutaneous tissue

2448

11237

2.12

245.52

1.9

1.7

1.18

1.19

g/l

0.82

2354

10746

Asthma, hospital admissions , main diagnosis only

2695

11818

2.04

240.31

1.6

1.8

1.22

1.18

g/l

12.09

2583

11317

COPD/asthma/ILD related infections

3035

7661

2.03

237.86

2.0

1.7

1.20

1.18

g/l

3.96

2904

7355

COPD/asthma related infections

3035

7661

2.03

237.86

2.0

1.7

1.20

1.18

g/l

3.96

2904

7355

Diseases of arteries, arterioles and capillaries (FINNGEN)

811

1488

3.94

237.15

1.7

1.5

1.19

1.17

g/l

0.93

775

1424

Gout

867

2177

3.57

236.41

1.5

1.24

1.18

g/l

5.25

834

2077

Other disorders involving the immune mechanism, not elsewhere classified

298

371

10.21

232.77

2.0

1.5

1.20

g/l

0.07

285

355

Asthma-related pneumonia

1282

4834

2.75

232.32

1.7

1.22

1.17

g/l

6.61

1232

4598

Asthma-related pneumonia or sepsis

1283

4849

2.75

231.41

1.7

1.22

1.17

g/l

6.61

1233

4612

Asthma, hospital admissions 3, pneumonia

1283

4849

2.75

231.41

1.7

1.22

1.17

g/l

6.61

1233

4612

Polymyalgia rheumatica

533

1173

4.89

226.78

1.7

1.2

1.24

1.20

g/l

2.04

511

1101

Erysipelas, including avohilmo

2169

7543

2.19

226.25

1.7

1.6

1.22

1.19

g/l

5.63

2078

7220

Chronic lower respiratory diseases

3685

10681

1.86

225.92

1.7

1.8

1.22

1.18

g/l

11.74

3537

10228

Polyneuropathies and other disorders of the peripheral nervous system

865

2692

3.42

224.94

1.8

1.6

1.16

1.19

g/l

2.56

829

2561

Cerebrovascular diseases (FINNGEN)

1012

2280

3.24

224.23

2.0

1.6

1.22

1.17

g/l

5.04

971

2185

Seropositive rheumatoid arthritis, wide

1027

3545

3.06

223.28

2.1

1.6

1.16

1.20

g/l

3.69

991

3371

Low back pain

2450

8116

2.09

222.98

1.8

1.22

1.18

g/l

10.55

2346

7792

Dorsalgia

3007

8269

1.97

220.42

1.8

1.21

1.18

g/l

6.26

2879

7941

Other and unspecified polyneuropathies, also in other diseases

779

2303

3.61

220.22

1.8

1.6

1.15

1.19

g/l

2.34

747

2192

Disorders of lacrimal system

1599

6771

2.42

219.78

2.3

1.7

1.18

1.19

g/l

1.39

1545

6469

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

280

347

10.29

219.65

1.9

1.5

1.20

g/l

0.04

267

332

Enlarged lymph nodes

626

1596

4.17

219.02

2.8

1.7

1.18

g/l

0.01

611

1519

Hypothyroidism, strict autoimmune

1966

5824

2.27

218.63

1.9

1.3

1.20

g/l

0.30

1870

5572

Other diseases of pericardium

290

369

9.08

218.54

2.7

1.5

1.21

1.20

g/l

0.09

277

348

3388

9284

1.89

217.42

1.9

1.7

1.21

1.18

g/l

6.28

3240

8908

Soft tissue disorders

3006

8001

1.96

217.28

1.8

1.19

1.18

g/l

2.56

2895

7663

Other/unspecified seropositive rheumatoid arthritis

1005

3509

3.03

213.98

2.1

1.6

1.16

1.20

g/l

3.60

970

3336

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

993

3471

3.02

211.08

2.0

1.6

1.16

1.20

g/l

3.54

958

3299

Diseases of oesophagus, stomach and duodenum

3239

10422

1.87

210.78

1.9

1.7

1.19

g/l

0.25

3083

10003

Migraine

1824

6459

2.27

208.86

2.0

1.9

1.19

1.17

g/l

1.93

1744

6205

Bronchitis

3342

11093

1.84

207.85

2.0

1.7

1.21

1.18

g/l

4.90

3193

10639

Methotrexate

542

1296

4.46

207.09

2.4

1.4

1.17

1.18

g/l

0.18

525

1240

Codeine or tramadol medication

3374

10154

1.84

204.15

1.8

1.22

1.18

g/l

13.12

3214

9737

Hypertensive diseases

2364

6568

2.08

203.93

2.1

1.7

1.24

1.17

g/l

20.11

2267

6311

Asthma, including avohilmo

3549

11022

1.81

203.20

1.7

1.8

1.22

1.17

g/l

16.26

3406

10556

Hypertension

2358

6562

2.08

202.43

2.1

1.7

1.24

1.17

g/l

20.04

2262

6305

Immunodeficiency with predominantly antibody defects

258

321

10.39

202.29

2.2

1.7

1.16

1.20

g/l

0.85

246

304

Heart failure, strict

1672

5105

2.35

202.21

1.8

1.5

1.17

1.20

g/l

3.95

1603

4874

Dental caries

925

2989

3.06

200.05

2.1

1.6

1.16

1.19

g/l

1.39

889

2838

Cough

1330

5096

2.52

200.01

1.9

1.6

1.20

1.18

g/l

1.17

1280

4890

Polyarthrosis

720

1896

3.60

199.92

1.7

1.5

1.20

g/l

0.00

695

1811

Erysipelas

1612

6165

2.32

199.57

1.7

1.6

1.21

1.19

g/l

2.58

1535

5903

Hypertension, essential

2273

6335

2.08

195.66

1.9

1.7

1.25

1.17

g/l

29.91

2185

6089

Pleural effusion

599

1611

3.96

194.88

2.2

1.5

1.06

1.19

g/l

12.51

572

1540

All-cause Heart Failure

1632

5018

2.33

194.60

1.8

1.5

1.16

1.20

g/l

4.02

1568

4788

CR(E)ST syndrome

195

180

15.75

193.02

2.0

1.7

1.08

1.22

g/l

5.49

186

171

Caries of dentine

836

2678

3.16

191.92

2.1

1.6

1.17

1.19

g/l

0.91

803

2548

Gout, FINNGEN

867

2930

3.06

191.54

1.5

1.24

1.17

g/l

6.75

834

2785

Lower back pain or/and sciatica

3256

11422

1.81

191.45

1.8

1.22

1.18

g/l

12.10

3115

10946

Parasetamol

2019

4783

2.18

191.03

1.9

1.7

1.20

1.15

g/l

9.90

1938

4575

Osteopathies and chondropathies

1832

8032

2.15

189.58

2.1

1.7

1.18

1.19

g/l

0.66

1761

7681

Seronegative rheumatoid arthritis

425

932

4.87

181.26

1.9

1.2

1.18

1.20

g/l

0.66

409

880

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

917

1474

3.20

180.76

1.8

1.5

1.19

1.18

g/l

0.51

869

1421

Acute upper respiratory infections

3077

10415

1.81

178.96

1.9

1.7

1.21

1.18

g/l

6.23

2943

9986

Chronic nephritic syndrome

264

385

8.08

177.65

3.5

1.4

1.12

1.22

g/l

4.12

256

367

Complications of surgical and medical care, not elsewhere classified

2972

11217

1.80

176.15

1.9

1.7

1.19

g/l

0.45

2830

10757

Acute upper respiratory infections of multiple and unspecified sites

2383

9240

1.92

175.78

2.0

1.7

1.21

1.18

g/l

4.31

2276

8862

General examination and investigation of persons without complaint and reported diagnosis

1722

4083

2.24

174.97

1.9

1.6

1.19

1.20

g/l

0.93

1652

3941

Other diseases of intestines

3137

9946

1.79

174.80

1.8

1.20

1.18

g/l

1.72

3009

9541

Persons encountering health services for specific procedures and health care

3192

10826

1.77

174.44

1.8

1.18

1.19

g/l

0.58

3053

10381

Hard cardiovascular diseases

2399

7463

1.94

173.93

1.8

1.7

1.22

1.19

g/l

3.33

2301

7143

Hypothyroidism (congenital or acquired)

767

1306

3.40

171.30

2.1

1.9

1.20

1.12

g/l

7.69

732

1254

Biological medication for rheuma

771

2649

3.09

169.77

1.6

1.8

1.21

1.20

g/l

0.72

731

2541

Other special examinations and investigations of persons without complaint or reported diagnosis

1740

4084

2.20

169.45

1.9

1.6

1.18

1.20

g/l

1.99

1658

3942

Myalgia

868

3190

2.84

167.18

1.9

1.7

1.19

1.18

g/l

0.49

835

3050

Codes for special purposes

1719

8424

2.08

166.55

1.9

1.8

1.20

1.18

g/l

1.38

1654

8062

Hypothyroidism and >3 levothyroxin purchases

756

1302

3.36

166.32

2.0

1.9

1.20

1.12

g/l

8.40

722

1250

Hypothyroidism, levothyroxine purchases

756

1302

3.36

166.32

2.0

1.9

1.20

1.12

g/l

8.40

722

1250

Provisional assignment of new diseases of uncertain etiology

1714

8415

2.08

165.27

1.9

1.8

1.20

1.18

g/l

1.33

1650

8053

IgA nephropathy (IgA glomerulonephritis)

213

269

10.00

164.38

1.6

1.5

1.20

1.18

g/l

0.23

202

258

Intestinal infectious diseases

2817

11983

1.78

164.08

1.9

1.7

1.19

g/l

0.03

2686

11494

Complications of medical and surgical care

2244

10895

1.90

163.95

1.8

1.7

1.20

1.19

g/l

0.74

2125

10457

Pain (limb, back, neck, head abdominally)

1858

4496

2.11

162.65

1.8

1.7

1.20

1.17

g/l

2.71

1778

4316

Metabolic disorders

2740

9232

1.82

162.54

1.7

1.22

1.18

g/l

7.26

2609

8863

Other dorsopathies, not elsewhere classified

2843

8298

1.81

162.38

1.7

1.8

1.20

1.18

g/l

3.48

2717

7968

Cardiac arrhythmias

1826

5776

2.08

162.08

1.9

1.8

1.21

1.15

g/l

12.32

1749

5535

Disorders of eyelid, lacrimal system and orbit

2606

10716

1.82

161.94

2.0

1.7

1.18

1.19

g/l

0.38

2506

10256

Other (seronegative) rheumatoid arthritis, wide

720

2452

3.11

160.74

2.0

1.7

1.17

1.20

g/l

1.52

687

2323

Episodal and paroxysmal disorders

3080

9002

1.77

160.71

1.8

1.22

1.17

g/l

16.62

2955

8638

Covid-19 confirmed case

1211

5302

2.36

159.95

1.9

1.7

1.20

1.18

g/l

1.05

1161

5063

Spondylopathies

2190

6799

1.95

159.80

1.6

1.7

1.22

1.18

g/l

4.87

2102

6516

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1298

3539

2.38

158.41

2.1

1.7

1.20

1.16

g/l

3.82

1246

3389

Neurological diseases

2367

6338

1.91

157.91

1.8

1.21

1.17

g/l

6.55

2270

6083

Certain infectious and parasitic diseases, including avohilmo

1884

4640

2.07

157.59

1.9

1.6

1.19

1.18

g/l

0.68

1799

4451

Obesity related asthma

1163

5057

2.39

156.91

1.6

1.8

1.32

1.18

g/l

40.55

1119

4826

Undetermined asthma, excluding more controls

462

1201

4.05

156.86

1.7

1.6

1.25

1.19

g/l

2.76

448

1144

Other abnormal immunological findings in serum

204

260

10.08

156.79

2.0

1.5

1.18

1.20

g/l

0.35

195

247

Diarrhoea and gastroenteritis of presumed infectious origin

2150

10372

1.89

156.64

1.9

1.7

1.19

g/l

0.24

2056

9945

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2707

12210

1.76

152.34

2.2

1.7

1.17

1.19

g/l

2.43

2601

11696

Persons encountering health services in other circumstances, wide

3205

9761

1.72

152.06

1.8

1.7

1.20

1.18

g/l

1.17

3088

9328

Pericarditis

211

283

8.50

151.80

3.2

1.4

1.21

g/l

0.00

199

266

Transplanted organ and tissue status

443

1156

4.16

151.65

1.9

1.6

1.10

1.20

g/l

7.23

422

1101

Symptoms and signs involving the nervous and musculoskeletal systems

1786

9259

1.98

151.09

1.9

1.7

1.18

1.19

g/l

0.66

1720

8859

Giant cell arteritis

231

346

7.61

150.63

1.7

1.2

1.31

1.21

g/l

2.85

219

327

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3108

9759

1.72

150.10

1.8

1.7

1.19

1.18

g/l

0.83

2994

9326

Undetermined asthma

462

1241

3.92

149.75

1.7

1.6

1.25

1.19

g/l

3.28

448

1186

Haemorrhage from respiratory passages

972

3476

2.55

149.47

1.8

1.6

1.19

g/l

0.11

923

3323

Isolated proteinuria

227

342

8.08

149.44

3.2

1.5

1.21

1.19

g/l

0.25

222

328

Asthma/COPD (KELA code 203)

2751

10670

1.75

149.14

1.6

1.8

1.23

1.18

g/l

13.41

2634

10217

Atrial fibrillation and flutter

837

1946

2.86

148.53

1.8

1.6

1.23

1.17

g/l

4.52

803

1868

Disturbances of skin sensation

1007

4219

2.49

148.27

1.9

1.8

1.19

1.20

g/l

0.43

966

4053

Nerve, nerve root and plexus disorders

3030

10809

1.71

147.84

1.7

1.8

1.21

1.18

g/l

3.52

2896

10350

Nutritional anaemias

1499

7016

2.09

146.84

1.9

1.7

1.17

1.18

g/l

0.74

1431

6712

Acute tubulo-interstitial nephritis

1757

7636

1.99

146.64

1.9

1.7

1.20

1.19

g/l

0.86

1682

7302

Allergic asthma (mode), excluding more controls

719

2487

2.92

146.59

1.6

1.8

1.23

1.18

g/l

5.11

676

2394

Depression medications

802

1359

3.05

146.52

1.9

1.22

1.13

g/l

11.97

774

1306

Osteoporosis

859

3066

2.68

145.57

2.3

1.5

1.15

1.20

g/l

4.49

824

2896

STROKE

1526

4968

2.12

144.63

1.9

1.7

1.22

1.19

g/l

3.42

1459

4762

Other disorders of fluid, electrolyte and acid-base balance

951

3684

2.52

143.14

1.7

1.6

1.15

1.18

g/l

1.48

905

3525

Other and unspecified iron deficiency

1104

4869

2.34

143.14

1.9

1.7

1.18

g/l

0.24

1055

4646

Vocal cord dysfunction

400

854

4.29

143.13

1.8

1.2

1.18

g/l

0.03

374

821

Iron deficiency anaemia

1322

6150

2.17

142.96

1.9

1.7

1.18

1.19

g/l

0.47

1265

5883

Other general symptoms and signs

275

509

5.89

142.06

1.7

1.6

1.19

1.17

g/l

0.71

263

484

Sciatica+with lumbago

1544

6841

2.05

141.39

1.7

1.8

1.23

1.18

g/l

8.35

1474

6567

Hypertensive heart and/or renal disease

707

1784

2.99

140.34

1.6

1.5

1.20

1.15

g/l

2.66

676

1711

Allergic asthma (mode)

719

2551

2.85

139.84

1.6

1.8

1.23

1.17

g/l

5.67

676

2458

Diseases of the respiratory system

1642

4022

2.09

139.57

1.9

1.7

1.19

1.18

g/l

0.99

1560

3865

Acute sinusitis

1641

7680

1.99

139.33

1.9

1.8

1.21

1.18

g/l

2.48

1568

7364

Other headache syndromes

1331

6383

2.14

138.97

1.9

1.8

1.21

1.17

g/l

4.09

1277

6121

Intestinal infectious diseases, including avohilmo, including avohilmo

3218

10946

1.66

138.83

1.9

1.7

1.19

g/l

0.03

3082

10495

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2890

11102

1.70

138.53

1.9

1.7

1.19

g/l

0.15

2778

10643

Rheumatism, unspecified

514

1567

3.48

138.43

2.0

1.6

1.24

1.20

g/l

2.47

496

1487

Diseases of salivary glands

1110

4999

2.31

138.02

2.2

1.7

1.18

1.19

g/l

0.43

1075

4777

Diabetic nephropathy, excluding more controls

574

1482

3.36

137.90

1.6

1.22

1.28

g/l

3.26

550

1430

Gout, idiopatic and unspecified

748

2812

2.77

137.81

1.5

1.24

1.17

g/l

7.31

719

2686

Infections of the skin and subcutaneous tissue

1795

9454

1.91

137.32

2.1

1.7

1.20

1.19

g/l

0.99

1729

9074

Complications of procedures, not elsewhere classified

2348

10876

1.77

136.69

1.9

1.7

1.19

g/l

0.43

2233

10429

Other acute lower respiratory infections

1603

7892

1.98

135.44

1.9

1.7

1.21

1.18

g/l

2.84

1536

7555

Other specified/unspecified necrotizing vasculopathies

136

122

14.74

135.39

2.5

1.2

1.21

1.20

g/l

0.06

131

117

Gastro-oesophageal reflux disease

1966

9104

1.86

134.95

1.8

1.7

1.18

1.19

g/l

1.29

1876

8739

Idiopathic pulmonary fibrosis

308

667

5.00

134.20

1.8

1.5

1.19

1.16

g/l

0.95

300

632

Migraine with aura

914

3840

2.48

133.43

2.0

1.18

1.17

g/l

1.03

873

3694

Chronic sinusitis

1322

6455

2.11

132.36

1.8

1.22

1.19

g/l

2.72

1267

6205

Abnormal findings on examination of urine, without diagnosis

260

499

5.92

132.14

3.0

1.5

1.21

1.20

g/l

0.15

254

477

Kidney transplant status

285

593

5.40

131.78

2.1

1.5

1.05

1.20

g/l

10.06

272

560

Dorsopathies

2778

8345

1.71

130.76

1.7

1.8

1.20

1.18

g/l

2.98

2659

8014

Other diseases of blood and blood-forming organs, wide

768

3020

2.67

129.90

2.3

1.7

1.13

1.20

g/l

5.94

732

2885

Chronic rhinitis, nasopharyngitis and pharyngitis

1066

4836

2.28

129.83

1.8

1.21

1.18

g/l

2.54

1015

4649

Diseases of the eye and adnexa

2210

6162

1.83

129.30

1.9

1.7

1.18

1.19

g/l

0.45

2129

5916

Non-ischemic cardiomyopathy

873

2822

2.54

129.09

1.8

1.5

1.16

1.19

g/l

1.72

837

2687

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

250

471

5.94

129.07

1.9

1.6

1.18

1.17

g/l

0.14

241

443

Non-allergic asthma (mode), excluding more controls

537

1724

3.20

129.01

1.8

1.5

1.22

1.19

g/l

1.47

518

1645

Spondylosis

1492

5916

2.02

128.19

1.6

1.7

1.21

1.19

g/l

2.62

1430

5667

Other disorders of skin and subcutaneous tissue, not elsewhere classified

520

1672

3.29

128.13

2.1

1.6

1.17

1.20

g/l

1.23

495

1588

Ischemic heart diseases

2218

7478

1.80

128.06

1.8

1.7

1.22

1.20

g/l

2.42

2122

7164

Bacterial pneumoniae

1134

4600

2.22

128.04

2.0

1.6

1.21

1.19

g/l

1.26

1071

4390

Pulmonary heart disease, diseases of pulmonary circulation

943

4097

2.38

127.20

1.9

1.6

1.23

1.19

g/l

4.11

896

3898

Syncope and collapse

1113

4248

2.24

127.15

1.8

1.6

1.17

1.18

g/l

0.69

1067

4062

Idiopathic urticaria

191

285

8.20

127.06

1.7

1.6

1.23

1.19

g/l

0.97

183

268

Gastrointestinal diseases

1613

4072

2.02

126.72

2.0

1.7

1.19

1.18

g/l

0.11

1537

3926

Asthma and allergy

453

1322

3.54

126.70

1.7

1.8

1.24

1.16

g/l

5.72

427

1278

Temporal arteritis

194

292

7.54

125.91

1.8

1.2

1.28

1.20

g/l

2.27

184

274

Anxiety disorders

2616

10785

1.69

125.87

1.9

1.8

1.20

1.19

g/l

0.85

2504

10348

Viral infections characterized by skin and mucous membrane lesions

1311

6516

2.07

125.34

2.4

1.7

1.17

1.19

g/l

1.02

1260

6243

Neurotic, stress-related and somatoform disorders

2596

10744

1.70

125.15

1.9

1.8

1.20

1.19

g/l

0.80

2485

10308

Heart failure and coronary heart disease

1090

3438

2.28

124.78

1.7

1.5

1.16

1.18

g/l

0.97

1050

3270

Noninfective enteritis and colitis

1421

7278

2.00

124.37

1.7

1.8

1.20

1.19

g/l

0.65

1359

6983

Gout, unspecified

621

2238

2.90

124.32

1.5

1.25

1.17

g/l

7.56

594

2137

Percutaneous Coronary Intervention

2087

7135

1.82

124.13

1.7

1.6

1.22

1.20

g/l

1.98

1996

6837

Anxiety disorders, excluding more controls

2377

8894

1.74

124.01

1.9

1.7

1.20

1.19

g/l

2.02

2271

8544

Chronic ulcer of skin, not elsewhere classified

287

631

4.93

122.84

2.1

1.4

1.20

1.19

g/l

0.23

273

600

Hypothyroidism, drug reimbursement

446

868

3.73

122.75

1.9

1.8

1.21

1.12

g/l

6.66

426

835

Non-rheumatic valve diseases

1208

4085

2.16

122.34

1.9

1.5

1.14

1.21

g/l

10.82

1155

3899

Bacterial pneumonia, not elsewhere classified

1066

4301

2.24

122.07

2.0

1.6

1.21

1.19

g/l

1.24

1007

4106

Valvular heart disease excluding rheumatic fever

1215

4126

2.16

121.98

1.9

1.5

1.14

1.21

g/l

10.43

1161

3939

Non-allergic asthma (mode)

538

1789

3.09

121.67

1.8

1.5

1.22

1.19

g/l

2.14

519

1710

Tumor necrosis factor alpha inhibitors

642

2394

2.83

121.30

1.6

1.9

1.21

1.20

g/l

0.59

606

2294

Other and unspecified coagulation defects

290

656

4.95

121.29

3.7

1.8

1.15

1.19

g/l

1.28

281

624

Exposure to unspecified factor

2875

12145

1.64

121.15

1.8

1.21

1.18

g/l

3.70

2754

11640

Atrial fibrillation and flutter with reimbursement

641

1403

2.97

120.64

1.7

1.5

1.23

1.17

g/l

3.39

616

1341

Coronary revascularization (ANGIO or CABG)

2076

7142

1.80

120.41

1.7

1.6

1.22

1.20

g/l

2.20

1986

6842

Diabetic nephropathy

577

2015

3.00

120.37

1.6

1.5

1.23

1.26

g/l

1.79

553

1936

Implicit fungal Sepsis, including avohilmo

319

776

4.46

120.26

1.7

1.6

1.20

1.19

g/l

0.24

301

740

Gout, strict definition

560

1947

3.01

119.95

1.5

1.25

1.17

g/l

7.45

535

1859

Other intervertebral disc disorders

2193

7527

1.77

119.53

1.6

1.8

1.21

1.18

g/l

4.54

2083

7216

Arthrosis

1688

4874

1.93

119.36

1.7

1.6

1.21

1.19

g/l

2.67

1627

4667

Asthma and allergy, excluding more controls

453

1374

3.40

119.29

1.7

1.8

1.24

1.17

g/l

5.05

427

1322

Gonarthrosis [arthrosis of knee](FG)

1554

4609

1.97

118.35

1.6

1.2

1.23

1.20

g/l

2.54

1494

4394

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

399

1154

3.72

117.49

1.6

1.8

1.22

1.19

g/l

1.55

375

1103

Osteoporosis with pathological fracture (FG)

243

481

5.39

117.16

2.2

1.2

1.14

1.21

g/l

2.02

235

450

Venous thromboembolism

1472

7492

1.94

116.73

1.9

1.6

1.22

1.19

g/l

2.44

1408

7159

Heart failure and bmi 25plus

920

2633

2.40

116.56

1.7

1.5

1.21

1.25

g/l

3.10

879

2515

Secondary right heart disease

218

399

6.13

116.23

1.8

1.5

1.19

1.18

g/l

0.10

210

383

Psoriatic and enteropathic arthropathies

367

1006

3.84

115.81

1.6

1.2

1.24

1.21

g/l

1.14

354

956

Other/unspecified dorsalgia

1091

5150

2.15

115.64

1.7

1.8

1.22

1.18

g/l

3.81

1038

4937

Acute bronchitis

1207

5877

2.07

115.36

1.9

1.7

1.21

1.18

g/l

3.36

1158

5622

Symptoms and signs concerning food and fluid intake

362

990

3.84

114.31

2.0

1.6

1.14

1.17

g/l

1.13

346

938

Oxycodone

1041

4151

2.20

114.17

1.7

1.6

1.22

1.17

g/l

4.23

988

3963

Bacterial pneumonia (organism specified)

1224

5527

2.06

113.74

2.0

1.6

1.20

1.18

g/l

1.44

1157

5273

Major coronary heart disease event

2174

7581

1.75

113.73

1.7

1.22

1.20

g/l

2.74

2083

7259

Preparatory care for dialysis

235

472

5.62

113.42

1.8

1.5

1.09

1.18

g/l

3.30

225

450

Other and unspecified immunodeficiencies with predominantly antibody defects

137

162

11.56

112.97

1.9

1.6

1.16

1.20

g/l

0.71

128

155

Other symptoms and signs involving the nervous and musculoskeletal systems

1273

6504

2.01

112.87

2.0

1.7

1.18

1.19

g/l

0.68

1229

6224

Genitourinary diseases

1389

3465

2.05

112.84

1.8

1.5

1.19

g/l

0.03

1347

3305

Emergency coronary revascularization (for ACS)

2188

7741

1.74

112.49

1.7

1.6

1.21

1.20

g/l

1.55

2094

7407

All influenza

774

3260

2.45

112.04

1.9

1.6

1.19

1.18

g/l

0.39

736

3118

Other pleural conditions

354

973

3.86

111.71

2.1

1.5

1.09

1.19

g/l

4.72

341

922

Symptoms and signs involving cognition, perception, emotional state and behaviour

2679

11163

1.63

110.76

1.8

1.7

1.19

g/l

0.00

2533

10728

Allergic purpura

198

349

6.57

110.75

1.7

1.6

1.22

1.20

g/l

0.29

186

334

Symptoms and signs involving the digestive system and abdomen

2574

7843

1.67

110.24

1.8

1.7

1.20

1.18

g/l

1.87

2462

7529

Abnormalities of heart beat

996

4538

2.18

109.89

2.0

1.6

1.17

1.18

g/l

0.41

954

4349

Disorders of conjunctiva

2417

11489

1.66

109.85

1.9

1.8

1.19

g/l

0.46

2332

11003

Other pulmonary heart/vessel disease

225

446

5.59

109.64

1.8

1.5

1.19

1.18

g/l

0.21

217

430

Other arthrosis

1253

4182

2.05

109.39

1.7

1.6

1.21

1.19

g/l

1.62

1205

4000

Other coagulation defects

345

952

3.93

109.30

3.4

1.8

1.15

1.18

g/l

1.22

335

905

Migraine without aura

739

3094

2.49

109.02

1.9

2.0

1.20

1.16

g/l

2.18

708

2982

Atopic dermatitis

1706

7602

1.82

108.98

1.9

1.8

1.19

g/l

0.24

1637

7294

Abdominal and pelvic pain

2562

7843

1.66

108.68

1.8

1.7

1.20

1.18

g/l

3.09

2447

7529

Shoulder lesions

1917

6547

1.79

108.33

1.7

1.21

1.18

g/l

4.24

1836

6260

Coxarthrosis [arthrosis of hip](FG)

1115

3679

2.12

108.05

1.7

1.2

1.22

1.20

g/l

0.72

1070

3507

Visual disturbances and blindness

1522

8348

1.87

108.00

1.9

1.7

1.20

1.19

g/l

1.07

1464

7988

Bleeding

2170

9085

1.70

107.42

1.8

1.7

1.19

g/l

0.15

2066

8713

Spondylopathies (FG)

408

1267

3.36

105.98

1.7

1.2

1.22

1.20

g/l

0.82

392

1207

Other and unspecified drugs and medicaments

369

1087

3.66

105.76

1.6

1.8

1.22

1.19

g/l

1.17

345

1038

Endocrine, nutritional and metabolic diseases

2096

6166

1.74

105.21

1.9

1.8

1.22

1.14

g/l

26.52

2009

5914

Other noninfective gastroenteritis and colitis

794

3480

2.36

105.17

1.8

1.20

1.19

g/l

0.22

766

3329

Seropositive rheumatoid arthritis, strict definition

533

1947

2.89

104.79

1.7

1.16

1.20

g/l

2.13

512

1848

Other disorders of urethra and urinary system

1977

8063

1.74

104.73

1.8

1.7

1.20

1.18

g/l

1.55

1870

7730

Wegener granulomatosis

125

142

10.97

104.64

2.7

1.1

1.25

1.21

g/l

0.43

117

137

Diseases of liver

1019

4951

2.12

104.18

1.8

1.7

1.21

1.20

g/l

0.52

966

4747

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2711

10846

1.60

104.08

1.8

1.18

1.19

g/l

1.83

2596

10399

Depression

2655

11216

1.61

104.04

1.8

1.21

1.19

g/l

4.22

2541

10770

Visual disturbances

1433

7817

1.88

104.04

1.9

1.7

1.20

1.19

g/l

1.13

1381

7479

Conjunctivitis

2214

10889

1.67

103.13

1.9

1.8

1.19

g/l

0.54

2136

10423

Hypertensive Renal Disease

166

260

6.99

102.95

1.4

1.17

1.13

g/l

0.59

158

246

Persons encountering health services for examination and investigation

1531

4084

1.91

102.91

1.9

1.6

1.18

1.20

g/l

1.39

1456

3942

Dysphagia

732

3128

2.42

102.70

1.8

1.6

1.18

g/l

0.01

708

2990

Mood disorders, excluding more controls

2529

9254

1.63

102.56

1.8

1.7

1.21

1.18

g/l

5.24

2413

8887

Dermatographic urticaria

319

875

3.96

102.06

1.7

1.9

1.19

1.18

g/l

0.24

301

831

Explicit bacterial Sepsis

360

1062

3.57

101.87

2.4

1.6

1.16

1.19

g/l

0.97

343

1019

Mycoses

880

4081

2.23

101.83

1.9

1.7

1.19

g/l

0.11

849

3907

Explicit bacterial Sepsis, including avohilmo

368

1103

3.51

101.56

2.4

1.6

1.15

1.19

g/l

1.07

351

1054

Other functional intestinal disorders

1282

6143

1.94

101.29

1.8

1.7

1.19

1.18

g/l

0.20

1226

5886

Budesonide

423

1380

3.20

101.18

1.6

1.4

1.20

1.18

g/l

0.48

400

1321

Irritable bowel syndrome

885

4123

2.22

101.10

1.7

1.8

1.19

g/l

0.09

850

3947

DVT of lower extremities and pulmonary embolism

1115

5629

2.02

100.78

1.9

1.6

1.22

1.19

g/l

1.88

1061

5370

Other arrhythmias

1702

7246

1.79

100.71

1.8

1.7

1.19

1.20

g/l

0.82

1636

6943

Thrombocytopenia, unspecified

300

795

4.07

100.55

2.7

1.6

1.10

1.19

g/l

4.32

281

761

Migraine with aura and triptan purchases

631

2567

2.58

99.72

1.9

2.1

1.20

1.18

g/l

0.70

606

2465

Other diseases of upper respiratory tract

2827

9421

1.59

99.59

1.7

1.20

1.18

g/l

2.12

2692

9042

Mood [affective] disorders

2781

11473

1.58

99.46

1.8

1.21

1.18

g/l

4.71

2656

11015

Giant cell arteritis with polymyalgia rheumatica

194

371

5.90

98.92

1.8

1.5

1.28

1.17

g/l

3.85

184

352

Diseases of the digestive system

1233

6460

1.94

98.76

1.8

1.7

1.16

1.19

g/l

1.74

1176

6181

Mood disorders

2783

11481

1.57

98.75

1.8

1.21

1.18

g/l

4.85

2658

11022

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1667

9466

1.76

98.08

1.9

1.7

1.19

g/l

0.34

1580

9080

Disorders of skin appendages

1499

8403

1.82

97.57

2.1

1.8

1.19

g/l

0.11

1427

8069

Nausea and vomiting

794

3493

2.28

97.41

1.8

1.7

1.18

1.17

g/l

0.35

754

3352

Vasomotor and allergic rhinitis

1140

5759

1.98

97.19

1.6

1.9

1.20

1.18

g/l

1.22

1082

5546

Care involving use of rehabilitation procedures

1746

9203

1.74

96.89

1.9

1.7

1.21

1.19

g/l

0.92

1655

8812

Candidiasis, including avohilmo

980

4831

2.10

96.61

2.0

1.8

1.19

g/l

0.03

940

4624

Symptoms and signs involving the urinary system

1998

9133

1.68

94.84

1.8

1.7

1.18

1.19

g/l

0.64

1902

8765

Sleep apnoea

2516

10106

1.59

94.14

1.7

1.28

1.17

g/l

53.05

2410

9678

Other CVD (FINNGEN)

320

664

3.83

94.08

1.7

1.6

1.19

1.17

g/l

0.56

300

630

Peripheral artery disease

1018

3982

2.07

93.94

1.6

1.5

1.18

g/l

0.04

978

3784

Other nutritional deficiencies

1943

10815

1.67

93.49

1.7

1.8

1.32

1.17

g/l

82.83

1871

10369

Liquid cancers

833

3690

2.20

92.91

1.7

1.6

1.15

1.19

g/l

3.23

801

3503

Other diseases of urinary system

2595

9332

1.58

92.50

1.9

1.7

1.19

g/l

0.40

2478

8964

Pulmonary embolism

810

3781

2.21

91.88

1.9

1.6

1.24

1.19

g/l

4.40

768

3602

5-aminosalicylic acid

555

2204

2.60

91.24

1.6

1.4

1.20

1.18

g/l

0.84

525

2120

Disorders resulting from impaired renal tubular function

194

402

5.43

90.35

2.0

1.6

1.13

1.20

g/l

2.29

184

383

Pulmonary heart disease

810

3809

2.19

90.18

1.9

1.6

1.24

1.19

g/l

4.49

768

3627

Other reaction to severe stress, and adjustment disorders

1127

5961

1.94

90.04

2.2

1.9

1.20

1.19

g/l

0.55

1085

5723

Disorders of the thyroid gland

2499

10446

1.57

89.46

1.9

1.8

1.21

1.18

g/l

3.65

2380

10016

Zoster [herpes zoster], including avohilmo

1406

7685

1.80

89.41

2.3

1.6

1.17

1.19

g/l

1.80

1360

7345

Atherosclerosis, excluding cerebral and coronary sclerosis

945

3643

2.08

89.30

1.6

1.5

1.18

g/l

0.11

905

3461

Disorders of sclera, cornea, iris and ciliary body

1538

8972

1.75

88.75

1.9

1.7

1.20

1.19

g/l

0.17

1473

8598

Disorders of lipoprotein metabolism and other lipidaemias

2041

7617

1.65

88.30

1.6

1.7

1.25

1.19

g/l

15.26

1944

7302

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2504

10231

1.57

87.96

1.9

1.7

1.18

1.19

g/l

1.05

2399

9794

Dizziness and giddiness

2012

9711

1.64

87.48

1.7

1.19

g/l

0.18

1912

9328

Adalimumab

404

1406

3.05

87.36

1.5

1.9

1.21

1.20

g/l

0.32

381

1343

Streptococcal septicaemia, including avohilmo

301

876

3.62

87.16

2.2

1.5

1.18

g/l

0.05

284

838

Lumbar disc prolapse

1648

7185

1.73

87.04

1.6

1.7

1.21

1.18

g/l

3.04

1571

6895

Streptococcal septicaemia

295

849

3.67

86.91

2.3

1.5

1.18

g/l

0.01

278

812

Fungal Sepsis

195

417

5.13

86.86

1.8

1.5

1.19

g/l

0.01

185

398

Paroxysmal tachycardia

579

1959

2.53

86.61

1.8

1.7

1.19

1.17

g/l

0.90

556

1873

Rosacea

479

1832

2.75

86.26

2.4

1.8

1.17

1.19

g/l

0.93

462

1748

Other and unspecified rosacea

370

1236

3.19

86.17

2.4

1.8

1.17

1.20

g/l

1.07

355

1178

Anxiety (asthma-related co-morbidities)

1747

7982

1.69

85.99

1.8

1.20

1.19

g/l

0.90

1675

7664

Sleep apnoea, including avohilmo

2619

10376

1.55

85.92

1.7

1.27

1.17

g/l

56.99

2509

9932

All anxiety disorders

1789

8407

1.68

85.89

1.8

1.20

1.19

g/l

0.55

1713

8058

Other bacterial intestinal infections

550

2250

2.54

85.38

1.9

1.7

1.16

1.19

g/l

1.58

517

2147

Sleep disorders (combined)

2851

9895

1.52

84.87

1.7

1.8

1.22

1.17

g/l

17.71

2733

9468

Persons encountering health services in other circumstances

1149

6167

1.89

84.63

2.0

1.7

1.18

g/l

0.02

1119

5899

Acquired haemolytic anaemia

151

266

6.57

84.62

3.7

1.4

1.00

1.19

g/l

9.03

144

254

Other skin changes

602

2580

2.42

84.37

1.8

1.7

1.19

g/l

0.23

579

2453

Disorders of synovium and tendon

1381

6669

1.79

84.17

1.7

1.19

1.18

g/l

0.70

1335

6377

Somatoform disorder

558

2320

2.51

83.99

1.8

1.20

g/l

0.12

525

2215

Other/unspecified rheumatoid arthritis

405

1438

2.96

83.99

2.0

1.6

1.13

1.19

g/l

3.82

380

1373

Continuous positive airway pressure

479

1505

2.73

83.94

1.7

1.5

1.25

1.16

g/l

6.24

449

1446

Rotator cuff syndrome

1503

5978

1.76

83.75

1.6

1.22

1.19

g/l

3.98

1437

5713

Cerebrovascular diseases

1801

7587

1.67

83.53

1.8

1.6

1.21

1.19

g/l

1.09

1725

7261

Hypothyroidism, other/unspecified

2338

9923

1.57

83.36

1.8

1.20

1.18

g/l

3.14

2217

9517

Atopic dermatitis, strict definition with reimbursement

898

4332

2.05

83.18

1.8

1.9

1.19

1.18

g/l

0.03

863

4161

ILD and respiratory illness in diseases classified elsewhere

19.42

82.99

2.9

1.3

1.23

1.20

g/l

0.27

Other antidepressants

2608

8711

1.55

82.91

1.8

1.21

1.17

g/l

7.91

2511

8358

Early onset COPD, excluding more controls

457

1728

2.72

82.72

1.7

1.4

1.21

1.19

g/l

0.57

436

1647

Hypothyreosis and Thyroxine purchase for inclusion criteria

2435

10413

1.55

82.50

1.9

1.8

1.20

1.18

g/l

2.89

2311

9990

Other disorders of kidney and ureter

428

1581

2.84

82.37

1.8

1.6

1.16

1.20

g/l

1.25

411

1507

Hypermobility syndrome

238

618

4.17

82.34

1.9

1.3

1.21

1.22

g/l

0.31

227

582

Haemolytic anaemias

179

376

5.31

81.91

3.4

1.5

1.02

1.21

g/l

10.75

171

357

Spondyloarthritis

498

1980

2.60

81.90

1.7

1.3

1.22

1.20

g/l

0.54

478

1886

Implicit fungal Sepsis

182

388

5.16

81.46

1.8

1.6

1.18

1.19

g/l

0.07

172

371

Hypertensive Heart Disease

544

1663

2.55

81.34

1.7

1.5

1.20

1.15

g/l

2.79

516

1597

Other bacterial intestinal infections, including avohilmo

684

3142

2.25

81.02

1.8

1.7

1.16

1.19

g/l

1.47

641

3002

Other anxiety disorders

1376

6759

1.77

80.29

1.8

1.9

1.20

1.19

g/l

1.49

1322

6490

Diverticular disease of intestine

1737

6538

1.68

80.23

1.7

1.6

1.21

1.20

g/l

0.69

1661

6259

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1362

7612

1.76

79.75

1.8

1.7

1.21

1.19

g/l

2.07

1279

7313

Disorders of other endocrine glands

1243

6925

1.81

79.64

2.0

1.7

1.20

1.19

g/l

0.87

1184

6632

Conjunctivitis (acute, non atopic), including avohilmo

2605

10466

1.52

79.47

2.0

1.7

1.19

g/l

0.36

2496

10026

L04AC Interleukin inhibitors

287

873

3.54

78.44

1.8

1.7

1.25

1.21

g/l

1.09

276

829

Kela reimbursement Agammaglobulinemia (D80-84)

115

11.39

78.41

2.1

1.5

1.22

1.20

g/l

0.16

110

Primary_lymphoid and hematopoietic malignant neoplasms

648

2963

2.26

77.70

1.8

1.6

1.16

1.19

g/l

1.21

625

2821

19.92

77.41

3.0

1.3

1.24

1.20

g/l

0.36

Follow-up examination after treatment for conditions other than malignant neoplasms

1031

3607

1.94

77.41

1.9

1.6

1.19

1.20

g/l

0.39

977

3483

COPD (mode)

619

2115

2.33

77.38

1.5

1.4

1.18

1.19

g/l

0.37

593

2011

Other diseases of lip and oral mucosa

1192

6734

1.81

77.32

1.9

1.7

1.17

1.20

g/l

1.67

1143

6452

Other viral diseases, including avohilmo

1137

6276

1.84

76.97

2.1

1.8

1.18

1.19

g/l

0.12

1089

6042

Diseases of the myoneural junction and muscle

393

1439

2.86

76.86

2.7

1.6

1.16

1.19

g/l

1.15

378

1371

Mycoses, including avohilmo

2445

12423

1.52

76.74

1.9

1.7

1.19

g/l

0.21

2353

11895

Cystitis

2195

8438

1.57

76.38

2.0

1.7

1.19

1.18

g/l

0.79

2102

8095

Zoster [herpes zoster]

549

2364

2.41

76.16

2.6

1.6

1.17

1.19

g/l

1.02

531

2230

Allergic rhinitis

935

4859

1.95

76.04

1.6

1.9

1.20

1.18

g/l

1.28

890

4704

Sequelae of external causes of morbidity and mortality

739

3588

2.12

75.99

1.6

1.7

1.22

1.19

g/l

1.35

708

3420

Hernia of abdominal wall, postoperative

446

1730

2.63

75.70

1.5

1.21

1.19

g/l

0.63

419

1671

Depression or dysthymia

1673

5523

1.68

75.18

1.7

1.21

1.18

g/l

4.14

1603

5302

Viral pneumonia

398

1484

2.79

74.91

2.2

1.5

1.20

g/l

0.09

387

1416

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1514

9183

1.68

74.66

1.9

1.7

1.19

g/l

0.31

1432

8800

Recurrent or chronic depression

1099

4166

1.87

74.14

1.9

1.8

1.22

1.19

g/l

3.61

1060

4010

Bacterial intestinal infections, IBD co-morbidities

545

2369

2.38

73.97

1.9

1.7

1.16

1.20

g/l

1.47

514

2253

Concussion

1219

5362

1.79

73.88

1.8

1.19

1.17

g/l

1.77

1162

5149

Intracranial trauma

1382

5450

1.74

73.74

1.8

1.20

1.17

g/l

2.12

1319

5231

Hyperkalaemia

203

508

4.25

73.36

1.5

1.17

1.16

g/l

0.30

189

490

Convulsions, not elsewhere classified

557

2415

2.33

72.99

2.0

1.6

1.16

1.18

g/l

0.61

523

2316

Allergic urticaria

314

1053

3.16

72.54

2.0

1.9

1.25

1.18

g/l

3.52

305

999

Type 2 diabetes, wide definition

1919

7697

1.60

72.47

1.5

1.7

1.29

1.17

g/l

52.62

1849

7346

Chronic gastritis

682

3268

2.14

72.35

1.8

1.6

1.17

1.20

g/l

1.55

654

3112

Liquid cancers, including Hilmo

940

4411

1.92

72.27

1.7

1.6

1.15

1.20

g/l

3.93

905

4197

Cutaneous abscess, furuncle and carbuncle

763

3817

2.06

72.23

2.0

1.7

1.20

1.19

g/l

0.67

734

3652

Ischaemic heart disease, wide definition

1808

6989

1.62

71.77

1.8

1.6

1.22

1.20

g/l

2.02

1730

6696

Urinary track infection

1710

5252

1.66

71.73

2.0

1.8

1.19

g/l

0.24

1646

5028

Dermatitis due to substances taken internally

208

540

4.12

71.70

2.8

1.8

1.15

1.19

g/l

0.79

201

514

Pain in thoracic spine

467

1929

2.51

71.10

1.9

1.8

1.19

g/l

0.01

449

1841

Hyperlipidaemia, other/unspecified

918

4385

1.92

70.95

1.6

1.22

1.18

g/l

3.86

870

4202

Enterocolitis due to Clostridium difficile

333

1167

2.99

70.62

1.8

1.6

1.16

1.19

g/l

0.71

315

1108

Subjective visual disturbances

753

3783

2.05

70.57

2.1

1.7

1.21

1.19

g/l

0.63

726

3609

Migraine without aura and triptan purchases

585

2676

2.27

70.57

1.8

2.0

1.19

1.18

g/l

0.39

562

2576

Diagnoses used for exclusion with ILD

672

3235

2.14

70.55

1.7

1.6

1.21

1.19

g/l

1.09

649

3083

Triptan medication for migraine, min. 3 purchases

1659

7741

1.63

70.42

1.9

1.19

g/l

0.50

1595

7439

Rash and other nonspecific skin eruption

341

1217

2.96

70.31

2.2

1.8

1.17

1.19

g/l

0.45

328

1160

Cardiomyopathy

418

1653

2.61

69.41

1.6

1.5

1.18

1.20

g/l

0.56

397

1566

Obesity and other hyperalimentation

1760

10603

1.59

69.19

1.6

1.8

1.34

1.17

g/l

98.21

1695

10163

Obesity

1753

10568

1.59

69.17

1.6

1.8

1.34

1.17

g/l

98.95

1688

10130

Gonarthrosis

1324

4347

1.74

69.09

1.6

1.23

1.19

g/l

5.74

1270

4162

Juvenile arthritis (FINNGEN)

181

439

4.42

68.49

2.8

1.2

1.14

1.20

g/l

1.35

176

411

Spinal stenosis

1146

4810

1.79

68.12

1.5

1.6

1.21

1.19

g/l

1.84

1095

4595

Other disorders of white blood cells

220

618

3.84

68.03

2.0

1.7

1.15

1.19

g/l

0.94

210

588

Bronchiectasis

257

798

3.41

67.48

1.8

1.5

1.17

1.18

g/l

0.25

248

756

Symptoms and signs involving speech and voice

913

4973

1.88

66.98

1.9

1.7

1.19

g/l

0.03

870

4737

Other diseases of the respiratory system

527

2359

2.30

66.56

1.6

1.22

1.18

g/l

2.01

499

2244

Other respiratory disorders and diseases

527

2359

2.30

66.56

1.6

1.22

1.18

g/l

2.01

499

2244

Disorders of lens

1595

6143

1.64

66.48

2.0

1.6

1.19

1.21

g/l

0.83

1526

5889

Other neurological diseases

1757

8744

1.58

66.42

1.7

1.19

g/l

0.29

1672

8371

Pure hypercholesterolaemia

1755

7087

1.59

66.41

1.6

1.7

1.25

1.19

g/l

14.08

1670

6797

Insulin, combination of fast acting with intermediate-acting or long-acting

1482

8338

1.64

66.33

1.5

1.7

1.24

1.18

g/l

9.84

1418

7983

Other viral diseases

851

4538

1.92

65.98

2.1

1.8

1.18

1.19

g/l

0.27

815

4360

Reactive arthropathies, FINNGEN

215

603

3.75

65.93

2.7

1.2

1.23

1.20

g/l

0.73

208

572

Hypo-osmolality and hyponatraemia

464

1960

2.42

65.78

1.9

1.6

1.12

1.18

g/l

3.98

442

1866

Other enthesopathies

772

4007

1.97

65.42

1.7

1.21

1.19

g/l

1.22

743

3830

Papulosquamous disorders

1046

5974

1.79

65.41

1.6

1.7

1.24

1.19

g/l

4.78

1007

5714

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1528

9212

1.62

65.13

1.9

1.8

1.19

g/l

0.13

1464

8815

Unspecified haematuria

1004

4569

1.82

64.97

1.7

1.6

1.19

g/l

0.15

960

4371

Fibrosis and cirrhosis of liver

267

869

3.26

64.97

1.5

1.6

1.17

1.19

g/l

0.45

254

830

Idiopathic thrombocytopenic purpura

154

347

4.94

64.86

4.0

1.5

1.11

1.19

g/l

2.27

146

332

Insulin, fast-acting

933

5164

1.85

64.67

1.5

1.7

1.20

1.18

g/l

1.42

894

4946

Myocarditis

157

355

4.68

64.64

2.1

1.6

1.18

g/l

0.06

151

340

Coxarthrosis

1018

3640

1.83

64.37

1.7

1.5

1.21

1.19

g/l

1.62

975

3480

Insulin medication

1482

7668

1.63

64.06

1.5

1.8

1.24

1.16

g/l

16.82

1418

7343

Temporomandibular joint disorders, including avohilmo

1320

7814

1.67

63.83

2.0

1.9

1.18

1.19

g/l

0.77

1262

7490

Peripheral artery operations in Hilmo

323

1173

2.85

63.73

1.6

1.5

1.18

1.17

g/l

0.01

311

1114

Functional dyspepsia

737

3810

1.99

63.47

1.8

1.7

1.21

1.20

g/l

0.28

698

3641

Amputation

281

952

3.08

63.22

1.6

1.5

1.18

1.17

g/l

0.19

267

900

Noninfectious colitis NAS

428

1798

2.48

63.05

2.0

1.8

1.20

1.19

g/l

0.22

419

1722

Other gastritis (incl. Duodenitis)

577

2740

2.17

62.87

1.7

1.6

1.17

1.20

g/l

1.35

547

2613

Soft tissue disorders related to use, overuse and pressure

694

3526

2.02

62.71

1.8

1.6

1.21

1.19

g/l

1.08

660

3363

Anaemia in chronic diseases classified elsewhere

122

233

5.86

62.31

2.1

1.5

1.03

1.18

g/l

4.59

112

222

Inflammatory bowel disease

869

4769

1.87

62.23

1.6

1.8

1.21

1.19

g/l

0.97

827

4581

Allergic conjunctivitis

1595

9873

1.58

61.94

1.9

1.8

1.20

1.19

g/l

0.32

1528

9456

Reactive arthropathies

257

838

3.21

61.93

2.7

1.5

1.22

1.19

g/l

0.64

247

795

Thyroiditis, ILD-related definition

350

1349

2.71

61.89

2.2

1.3

1.18

1.20

g/l

0.54

340

1282

Constipation

2245

10408

1.48

61.17

1.8

1.7

1.19

g/l

0.05

2142

9980

Hypothyroidism, strict autoimmune, 3 medication purchases required

2148

9791

1.49

61.13

1.8

1.21

1.18

g/l

2.99

2045

9390

Other complications of surgical and medical care, not elsewhere classified

335

1274

2.76

61.11

1.8

1.20

1.19

g/l

0.17

323

1216

Meniscus derangement

1126

4341

1.75

61.05

1.6

1.21

1.19

g/l

1.04

1083

4149

Any mental disorder

2677

9384

1.44

60.92

1.8

1.7

1.20

1.18

g/l

2.89

2560

9008

Candidiasis

461

2034

2.36

60.81

2.0

1.8

1.17

1.18

g/l

0.28

444

1937

Childhood asthma (age<16), excluding more controls

360

1074

2.69

60.75

1.9

1.17

1.16

g/l

0.37

340

1046

Psoriatic arthropathies

287

1008

2.97

60.59

1.6

1.5

1.25

1.20

g/l

2.17

276

962

Cervicalgia

553

2624

2.17

60.39

1.7

1.8

1.19

g/l

0.19

532

2501

Insulin, intermediate and long-acting

1301

7741

1.65

60.34

1.4

1.7

1.24

1.18

g/l

9.16

1243

7404

Benign neoplasm of colon, rectum, anus and anal canal

1491

7997

1.60

60.20

1.7

1.6

1.19

g/l

0.01

1433

7637

Insulin, fast-acting or short human

935

5295

1.80

60.03

1.5

1.7

1.20

1.18

g/l

1.11

896

5068

Triptan medication for migraine, single purchase ok

2013

9179

1.51

59.72

1.9

1.8

1.19

1.20

g/l

0.58

1938

8806

Migraine, single triptan purchase ok & required. ICD-code if available is included

2013

9179

1.51

59.72

1.9

1.8

1.19

1.20

g/l

0.58

1938

8806

Other diseases of arteries and capillaries

279

975

3.00

59.65

1.8

1.6

1.18

1.20

g/l

0.31

262

927

Childhood asthma (age<16)

360

1086

2.66

59.46

1.9

1.17

1.16

g/l

0.43

340

1058

Small fibre neuropathy

145

334

4.82

59.41

2.2

1.5

1.13

1.21

g/l

2.39

140

317

Carpal tunnel syndrome

1546

8611

1.58

59.26

1.6

1.7

1.21

1.19

g/l

2.28

1492

8247

Pain and other conditions associated with female genital organs and menstrual cycle

663

2802

2.04

59.18

2.0

1.9

1.17

1.19

g/l

1.15

632

2676

Other viral diseases, not elsewhere classified, including avohilmo

791

4258

1.89

59.11

2.1

1.8

1.18

g/l

0.28

755

4097

Voice disturbances

744

3972

1.93

58.37

1.9

1.8

1.19

1.20

g/l

0.11

712

3782

Autoimmune hepatitis, wide definition

152

364

4.44

58.36

2.3

1.2

1.18

1.24

g/l

1.27

142

345

Cervical disc disorders

854

4750

1.83

58.30

1.6

1.7

1.21

1.19

g/l

1.53

814

4557

Dentofacial anomalies [including malocclusion]

1907

10056

1.51

57.72

1.8

1.18

1.19

g/l

0.93

1815

9659

Diaphragmatic hernia

894

5061

1.81

57.67

2.0

1.6

1.20

g/l

0.14

849

4837

Other or ill-defined heart diseases

173

460

3.96

57.40

2.0

1.6

1.16

1.21

g/l

1.06

164

438

Coronary atherosclerosis

1389

5459

1.63

57.32

1.8

1.6

1.20

g/l

0.14

1331

5226

Iridocyclitis

622

3148

2.03

57.18

1.9

1.7

1.20

g/l

0.11

602

3011

Cellulitis

608

3053

2.05

57.09

2.1

1.7

1.23

1.19

g/l

2.29

587

2917

Pruritus

349

1397

2.60

57.09

2.0

1.8

1.19

1.18

g/l

0.06

334

1331

440

1954

2.33

57.02

1.9

1.7

1.24

1.19

g/l

2.58

415

1868

Peripheral arterial reconstruction

399

1696

2.42

56.92

1.5

1.18

1.16

g/l

0.30

384

1610

Internal derangement of knee

806

4388

1.85

56.79

1.8

1.6

1.21

1.19

g/l

1.42

765

4208

Obesity due to excess calories

1304

8217

1.62

56.00

1.6

1.9

1.34

1.17

g/l

73.01

1258

7882

Collagenous colitis

310

1190

2.74

55.63

1.9

1.8

1.20

1.19

g/l

0.17

296

1137

Other diseases of liver

528

2548

2.14

55.51

1.8

1.7

1.25

1.20

g/l

2.17

501

2439

Benign neoplasm: Colon

1259

7379

1.63

55.32

1.7

1.6

1.20

1.19

g/l

0.10

1210

7044

Factors influencing health status and contact with health services

591

1404

2.14

54.84

1.6

1.5

1.19

1.21

g/l

0.40

562

1351

Diabetes mellitus

2538

10416

1.42

54.76

1.6

1.8

1.28

1.16

g/l

63.14

2433

9968

Chronic apical periodontitis

2777

11228

1.40

54.75

1.8

1.20

1.18

g/l

1.62

2678

10739

Etanercept

250

867

3.06

54.69

1.6

1.8

1.21

1.19

g/l

0.31

236

823

Major coronary heart disease event excluding revascularizations

1271

5185

1.64

54.67

1.7

1.6

1.21

1.20

g/l

0.98

1212

4958

Later onset COPD, excluding more controls

388

1231

2.46

54.40

1.4

1.16

1.18

g/l

0.35

370

1159

Diabetes, varying definitions

2523

10407

1.42

54.14

1.6

1.8

1.28

1.16

g/l

63.98

2418

9961

Disorders of choroid and retina

1884

8951

1.49

53.90

1.8

1.7

1.18

1.20

g/l

2.02

1815

8557

Inflammatory diseases of the central nervous system

279

1035

2.84

53.57

3.7

1.7

1.17

1.19

g/l

0.33

265

983

Cervicobrachial syndrome

581

2939

2.03

53.37

1.6

1.8

1.20

1.19

g/l

0.20

554

2808

Drug-induced cataract

124

278

5.01

52.79

3.3

1.6

1.14

1.22

g/l

1.79

118

264

Crohn disease

404

1793

2.34

52.60

1.6

1.9

1.21

1.19

g/l

0.79

385

1718

Respiratory insufficiency

190

570

3.44

52.03

1.7

1.4

1.21

1.19

g/l

0.45

177

539

Sarcoidosis

388

1702

2.37

51.97

1.7

1.22

1.20

g/l

0.71

376

1626

Inflammatory diseases of female pelvic organs

1731

7973

1.51

51.82

1.9

1.18

1.19

g/l

0.96

1645

7642

Pollen allergy

591

3001

2.00

51.71

1.7

1.9

1.18

g/l

0.26

563

2899

Conjunctivitis (acute, non atopic)

779

4365

1.82

51.41

2.0

1.8

1.20

1.19

g/l

0.13

752

4190

Primary biliary cholangitis, wide definition

168

6.12

51.28

1.7

1.2

1.23

1.24

g/l

0.08

158

Stroke, excluding SAH

1322

6076

1.59

51.24

1.7

1.6

1.21

1.19

g/l

1.37

1264

5810

Amputation of toe

210

683

3.23

51.07

1.7

1.5

1.17

1.18

g/l

0.18

203

651

Adrenocortical insufficiency

161

447

3.92

50.99

1.6

1.29

1.19

g/l

3.12

150

426

COPD

937

4490

1.72

50.22

1.6

1.18

g/l

0.04

895

4261

Type 2 diabetes

2390

9882

1.41

50.19

1.6

1.8

1.29

1.16

g/l

72.15

2294

9461

Weight loss

308

1238

2.60

50.17

2.0

1.6

1.13

1.19

g/l

2.49

296

1177

Sequelae of other external causes

204

662

3.27

50.05

1.5

1.7

1.22

1.20

g/l

0.37

195

630

Enthesopathies of lower limb, excluding foot

585

3034

1.98

49.99

1.7

1.8

1.23

1.19

g/l

2.24

558

2907

Acute generalized exanthematous pustulosis

178

534

3.58

49.90

2.9

1.7

1.17

1.19

g/l

0.49

171

508

Phlebitis and thrombophlebitis (not including DVT)

587

3056

1.97

49.72

2.1

1.7

1.20

g/l

0.21

562

2916

Idiopathic gout

254

931

2.85

49.69

1.5

1.4

1.24

1.17

g/l

2.70

248

886

Use of hypnotics and sedatives

2589

10727

1.39

49.68

1.8

1.7

1.19

g/l

0.29

2482

10281

Fall on same level

2850

11163

1.37

49.62

1.8

1.20

1.18

g/l

1.86

2735

10700

Senile cataract

1373

5363

1.58

49.60

1.8

1.6

1.19

1.20

g/l

0.68

1314

5136

Deforming dorsopathies

686

3753

1.87

49.54

1.8

1.19

g/l

0.01

651

3592

Benign neoplasms

2372

9213

1.42

49.38

1.8

1.20

1.18

g/l

1.15

2271

8852

Other infectious diseases, including avohilmo

270

1031

2.73

48.84

2.2

1.7

1.21

1.18

g/l

0.69

255

975

Benzodiazepine use

2472

12097

1.39

48.82

1.7

1.8

1.20

1.19

g/l

2.05

2354

11604

Abnormal results of function studies

284

1114

2.67

48.75

1.9

1.6

1.20

g/l

0.10

275

1061

GI-bleeding

724

4047

1.82

48.67

1.7

1.6

1.17

1.18

g/l

0.64

686

3858

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1240

6203

1.59

48.48

1.4

1.7

1.28

1.16

g/l

28.35

1185

5922

Herpesviral [herpes simplex] infections, including avohilmo

728

4091

1.82

48.46

2.1

1.8

1.17

1.19

g/l

1.14

702

3922

Sequelae with surgical and medical care as external cause

534

2718

2.02

48.43

1.7

1.21

1.19

g/l

1.07

512

2584

Volume depletion

248

908

2.83

48.42

1.6

1.5

1.16

1.17

g/l

0.24

234

868

Stroke, including SAH

1388

6496

1.55

48.40

1.8

1.6

1.21

1.19

g/l

1.32

1326

6219

Disorders of parathyroid gland

513

2542

2.05

48.33

2.1

1.6

1.17

1.20

g/l

0.93

484

2408

Non-selective monoamine reuptake inhibitors

892

5078

1.72

48.31

1.6

1.7

1.23

1.18

g/l

4.47

845

4862

Abnormal weight loss

285

1127

2.64

48.10

2.1

1.6

1.13

1.19

g/l

2.29

274

1073

Other viral diseases, not elsewhere classified

527

2672

2.02

47.88

2.1

1.8

1.17

1.18

g/l

0.56

504

2568

Other disorders of adrenal gland

182

569

3.43

47.80

1.6

1.7

1.28

1.19

g/l

2.79

171

542

Trochanteric bursitis

386

1750

2.27

47.54

1.7

1.6

1.22

1.19

g/l

0.89

369

1655

Disorders of muscles

280

1101

2.64

47.53

1.9

1.7

1.22

1.19

g/l

0.84

274

1042

Statin medication

1662

6305

1.50

47.42

2.0

1.8

1.23

1.15

g/l

21.99

1598

6046

Scleritis and episcleritis

232

837

2.94

47.29

2.3

1.9

1.23

1.19

g/l

1.11

221

798

Presence of other functional implants

1320

5853

1.56

47.10

1.7

1.6

1.18

1.20

g/l

1.16

1259

5585

Coeliac disease

366

1635

2.33

47.01

2.3

1.8

1.14

1.19

g/l

2.91

353

1564

Other encephalitis

129

325

4.36

46.98

5.3

1.6

1.10

1.19

g/l

2.97

123

312

Other infectious diseases

226

804

2.94

46.91

2.2

1.6

1.19

g/l

0.08

214

766

Other disorders of eye and adnexa

435

2085

2.16

46.78

1.8

1.21

1.19

g/l

0.77

418

1985

Ischaemic Stroke, excluding all haemorrhages

1216

5723

1.59

46.53

1.7

1.6

1.21

1.19

g/l

1.68

1158

5466

Other diseases of the digestive system

718

4060

1.80

46.48

1.7

1.6

1.16

1.18

g/l

1.09

681

3872

Hypokalaemia

331

1422

2.41

46.40

1.6

1.7

1.20

1.18

g/l

0.49

313

1357

Exposure to other specified factors

2028

12409

1.42

46.15

1.9

1.7

1.19

g/l

0.23

1947

11899

Diseases of the ear and mastoid process

2808

10416

1.36

46.12

1.9

1.8

1.19

g/l

0.08

2681

9995

Disorders of mineral metabolism

256

980

2.73

46.12

1.7

1.18

g/l

0.11

245

947

Osteomyelitis

202

683

3.11

46.07

1.8

1.5

1.21

1.19

g/l

0.35

196

652

Other diseases of anus and rectum

710

3998

1.80

46.01

1.9

1.6

1.18

1.19

g/l

0.52

676

3815

Oxicams

520

1449

2.08

45.88

1.9

1.20

1.15

g/l

2.54

498

1383

Anterior Iridocyclitis

542

2827

1.97

45.82

1.9

1.8

1.19

1.20

g/l

0.15

522

2704

Other external causes of accidental injury

1936

6749

1.45

45.69

1.8

1.19

1.18

g/l

0.51

1852

6493

Dermatopolymyositis, unspecified

12.82

45.62

1.9

1.1

1.13

1.25

g/l

1.76

Myocardial infarction

983

4190

1.66

45.24

1.7

1.6

1.21

1.19

g/l

0.76

941

4003

Other inflammation of eyelid, including avohilmo

1164

7517

1.57

44.95

2.0

1.8

1.19

g/l

0.21

1121

7197

Encephalitis

132

349

4.13

44.93

5.2

1.6

1.10

1.20

g/l

3.26

126

335

Acute and subacute iridocyclitis

507

2605

2.00

44.80

1.9

1.7

1.20

g/l

0.08

488

2492

Nonorganic sleeping disorders, excluding more controls

558

2965

1.93

44.44

1.9

1.8

1.19

1.18

g/l

0.35

536

2853

Other retinal disorders

1426

7255

1.51

44.36

1.8

1.6

1.17

1.19

g/l

1.65

1369

6927

Chronic diseases of tonsils and adenoids

1881

8330

1.44

44.34

1.7

1.8

1.19

g/l

0.08

1801

8015

Presence of cardiac and vascular implants and grafts

898

3968

1.69

44.26

1.7

1.5

1.17

1.19

g/l

1.47

851

3781

Atopic dermatitis, strict definition

842

4937

1.70

44.23

1.8

1.9

1.18

g/l

0.01

809

4758

Other disorders of veins

1021

6325

1.62

44.00

1.7

1.19

1.20

g/l

0.43

981

6032

Stomatitis and related lesions

553

2947

1.93

43.83

2.0

1.8

1.17

1.19

g/l

0.70

527

2819

Recurrent aphthous stomatitis , including avohilmo

419

2030

2.13

43.78

2.1

1.8

1.17

1.19

g/l

0.39

403

1938

Conduction disorders

615

2676

1.87

43.72

1.6

1.17

1.20

g/l

2.05

580

2534

Hallux valgus (acquired)

680

2711

1.82

43.44

1.7

1.6

1.15

1.19

g/l

2.64

645

2588

Abnormalities of gait and mobility

322

1410

2.37

43.30

1.6

1.5

1.19

1.18

g/l

0.11

312

1344

Generalized skin eruption due to drugs and medicaments

154

462

3.58

43.26

3.0

1.6

1.14

1.20

g/l

1.32

147

438

Unspecified acute lower respiratory infection

408

1969

2.13

42.92

1.8

1.7

1.22

1.19

g/l

1.58

388

1878

IBD patients in KELA-register

602

3324

1.85

42.52

1.6

1.8

1.19

g/l

0.03

574

3195

Disorders of gallbladder, biliary tract and pancreas

2350

10739

1.38

42.42

1.8

1.7

1.25

1.18

g/l

24.66

2250

10288

Monoarthritis, not elsewhere classified

132

362

3.85

42.12

1.3

1.5

1.20

1.19

g/l

0.19

126

344

Erythema multiforme

108

259

4.60

42.08

2.8

1.4

1.14

1.19

g/l

0.88

102

246

Selective serotonin reuptake inhibitors

2310

8758

1.38

42.02

1.8

1.21

1.17

g/l

7.27

2207

8403

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

140

403

3.73

41.90

2.4

1.6

1.20

1.21

g/l

0.19

135

380

Pacemaker

744

4058

1.73

41.76

1.5

1.6

1.17

1.18

g/l

0.55

700

3853

Other disorders of patella

397

1918

2.12

41.49

1.8

1.7

1.20

1.19

g/l

0.20

374

1841

Neoplasms

1855

6856

1.43

41.40

1.9

1.8

1.19

1.18

g/l

0.45

1784

6603

Accidents

1906

6749

1.43

41.38

1.9

1.8

1.19

1.18

g/l

0.55

1823

6493

Agranulocytosis

325

1460

2.31

41.31

2.7

1.7

1.10

1.19

g/l

5.35

310

1394

Diplopia

365

1716

2.20

41.30

1.7

1.20

1.19

g/l

0.22

356

1629

Other dermatomyositis

12.44

41.26

1.6

1.1

1.13

1.25

g/l

1.28

Unspecified privation

308

1356

2.36

41.01

1.8

1.7

1.18

g/l

0.03

295

1290

Herpesviral [herpes simplex] infections

345

1593

2.24

40.92

2.1

1.7

1.19

g/l

0.14

330

1514

Valvular operations

296

1279

2.37

40.75

1.8

1.4

1.16

1.20

g/l

1.34

283

1206

Paracetamol or NSAID medication

353

771

2.35

40.62

1.5

1.9

1.19

1.13

g/l

2.63

343

740

Other chronic obstructive pulmonary disease

867

4345

1.66

40.52

1.6

1.18

g/l

0.11

827

4125

Angina pectoris

1129

4842

1.57

40.46

1.7

1.6

1.21

1.19

g/l

0.76

1079

4631

Other diseases of intestine

385

1860

2.13

40.37

1.8

1.5

1.20

g/l

0.04

372

1770

Psoriasis

694

4061

1.74

40.10

1.6

1.7

1.26

1.19

g/l

6.29

668

3885

Misadventures to patients during surgical and medical care

389

1896

2.12

39.99

1.8

1.7

1.21

1.19

g/l

0.69

370

1812

Disorders of calcium metabolism

196

705

2.91

39.98

1.7

1.6

1.16

1.18

g/l

0.29

187

681

Ocular pain

279

1193

2.44

39.92

1.8

1.9

1.22

1.19

g/l

0.89

267

1135

Adjustment and management of implanted device

396

1941

2.09

39.82

1.5

1.17

1.18

g/l

0.18

373

1834

Psychiatric diseases

2248

8239

1.38

39.82

1.8

1.7

1.21

1.18

g/l

2.94

2163

7896

864

4797

1.65

39.80

1.7

1.5

1.16

1.19

g/l

1.64

816

4561

Other erythematous conditions

132

378

3.74

39.80

2.1

1.6

1.24

1.19

g/l

1.04

127

361

Exclusions for E4_PCOS_BROAD

480

2524

1.95

39.63

1.8

1.23

1.18

g/l

2.47

461

2419

Coxibs

597

1687

1.88

39.62

1.7

1.9

1.20

1.15

g/l

3.86

565

1615

Crohn's disease NAS

212

800

2.78

39.54

1.7

1.8

1.22

1.19

g/l

0.44

204

762

Other cataract

968

4539

1.61

39.45

2.0

1.6

1.19

1.20

g/l

0.78

926

4338

Ulcerative colitis

616

3504

1.80

39.38

1.6

1.8

1.21

1.19

g/l

0.53

582

3365

Viral and other specified intestinal infections, including avohilmo

722

4120

1.72

39.36

1.9

1.19

1.18

g/l

0.22

691

3969

Ulcerative colitis, NAS

385

1884

2.11

39.18

1.6

1.8

1.19

g/l

0.21

365

1803

Lichen simplex chronicus and prurigo

183

642

2.98

39.07

1.5

1.7

1.23

1.19

g/l

0.93

173

613

All influenza (not pneumonia)

365

1751

2.14

38.97

1.9

1.6

1.18

1.20

g/l

0.35

343

1671

Other symptoms and signs involving cognitive functions and awareness

1043

5990

1.57

38.96

1.8

1.6

1.18

1.19

g/l

0.61

976

5742

Inflammatory bowel disease, strict (require KELA)

602

3418

1.80

38.80

1.6

1.8

1.19

g/l

0.01

574

3286

Amyloidosis

211

4.80

38.73

1.6

1.17

1.15

g/l

0.22

204

Suggestive for eosinophilic asthma

253

1048

2.51

38.71

1.6

1.7

1.22

1.19

g/l

0.90

247

999

Obesity, other/unspecified

901

5691

1.61

38.59

1.6

1.9

1.35

1.17

g/l

56.14

862

5470

Missing teeth due to accident, extraction or parodontitis

1410

8706

1.46

38.44

1.8

1.7

1.19

g/l

0.18

1349

8331

Radiculopathy

371

1801

2.11

38.36

1.6

1.7

1.21

1.19

g/l

0.69

357

1710

Special screening examination for infectious and parasitic diseases

553

2207

1.86

37.74

1.9

1.7

1.14

1.20

g/l

4.13

528

2139

Drug-induced adrenocortical insufficiency

101

255

4.45

37.11

1.8

1.6

1.31

1.20

g/l

2.71

247

AV-block

346

1397

2.16

37.06

1.5

1.17

1.20

g/l

1.21

324

1316

Irregular menses

1324

6816

1.48

37.02

2.3

1.9

1.19

g/l

0.07

1271

6532

Progressive systemic sclerosis

10.67

36.94

3.3

1.5

1.07

1.15

g/l

0.71

Other symptoms and signs involving the circulatory and respiratory systems

186

680

2.84

36.67

2.1

1.5

1.21

1.19

g/l

0.33

174

651

Localized swelling, mass and lump of skin and subcutaneous tissue

752

4601

1.66

36.66

1.9

1.7

1.17

1.19

g/l

1.11

724

4400

Viral warts

291

1318

2.29

36.29

2.9

1.8

1.15

1.18

g/l

1.24

283

1250

Persons encountering health services for specific procedures, not carried out

257

1104

2.42

36.29

1.6

1.9

1.22

1.19

g/l

1.16

245

1049

Other and unspecified disorders of skin and subcutaneous tissue

184

677

2.84

36.01

2.4

1.7

1.12

1.19

g/l

2.30

177

647

Pneumonia due to other infectious organisms, not elsewhere classified

117

331

3.77

35.91

2.1

1.5

1.18

1.19

g/l

0.17

112

315

Injuries to the ankle and foot

1797

11189

1.39

35.89

1.9

1.8

1.20

1.19

g/l

0.79

1729

10726

Chronic laryngitis and laryngotracheitis

356

1756

2.09

35.44

1.9

1.7

1.16

1.19

g/l

1.09

337

1683

Gastroduodenal ulcer

530

2963

1.81

35.40

1.7

1.6

1.18

1.19

g/l

0.11

502

2832

Other embolism and thrombosis

325

1551

2.16

35.37

2.4

1.6

1.17

1.19

g/l

0.43

311

1472

Other inflammatory liver diseases

197

758

2.72

35.36

2.2

1.6

1.18

1.20

g/l

0.32

186

723

Calcific aortic valvular stenosis, diagnosis (helper)

571

3148

1.78

35.25

1.6

1.5

1.17

g/l

0.05

540

2980

Operations 2 for CAVS

571

3148

1.78

35.25

1.6

1.5

1.17

g/l

0.05

540

2980

Cardiomyopathy, other and unspecified

188

706

2.76

35.17

1.6

1.5

1.16

1.22

g/l

1.53

178

665

Cytomegaloviral disease, including avohilmo

107

291

4.02

35.15

2.4

1.6

1.11

1.20

g/l

1.75

101

280

Cardiomyopathies, Primary/intrinsic

256

1111

2.37

35.04

1.5

1.4

1.19

1.20

g/l

0.21

238

1052

Falls/tendency to fall

2552

9724

1.33

35.03

1.8

1.20

1.18

g/l

1.89

2452

9327

Calcific aortic valvular stenosis, including rheumatic fever

573

3165

1.77

35.01

1.6

1.5

1.17

g/l

0.07

542

2997

Other and unspecified erythematous conditions

120

352

3.65

34.96

2.2

1.6

1.24

1.18

g/l

1.21

115

335

Other inflammation of eyelid

376

1903

2.03

34.88

2.1

1.6

1.18

1.20

g/l

0.67

359

1802

Injury, poisoning and certain other consequences of external causes

1237

4173

1.50

34.79

1.9

1.8

1.18

g/l

0.08

1184

4016

Other shoulder lesions

251

1086

2.39

34.76

1.9

1.7

1.24

1.20

g/l

1.36

238

1028

Cytomegaloviral disease

106

289

4.01

34.71

2.5

1.6

1.11

1.20

g/l

1.68

100

278

Calcific aortic valvular stenosis, operated

571

3163

1.77

34.69

1.6

1.5

1.17

g/l

0.04

540

2994

Calcific aortic valvular stenosis

571

3163

1.77

34.69

1.6

1.5

1.17

g/l

0.04

540

2994

Abnormal findings on diagnostic imaging of other body structures

369

1861

2.04

34.58

1.8

1.7

1.21

1.20

g/l

0.16

351

1772

Myocardial infarction, strict

865

3874

1.60

34.54

1.7

1.5

1.21

1.19

g/l

0.79

826

3697

Non-invasive ventilation

504

2402

1.84

34.54

1.6

1.7

1.23

1.15

g/l

7.47

448

2317

Other disorders of bone

498

2771

1.84

34.46

1.8

1.7

1.21

1.19

g/l

0.50

472

2654

Keratitis

853

5463

1.59

34.40

2.0

1.7

1.20

1.19

g/l

0.17

813

5232

Other epidermal thickening

144

477

3.18

34.22

2.0

1.5

1.16

1.21

g/l

1.08

136

453

Diseases of pulp and periapical tissues, including avohilmo

2433

9548

1.33

34.21

1.7

1.8

1.21

1.17

g/l

5.68

2338

9140

Other symptoms and signs involving the digestive system and abdomen

413

2171

1.95

34.14

2.0

1.7

1.19

g/l

0.09

392

2079

Protozoal diseases

118

349

3.66

34.10

2.0

1.5

1.16

1.18

g/l

0.33

113

333

Non-Hodgkin lymphoma, all, including Hilmo

308

1461

2.17

34.04

1.8

1.6

1.14

1.19

g/l

1.82

299

1383

Allergic contact dermatitis

343

1695

2.08

33.99

1.6

1.8

1.20

1.19

g/l

0.28

325

1619

Injuries to the knee and lower leg

2822

11836

1.30

33.96

1.8

1.21

1.18

g/l

4.86

2716

11322

Other Crohn's disease

216

887

2.54

33.88

1.7

1.8

1.21

1.19

g/l

0.41

204

846

Hyperkinetic disorders, excluding more controls

359

1677

2.05

33.82

1.7

2.0

1.16

g/l

0.08

345

1618

External causes of morbidity and mortality

1489

5240

1.44

33.66

1.9

1.8

1.18

g/l

0.08

1421

5058

Cardiomyopathy (excluding other)

263

1176

2.29

33.57

1.5

1.4

1.19

1.21

g/l

0.22

245

1113

Other enthesopathy of foot (+metatarsalgia)

272

1240

2.26

33.29

2.0

1.7

1.20

1.19

g/l

0.25

264

1176

Hypotension

372

1903

2.00

33.27

1.7

1.5

1.18

1.17

g/l

0.12

349

1804

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2134

9502

1.34

33.24

1.5

1.8

1.28

1.16

g/l

55.98

2047

9105

Neuralgia and neuritis, unspecified

153

533

3.00

33.17

1.7

1.22

1.19

g/l

0.42

145

502

Chronic tubulo-interstitial nephritis

119

358

3.51

33.14

1.6

1.8

1.15

1.19

g/l

0.44

114

342

Cytomegalovirus infection, IBD co-morbidity

103

285

3.96

33.06

2.5

1.6

1.11

1.20

g/l

1.65

274

Diabetic retinopathy, excluding more controls

604

1950

1.77

33.05

1.4

1.6

1.21

1.29

g/l

8.16

579

1878

Type 2 diabetes, definitions combined

2160

9456

1.34

32.98

1.6

1.8

1.31

1.16

g/l

85.37

2071

9057

Nonsuppurative otitis media, including avohilmo

804

4418

1.60

32.81

2.1

1.9

1.18

g/l

0.09

778

4252

Viral warts, including avohilmo

568

3332

1.74

32.72

2.4

1.7

1.16

1.19

g/l

1.64

541

3198

Type 2 diabetes, strict (exclude DM1)

2170

9521

1.34

32.65

1.6

1.8

1.31

1.16

g/l

85.58

2081

9122

Metatarsalgia

253

1129

2.31

32.64

2.0

1.7

1.20

1.19

g/l

0.15

245

1072

Multiple myeloma, including Hilmo

132

428

3.25

32.53

1.7

1.14

1.17

g/l

0.50

126

403

Seborrhoeic dermatitis

242

1061

2.35

32.52

2.0

1.7

1.17

1.18

g/l

0.33

235

1012

Protozoal diseases, including avohilmo

118

361

3.52

32.31

2.0

1.5

1.16

1.18

g/l

0.34

113

344

Haemorrhage, not elsewhere classified

101

277

3.81

32.21

2.1

1.5

1.17

1.19

g/l

0.36

266

Vascular disorders of the intestines

171

641

2.76

32.13

2.0

1.5

1.14

1.18

g/l

0.92

162

602

Other hammer toe(s) (acquired)

334

1505

2.06

32.11

1.7

1.5

1.17

1.20

g/l

1.19

320

1436

Diseases of tongue

173

654

2.75

32.07

2.1

1.6

1.19

1.20

g/l

0.18

162

618

Other specified/unspecified soft tissue disorders

136

453

3.14

31.90

2.0

1.6

1.26

1.21

g/l

1.32

131

428

COPD, hospital admission 2, with asthma infections

636

3310

1.68

31.72

1.6

1.18

g/l

0.03

603

3153

Scleritis

166

5.03

31.70

1.9

1.4

1.24

1.23

g/l

0.11

160

Ovarian cyst

872

3202

1.58

31.67

1.8

1.19

1.20

g/l

0.01

839

3053

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1569

10425

1.39

31.64

1.7

1.8

1.18

1.19

g/l

0.58

1511

9988

Complications of internal orthopaedic prosthetic devices, implants and grafts

483

2730

1.80

31.64

1.7

1.6

1.23

1.19

g/l

2.10

456

2586

Other/unspecified synovitis and tenosynovitis

279

1311

2.19

31.62

2.1

1.7

1.18

1.20

g/l

0.46

269

1241

Other CVD

428

2335

1.87

31.48

1.7

1.5

1.18

g/l

0.09

402

2210

Myocardial infarction, without ST-elevation

765

4384

1.60

31.39

1.6

1.5

1.20

1.18

g/l

0.85

732

4174

Other diseases of oesophagus

230

1002

2.37

31.38

2.2

1.6

1.16

1.20

g/l

1.02

220

957

Sequelae of cerebrovascular disease

729

3904

1.62

31.38

2.0

1.6

1.19

1.18

g/l

0.54

698

3718

Open wound of lower leg

387

2051

1.93

31.35

2.1

1.7

1.17

1.19

g/l

0.53

376

1954

Crohn's disease of small intestine

210

884

2.48

31.23

1.7

1.9

1.19

g/l

0.06

203

843

Injuries to the thorax

1000

6756

1.50

31.21

1.7

1.20

1.19

g/l

0.26

956

6462

Actinic keratosis

752

4337

1.60

31.19

1.6

1.5

1.15

1.18

g/l

1.95

710

4124

Dermatophytosis

347

1778

2.01

31.15

1.9

1.6

1.19

g/l

0.01

338

1695

Type 1 diabetes

585

3497

1.70

31.14

1.6

1.8

1.15

1.16

g/l

0.19

557

3353

Iron deficiency anaemia secondary to blood loss (chronic)

371

1943

1.95

31.10

1.8

1.6

1.15

1.19

g/l

1.50

352

1836

Haemorrhoids and perianal venous thrombosis

729

4573

1.61

31.08

1.6

1.19

g/l

0.29

708

4364

DVT of lower extremities

424

2319

1.87

31.03

2.1

1.6

1.17

1.20

g/l

1.01

408

2202

Type 2 diabetes, definitions combined, including avohilmo

2167

9515

1.33

31.02

1.6

1.8

1.31

1.16

g/l

88.77

2078

9116

Nonalcoholic fatty liver disease

289

1394

2.15

30.84

1.7

1.8

1.31

1.20

g/l

6.13

275

1331

Adhesive capsulitis of shoulder

368

1930

1.95

30.68

1.5

1.6

1.21

1.19

g/l

0.70

354

1838

Other and unspecified disorders of white blood cells

133

450

3.13

30.63

2.3

1.6

1.10

1.20

g/l

2.76

126

428

Gastric ulcer

363

1897

1.95

30.51

1.7

1.6

1.19

g/l

0.10

343

1805

Disorders of vitreous body

1123

7415

1.46

30.45

1.6

1.7

1.18

1.20

g/l

0.97

1066

7095

Bullous disorders

161

604

2.79

30.43

1.8

1.5

1.18

g/l

0.06

156

575

Disorders of vitreous body and globe

1146

7552

1.45

30.37

1.6

1.7

1.18

1.20

g/l

1.09

1087

7231

Cirrhosis of liver, NAS

156

577

2.83

30.36

1.3

1.6

1.11

1.18

g/l

1.61

147

553

Skin changes due to chronic exposure to nonionizing radiation

772

4486

1.58

30.34

1.6

1.5

1.16

1.18

g/l

1.99

728

4265

Other/unspecified reactive arthropathies

197

818

2.52

30.26

2.8

1.8

1.23

1.19

g/l

0.66

190

781

Nonischemic cardiomyopathy

230

1018

2.33

30.18

1.9

1.6

1.16

1.19

g/l

0.54

216

967

Diseases of oral cavity, salivary glands and jaws

1155

4073

1.48

30.10

1.7

1.6

1.19

1.18

g/l

0.18

1097

3865

Artrosis, including avohilmo

1857

7580

1.35

29.91

1.7

1.8

1.21

1.18

g/l

5.44

1784

7246

Multiple myeloma and malignant plasma cell neoplasms

135

466

3.04

29.87

1.8

1.5

1.14

1.17

g/l

0.66

128

449

Disease of hard tissues of teeth, NOS

1120

4001

1.48

29.81

1.8

1.6

1.20

1.19

g/l

0.74

1067

3800

Other local infections of skin and subcutaneous tissue

272

1299

2.16

29.71

2.2

1.7

1.19

1.18

g/l

0.12

258

1238

Hyperparathyroidism

404

2183

1.87

29.63

1.9

1.6

1.17

1.20

g/l

1.03

378

2069

Other psoriatic arthropathies

277

1337

2.14

29.51

1.6

1.7

1.26

1.20

g/l

2.12

268

1271

Congenital malformations, deformations and chromosomal abnormalities

1421

9791

1.39

29.51

1.7

1.9

1.18

1.19

g/l

0.45

1367

9386

Endometriosis

831

3123

1.57

29.45

1.8

1.19

1.20

g/l

0.16

801

2975

Diseases of middle ear and mastoid

1383

8149

1.40

29.42

1.9

1.18

g/l

0.06

1322

7828

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

136

478

3.03

29.38

1.7

1.6

1.22

1.21

g/l

0.25

120

450

Psoriatic arthropathies, ICD10

284

1386

2.12

29.38

1.6

1.7

1.25

1.20

g/l

1.93

273

1319

Oter anti-inflammatory and antirheumatic agents, non-steroids

433

1281

1.89

29.34

1.6

1.8

1.20

1.15

g/l

2.62

406

1222

Polyuria

493

2871

1.75

29.16

1.9

1.6

1.17

1.18

g/l

0.34

468

2742

Benign neoplasm of other and ill-defined parts of digestive system

422

2353

1.84

29.15

1.6

1.7

1.22

1.19

g/l

1.22

404

2233

Paralytic ileus and intestinal obstruction

529

3136

1.71

29.08

1.5

1.18

1.20

g/l

0.68

502

2982

Episcleritis

178

720

2.60

29.05

2.3

1.8

1.23

1.20

g/l

0.86

170

685

COPD related to multimorbidity

759

4136

1.57

28.95

1.5

1.6

1.19

1.18

g/l

0.07

723

3934

Epilepsy

651

4062

1.62

28.95

2.1

1.7

1.17

g/l

0.09

618

3894

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

336

1747

1.97

28.89

1.4

1.6

1.13

1.20

g/l

2.75

320

1667

Other metabolic disorders

356

1889

1.94

28.85

1.7

1.8

1.22

1.19

g/l

1.52

335

1809

Postprocedural disorders of nervous system

227

1024

2.31

28.84

2.2

2.1

1.16

1.19

g/l

0.58

217

973

Sacroiliitis, not elsewhere classified

149

553

2.82

28.80

1.7

1.9

1.25

1.18

g/l

2.08

141

522

Crohn disease (strict definition, require KELA, min 2 HDR)

196

831

2.46

28.77

1.8

1.9

1.19

1.20

g/l

0.21

190

785

Other and unspecified local infections of skin and subcutaneous tissue

258

1227

2.17

28.53

2.2

1.7

1.20

1.18

g/l

0.35

244

1172

Infective dermatitis

258

1225

2.16

28.52

1.6

1.7

1.16

1.19

g/l

0.84

247

1162

Other disorders of pigmentation

138

495

2.93

28.52

1.5

1.6

1.16

1.20

g/l

0.75

130

467

Excessive, frequent and irregular menstruation

940

3343

1.52

28.50

2.2

1.8

1.20

1.19

g/l

0.56

901

3192

Pneumonia derived septicemia

113

363

3.30

28.43

3.1

1.4

1.14

1.20

g/l

1.08

108

343

Other medical care

1021

5904

1.47

28.22

1.5

1.7

1.17

1.19

g/l

1.08

988

5631

Nonorganic sleeping disorders

558

3394

1.68

28.14

1.9

1.8

1.19

g/l

0.19

536

3256

Other chronic obstructive pulmonary disease, including avohilmo

1070

6110

1.45

28.09

1.6

1.19

g/l

0.06

1023

5830

Other diseases of hard tissues of teeth

1134

4065

1.46

28.02

1.7

1.6

1.19

1.18

g/l

0.50

1079

3858

Hypoparathyroidism

123

420

3.11

27.96

2.6

1.7

1.20

1.21

g/l

0.12

116

401

Injuries to the abdomen, lower back, lumbar spine and pelvis

907

6061

1.49

27.96

1.9

1.7

1.18

1.19

g/l

0.48

866

5793

Behavioural syndromes associated with physiological disturbances and physical factors

2207

11578

1.30

27.93

1.8

1.19

g/l

0.18

2127

11086

Transient ischemic attack

1049

5791

1.46

27.91

1.8

1.6

1.20

1.19

g/l

0.60

994

5532

Crohn disease (strict definition, require KELA)

197

849

2.42

27.88

1.8

1.9

1.19

1.20

g/l

0.21

191

803

COPD, early/later onset

874

4915

1.51

27.86

1.6

1.18

1.19

g/l

0.27

834

4685

Disorders of ocular muscles, binocular movement, accommodation and refraction

1168

8240

1.42

27.78

1.8

1.19

g/l

0.00

1107

7905

Arthropathic psoriasis

292

1469

2.05

27.76

1.6

1.7

1.26

1.20

g/l

2.73

281

1397

Impingement syndrome of shoulder

482

2832

1.73

27.58

1.8

1.6

1.20

1.19

g/l

0.21

465

2703

Dental caries, including avohilmo

1543

5788

1.38

27.47

1.7

1.20

1.18

g/l

1.84

1481

5507

Amputation of foot

247

3.81

27.46

1.5

1.4

1.10

1.18

g/l

1.26

239

Acute pharyngitis

370

1998

1.87

27.33

1.9

1.8

1.22

1.18

g/l

1.53

353

1925

Retention of urine

673

3454

1.60

27.33

1.6

1.17

1.18

g/l

0.38

628

3296

Nummular dermatitis

193

829

2.40

27.30

1.4

1.6

1.20

1.18

g/l

0.25

186

790

Personality disorders, excluding more controls

597

3709

1.63

27.25

1.8

1.9

1.22

1.18

g/l

2.19

568

3565

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

205

909

2.35

27.14

1.8

1.9

1.18

1.20

g/l

0.37

198

861

COPD, hospital admissions

863

4886

1.51

27.14

1.6

1.18

1.19

g/l

0.34

824

4657

Corns and callosities

172

705

2.53

27.10

2.1

1.5

1.15

1.20

g/l

1.32

164

676

Hernia

2100

10789

1.30

27.08

1.7

1.19

g/l

0.18

1997

10349

Post-traumatic stress disorder

258

1253

2.13

27.05

1.6

2.1

1.23

1.17

g/l

2.55

244

1198

Diabetic maculopathy, excluding more controls

254

1226

2.13

26.95

1.4

1.7

1.20

1.16

g/l

1.04

245

1166

Psoriasis vulgaris

433

2489

1.78

26.95

1.5

1.7

1.27

1.20

g/l

5.13

418

2369

Other and unspecified myopathies

203

897

2.33

26.90

1.4

1.5

1.17

1.18

g/l

0.17

191

852

Brachial plexus disorders

260

1270

2.11

26.86

1.6

1.9

1.23

1.20

g/l

0.91

254

1212

Abnormal involuntary movements

333

1771

1.93

26.83

1.8

1.7

1.18

1.19

g/l

0.20

314

1683

Other extrapyramidal and movement disorders in other diseases

566

3497

1.65

26.80

1.7

1.19

g/l

0.21

543

3324

Cerebral palsy and other paralytic syndromes

283

1426

2.04

26.75

2.1

1.7

1.26

1.19

g/l

3.03

267

1357

Problems related to lifestyle

271

1344

2.07

26.74

1.8

1.7

1.21

1.19

g/l

0.57

264

1280

Lichen ruber planus, wide definition including periferal and oral lichen planus

528

3211

1.68

26.68

1.7

1.21

g/l

0.05

507

3058

COPD, hospital admissions 3, with asthma pneumonia sepsis

514

2638

1.69

26.66

1.6

1.5

1.18

g/l

0.07

487

2515

Ankylosing spondylitis

218

997

2.25

26.61

1.7

1.22

1.19

g/l

0.66

211

954

Prurigo nodularis

229

3.87

26.56

1.3

1.7

1.23

1.18

g/l

0.72

220

Erythema nodosum

101

317

3.39

26.51

1.9

1.6

1.22

1.21

g/l

0.13

299

Spondylolisthesis/Spondylolysis

401

2264

1.81

26.50

1.8

1.7

1.19

1.20

g/l

0.09

384

2157

Cervicocranial syndrome

260

1274

2.10

26.50

1.5

1.8

1.18

1.19

g/l

0.37

248

1211

Other bursopathies

283

1429

2.03

26.46

1.8

1.6

1.19

1.20

g/l

0.16

271

1352

Nonsuppurative otitis media

566

3025

1.65

26.46

1.9

1.19

1.17

g/l

0.51

547

2905

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

807

5415

1.51

26.45

1.8

1.20

1.19

g/l

0.48

768

5188

Systemic disorders of connective tissue in diseases classified elsewhere

10.39

26.37

1.5

1.2

1.20

1.16

g/l

0.27

Fenamates

325

1143

1.97

26.36

1.7

2.0

1.22

1.15

g/l

3.87

312

1091

Other follicular disorders

217

998

2.25

26.26

1.6

1.9

1.22

1.19

g/l

0.77

207

952

Emphysema

164

667

2.54

26.16

1.7

1.5

1.17

g/l

0.03

157

629

Other and unspecified tonsillitis

765

4202

1.53

26.09

1.7

1.8

1.21

1.18

g/l

2.86

726

4050

Dental operations

1233

4517

1.42

26.03

1.6

1.19

g/l

0.31

1174

4299

Heartburn

271

1357

2.05

26.01

1.6

1.20

1.19

g/l

0.18

255

1298

Viral infections of the central nervous system

201

900

2.32

25.99

2.7

1.7

1.14

1.20

g/l

1.74

191

853

Amyloidosis, other/unspecified

192

4.18

25.98

1.3

1.6

1.17

1.14

g/l

0.24

187

Disorders of vestibular function (Vertigo)

1031

7078

1.44

25.88

1.7

1.21

1.19

g/l

1.10

991

6760

Polycystic ovarian syndrome, consortium definition

1796

7829

1.33

25.87

2.1

1.9

1.19

g/l

0.12

1717

7494

Covid-19 suspected case

536

3299

1.66

25.82

2.0

1.8

1.21

1.19

g/l

0.80

520

3160

Abnormal findings on diagnostic imaging of central nervous system

153

609

2.63

25.81

1.8

1.15

1.20

g/l

1.08

148

575

Diseases of pulp and periapical tissues and dental caries

1373

5116

1.39

25.79

1.7

1.20

1.17

g/l

2.11

1318

4861

Sleep disorders

2118

11374

1.29

25.78

1.7

1.8

1.20

1.19

g/l

0.36

2037

10887

COPD-related respiratory insufficiency

246

1194

2.11

25.70

1.5

1.18

g/l

0.00

228

1139

Vitreous haemorrhage

241

1164

2.13

25.61

1.4

1.6

1.18

1.19

g/l

0.26

227

1105

Seborrhoeic keratosis

509

3097

1.67

25.56

2.0

1.6

1.17

1.20

g/l

2.05

483

2947

Fracture of rib(s), sternum and thoracic spine

641

4123

1.58

25.51

1.7

1.6

1.20

1.19

g/l

0.17

615

3934

Lesion of ulnar nerve

324

1736

1.91

25.49

1.7

1.20

g/l

0.02

314

1665

Suppurative and unspecified otitis media

868

5253

1.48

25.43

1.9

1.20

1.18

g/l

1.04

828

5055

Mucosal proctocolitis

321

1719

1.92

25.35

1.6

1.8

1.22

1.19

g/l

0.59

304

1643

Other/unspecified enthesopathies of lower limb, excluding foot

196

877

2.31

25.32

1.5

1.8

1.24

1.19

g/l

1.40

189

840

Substance abuse, excluding more controls

1172

7054

1.40

25.30

1.7

1.21

1.18

g/l

1.94

1117

6781

Neuromuscular dysfunction of bladder

218

1019

2.20

25.23

2.0

1.6

1.20

1.18

g/l

0.28

200

974

Type 1 diabetes, wide definition, subgroup 1

484

2916

1.69

25.22

1.5

1.8

1.13

1.16

g/l

1.29

459

2796

Cerebral cysts

168

706

2.48

25.18

1.7

1.8

1.14

1.18

g/l

0.88

162

675

Diabetes, insulin treatment (Kela reimbursement)

2242

10478

1.28

25.15

1.5

1.8

1.28

1.17

g/l

48.80

2152

10041

Deviated nasal septum

660

4284

1.56

25.05

1.6

1.7

1.22

1.19

g/l

1.61

629

4118

Superficial injury of lower leg

630

4060

1.58

24.95

1.7

1.8

1.22

1.19

g/l

2.26

599

3882

Injuries to the head

2582

12244

1.26

24.94

1.8

1.19

g/l

0.17

2478

11730

Generalized anxiety disorder

424

2474

1.75

24.91

1.7

1.9

1.18

g/l

0.10

406

2386

Viral and other specified intestinal infections

489

2892

1.68

24.85

2.0

1.9

1.18

g/l

0.00

468

2788

Other diseases of blood and blood-forming organs

179

779

2.38

24.75

1.9

1.6

1.20

1.19

g/l

0.12

166

744

Abnormal serum enzyme levels

578

3525

1.61

24.68

1.7

1.5

1.22

1.17

g/l

3.01

555

3379

Unspecified fall

1133

8053

1.40

24.30

1.7

1.19

g/l

0.14

1076

7714

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

244

1211

2.08

24.17

1.7

1.20

1.18

g/l

0.49

230

1155

Endometriosis of pelvic peritoneum

422

2251

1.74

24.16

1.7

1.8

1.18

1.20

g/l

0.63

403

2142

Viral infections of the central nervous system, including avohilmo

213

1007

2.19

24.09

2.6

1.7

1.13

1.20

g/l

2.41

203

956

Cluster headache, wide

116

416

2.92

24.02

1.9

1.7

1.21

1.17

g/l

0.67

111

394

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

863

3723

1.48

23.83

2.6

2.0

1.15

1.18

g/l

1.40

837

3568

Trigeminal neuralgia

161

683

2.45

23.63

1.6

1.7

1.24

1.19

g/l

1.18

151

649

Acetic acid derivatives and related substances

526

1648

1.67

23.55

1.5

1.9

1.18

1.15

g/l

1.66

499

1576

Caries of enamel

2234

11594

1.27

23.51

1.9

1.7

1.19

g/l

0.12

2148

11115

Acute suppurative otitis media

647

3953

1.55

23.49

2.0

1.19

1.18

g/l

0.44

620

3812

Golimumab

116

423

2.89

23.39

1.7

1.8

1.22

1.21

g/l

0.15

111

402

Injuries to the wrist and hand

2347

12426

1.26

23.35

1.7

1.8

1.19

g/l

0.02

2246

11911

Insomnia

2077

11392

1.28

23.26

1.7

1.8

1.19

g/l

0.35

1995

10908

Persistent mood disorders

440

2648

1.69

23.19

1.8

1.22

1.19

g/l

1.56

410

2539

Cluster headache, strict

111

397

2.93

23.14

1.9

1.7

1.21

1.18

g/l

0.48

106

376

Spirochaetal infections, other/unspecified

226

1110

2.10

23.10

1.8

1.7

1.15

1.20

g/l

1.30

208

1060

Special screening examination for other diseases and disorders

251

1275

2.01

23.03

1.7

1.5

1.24

1.20

g/l

1.12

240

1224

Acute laryngitis and tracheitis

286

1496

1.92

23.02

2.1

1.8

1.22

1.18

g/l

1.36

272

1445

Excessive attrition of teeth

1441

10810

1.33

22.99

1.9

1.8

1.18

1.19

g/l

1.46

1393

10361

Early onset COPD

457

2784

1.67

22.97

1.7

1.6

1.21

1.20

g/l

0.35

436

2664

Other obstetric conditions, not elsewhere classified

875

3820

1.47

22.95

2.6

2.0

1.15

1.18

g/l

1.62

848

3659

Melanocytic naevi

737

5004

1.50

22.87

2.1

1.8

1.16

1.19

g/l

2.73

707

4801

Caries of dentine, including avohilmo

1656

6450

1.32

22.82

1.8

1.7

1.20

1.18

g/l

2.17

1592

6148

Chronic iridocyclitis

141

573

2.57

22.81

2.1

1.6

1.18

1.20

g/l

0.17

136

543

Postprocedural endocrine and metabolic disorders, not elsewhere classified

317

1752

1.85

22.72

1.6

1.8

1.23

1.18

g/l

1.73

297

1681

Diseases of external ear

784

5392

1.47

22.72

1.7

1.21

1.19

g/l

1.24

750

5166

Fissure and fistula of anal and rectal regions

510

3199

1.62

22.71

1.7

1.20

1.19

g/l

0.27

487

3048

Lichen planus

301

1638

1.88

22.67

1.7

1.6

1.20

g/l

0.04

289

1558

Type 1 diabetes, wide definition

494

3074

1.63

22.67

1.5

1.8

1.13

1.16

g/l

1.22

468

2945

Diabetes medication

2359

11034

1.26

22.45

1.5

1.8

1.29

1.16

g/l

67.01

2265

10562

Crohn's disease of large intestine

149

626

2.48

22.44

1.8

1.21

1.19

g/l

0.29

139

595

Extrapyramidal and movement disorders

805

5577

1.46

22.43

1.7

1.17

1.19

g/l

0.80

772

5307

Disturbance of activity and attention

360

2021

1.78

22.41

1.7

2.0

1.15

1.17

g/l

0.33

347

1943

Vitamin deficiency, wide

137

554

2.58

22.38

2.4

1.7

1.16

1.17

g/l

0.19

128

522

Vitamin deficiency

137

554

2.58

22.38

2.4

1.7

1.16

1.17

g/l

0.19

128

522

Cholelithiasis, broad definition with cholecystitis

1916

9994

1.29

22.38

1.8

1.7

1.26

1.18

g/l

28.50

1832

9571

Other disorders of bladder

251

1293

1.99

22.29

3.7

1.5

1.18

g/l

0.11

240

1237

Acute pancreatitis

408

2433

1.71

22.26

1.8

1.6

1.24

1.18

g/l

3.91

395

2323

Other and unspecified visual disturbances

268

1415

1.95

22.23

2.0

1.7

1.23

1.19

g/l

1.55

262

1348

Diseases of inner ear

1158

8168

1.37

22.20

1.7

1.20

1.19

g/l

0.85

1112

7808

Supplementary factors related to causes of morbidity and mortality classified elsewhere

700

4737

1.50

22.07

1.9

1.7

1.18

1.19

g/l

0.40

668

4521

Intestinal malabsorption

135

547

2.58

22.01

1.5

1.7

1.15

1.20

g/l

1.04

130

520

Infections with a predominantly sexual mode of transmission

749

5131

1.48

21.96

2.3

1.9

1.16

1.19

g/l

2.60

713

4946

Need for other prophylactic measures

155

672

2.40

21.72

1.9

1.6

1.24

1.20

g/l

0.70

149

641

Gingivitis and periodontal diseases

2170

8905

1.27

21.64

1.8

1.7

1.19

1.18

g/l

0.67

2078

8516

Elevated blood glucose level

202

975

2.13

21.61

1.5

1.6

1.26

1.18

g/l

2.87

195

927

Other/unspecified enthesopathies, not elsewhere classified

187

876

2.19

21.56

1.8

1.6

1.21

1.20

g/l

0.15

182

829

Diseases of peritoneum

235

1200

2.01

21.51

1.8

1.7

1.16

1.18

g/l

0.64

228

1147

Cholelithiasis

1838

9854

1.28

21.21

1.8

1.7

1.27

1.18

g/l

29.23

1757

9435

Lichen planus, including avohilmo

429

2629

1.66

21.18

1.6

1.7

1.20

g/l

0.03

411

2503

Spontaneous rupture of synovium and tendon

178

824

2.22

21.15

1.8

1.5

1.22

1.20

g/l

0.45

172

777

Tonsillectomy and adenotomy

1357

7143

1.33

20.98

1.8

1.9

1.18

1.19

g/l

0.53

1300

6872

Other and unspecified nerve root and plexus disorders, also in other diseases

459

2868

1.63

20.89

1.6

1.7

1.21

1.20

g/l

0.43

431

2750

Disorder of lipoprotein metabolism, unspecified

251

1323

1.94

20.80

1.6

1.5

1.24

1.18

g/l

2.38

240

1270

Other noninfective disorders of lymphatic vessels and lymph nodes

112

427

2.75

20.76

1.8

1.7

1.18

1.21

g/l

0.46

106

403

KRA_PSY_EATING, excluding more controls

223

1123

2.02

20.64

2.0

2.1

1.13

1.15

g/l

0.48

216

1080

Hyperkinetic disorders

371

2151

1.72

20.53

1.7

2.0

1.16

1.17

g/l

0.38

357

2068

Other disorders of ear

2026

10441

1.26

20.41

1.7

1.18

1.19

g/l

1.01

1929

10009

Left ventricular outflow tract obstruction (LVOTO), broad definition

245

1295

1.95

20.33

2.2

1.6

1.18

1.20

g/l

0.53

228

1245

Restless leg syndrome

345

2021

1.75

20.30

1.8

1.19

g/l

0.03

335

1923

Tongue abnormality

159

718

2.30

20.28

2.2

1.6

1.19

g/l

0.02

150

686

Pain associated with micturition

286

1589

1.84

20.20

2.2

1.7

1.20

1.19

g/l

0.26

271

1509

Arterial embolism and thrombosis

124

502

2.54

20.08

1.5

1.18

1.17

g/l

0.07

117

480

Fracture of lumbar spine and pelvis

451

2825

1.62

20.06

2.0

1.6

1.14

1.19

g/l

2.79

432

2669

Atypical facial pain

144

627

2.39

20.05

1.6

1.8

1.20

g/l

0.12

133

601

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

487

3120

1.59

20.05

2.1

2.0

1.17

1.19

g/l

0.72

471

3006

Aortic valve malfunction, age under 60 years

227

1176

1.99

20.02

2.2

1.6

1.18

1.20

g/l

0.53

212

1130

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

544

3099

1.55

19.97

1.8

2.0

1.18

1.17

g/l

0.16

527

2987

Infections with a predominantly sexual mode of transmission, including avohilmo

963

6416

1.39

19.97

2.3

1.9

1.16

1.19

g/l

2.47

914

6181

Synovial cyst of popliteal space [Baker]

160

727

2.26

19.96

1.6

1.23

1.20

g/l

0.68

155

686

Visual field defects

193

945

2.10

19.91

2.0

1.6

1.18

g/l

0.02

181

899

Varicose veins

1233

7012

1.34

19.90

1.8

1.6

1.18

1.20

g/l

1.05

1183

6686

Persons with potential health hazards related to communicable diseases

900

6441

1.40

19.89

2.2

1.9

1.19

1.18

g/l

0.17

863

6203

Ganglion

440

2761

1.62

19.65

1.5

1.8

1.20

1.18

g/l

0.44

424

2646

Non-follicular lymphoma

201

1004

2.06

19.62

1.7

1.5

1.11

1.18

g/l

2.15

195

956

Unspecified/other endometriosis

254

1345

1.90

19.59

1.7

2.0

1.21

1.18

g/l

0.80

240

1278

Other diseases of stomach and duodenum

151

676

2.30

19.58

2.0

1.5

1.18

1.21

g/l

0.58

146

644

Other and unspecified follicular disorders

120

488

2.57

19.48

1.5

1.8

1.21

1.20

g/l

0.14

115

464

Suppurative and necrotic conditions of lower respiratory tract

132

560

2.44

19.43

2.1

1.5

1.12

1.19

g/l

1.26

121

536

Ethmoidectomy

308

1772

1.78

19.36

1.8

1.22

1.20

g/l

0.54

295

1692

Cardiodefibrillation

642

4373

1.48

19.32

1.7

1.5

1.18

1.19

g/l

0.07

617

4163

Postmenopausal osteoporosis with pathological fracture

151

681

2.29

19.29

2.0

1.5

1.13

1.20

g/l

2.17

144

642

Other disorders of eyelid

871

5923

1.40

19.27

1.7

1.6

1.20

1.19

g/l

0.53

835

5635

Hepatomegaly and splenomegaly, not elsewhere classified

5.00

19.22

1.9

1.5

1.17

1.20

g/l

0.18

Benign paroxysmal vertigo

624

4251

1.49

19.14

1.7

1.21

1.19

g/l

0.78

601

4038

Meningitis

135

584

2.40

19.09

3.0

1.6

1.19

1.21

g/l

0.16

125

552

FESS (DNB20)

301

1728

1.78

19.09

1.8

1.22

1.20

g/l

0.43

288

1650

Panic disorder

362

2184

1.69

19.05

1.7

1.9

1.22

1.18

g/l

1.48

341

2101

Intracranial injury

1260

8961

1.32

19.05

1.8

1.7

1.19

g/l

0.07

1202

8585

Cluster headache, wide,, including avohilmo

154

707

2.26

18.95

1.8

1.22

1.19

g/l

0.50

149

666

Injuries to the neck

534

3533

1.54

18.94

1.7

1.8

1.22

1.19

g/l

1.79

514

3391

Disorders of continuity of bone

250

1362

1.88

18.90

2.0

1.7

1.18

1.20

g/l

0.40

242

1299

Other sleep disorders

250

1360

1.88

18.89

2.0

1.7

1.21

1.16

g/l

1.93

238

1301

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

605

4054

1.49

18.82

1.7

1.9

1.20

1.18

g/l

1.31

568

3896

Sub-endpoint used in defining T1D endpoints

597

3976

1.50

18.78

1.6

1.7

1.15

1.18

g/l

1.81

567

3808

Cluster headache, strict, including avohilmo

149

678

2.29

18.76

1.8

1.21

1.20

g/l

0.36

144

637

Type of accident

639

4404

1.47

18.46

2.0

1.8

1.18

1.19

g/l

0.49

609

4207

Retinal detachments and breaks

694

4857

1.45

18.42

1.6

1.17

1.19

g/l

1.50

668

4625

Other female pelvic inflammatory diseases

380

2345

1.65

18.39

1.8

1.9

1.17

1.20

g/l

0.78

361

2236

Hydronephrosis

222

1173

1.93

18.35

1.5

1.6

1.19

1.18

g/l

0.18

216

1112

Decubitus ulcer and pressure area

127

543

2.40

18.31

1.7

1.4

1.23

1.18

g/l

0.88

118

519

Inflammatory disease of uterus

365

2234

1.67

18.28

2.1

2.0

1.18

g/l

0.10

342

2144

Xerosis cutis

177

3.69

18.28

1.7

1.5

1.16

1.19

g/l

0.28

172

Chronic pancreatitis

262

1464

1.83

18.19

1.5

1.6

1.19

g/l

0.01

248

1401

Melanocytic naevi of trunk

293

1693

1.77

18.18

2.2

1.8

1.15

1.19

g/l

1.23

284

1606

Unstable angina pectoris

617

3301

1.48

18.18

1.8

1.5

1.22

1.18

g/l

1.79

579

3136

Lateral epicondylitis

280

1597

1.79

18.09

1.7

1.22

1.20

g/l

0.44

267

1525

Other demyelinating diseases of the central nervous system

121

513

2.47

18.06

1.7

1.8

1.18

1.19

g/l

0.32

116

483

Other or unspecified ileus, impaction or obstruction

347

2098

1.68

18.00

1.4

1.6

1.21

1.19

g/l

0.50

330

1994

Disorders of optic nerve and visual pathways

241

1320

1.88

17.98

2.0

1.8

1.19

1.18

g/l

0.20

232

1252

Injuries to the hip and thigh

974

6475

1.36

17.94

1.8

1.6

1.18

1.19

g/l

0.06

932

6186

Acute pancreatitis (for exclusion)

408

2580

1.61

17.75

1.8

1.6

1.24

1.19

g/l

2.58

395

2462

Speech therapy

543

3657

1.51

17.70

2.0

1.6

1.19

1.20

g/l

0.31

518

3482

Aortic aneurysm

384

2349

1.62

17.51

1.6

1.5

1.18

g/l

0.01

368

2245

Dermatophytosis, including avohilmo

1424

10953

1.28

17.51

1.8

1.7

1.19

g/l

0.02

1375

10495

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

380

2303

1.63

17.35

1.7

1.8

1.17

1.19

g/l

0.50

371

2204

Carrier of infectious disease

327

2.85

17.34

2.3

1.6

1.18

1.19

g/l

0.04

310

Fibroblastic disorders

419

2678

1.58

17.33

1.6

1.20

1.18

g/l

0.49

401

2541

Other diseases of pancreas

188

960

2.01

17.33

1.9

1.6

1.19

1.18

g/l

0.10

177

915

Other disorders of conjunctiva

298

1753

1.73

17.31

1.8

1.6

1.18

1.19

g/l

0.25

286

1665

Hereditary angioödema type 1

45.86

17.29

3.2

1.4

1.14

1.20

g/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

399

2453

1.61

17.27

1.7

1.8

1.17

1.19

g/l

0.36

389

2348

Ankylosing spondylitis, ICD10

212

1130

1.93

17.24

1.6

1.7

1.22

1.20

g/l

0.53

205

1079

Lung cancer and mesothelioma

274

1323

1.78

17.21

1.5

1.4

1.15

1.19

g/l

1.01

259

1252

Benign neoplasm: Colon, unspecified

489

3242

1.53

17.20

1.7

1.6

1.19

g/l

0.02

466

3085

Secondary and unspecified malignant neoplasm of lymph nodes

184

935

2.02

17.18

1.5

1.6

1.20

1.19

g/l

0.14

177

883

Other and unspecified diseases of blood and blood-forming organs

285

2.96

16.99

2.4

1.7

1.22

1.18

g/l

0.59

273

Superficial injury of wrist and hand

483

3207

1.53

16.91

1.6

1.8

1.20

1.19

g/l

0.38

465

3076

Vascular diseases of the intestine

346

2.72

16.90

2.1

1.6

1.12

1.18

g/l

0.91

330

Oesophageal varices

101

405

2.59

16.90

1.4

1.6

1.03

1.19

g/l

4.47

386

Nasal polyp

372

2330

1.62

16.86

1.5

1.7

1.20

1.18

g/l

0.60

360

2234

Diabetic retinopathy

726

3197

1.43

16.73

1.4

1.6

1.21

1.28

g/l

6.73

694

3068

Menorrhagia

752

2983

1.42

16.68

2.0

1.8

1.21

1.19

g/l

0.39

710

2844

Invasive ventilation

167

830

2.07

16.65

1.6

1.5

1.22

1.18

g/l

0.82

153

792

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

199

1033

1.95

16.63

2.8

1.8

1.17

g/l

0.06

192

986

Dental pulpitis, including avohilmo

2090

10964

1.23

16.58

1.7

1.8

1.23

1.18

g/l

9.62

2011

10522

Other postsurgical states

154

744

2.13

16.58

1.3

1.7

1.22

1.19

g/l

0.58

147

705

Other disorders of the musculoskeletal system and connective tissue

318

1928

1.68

16.52

1.5

1.7

1.23

1.20

g/l

0.98

305

1837

Cholecystectomy

1513

10213

1.27

16.50

1.8

1.7

1.28

1.18

g/l

29.12

1449

9778

Childhood allergy (age < 16)

348

1767

1.65

16.45

1.8

2.1

1.16

g/l

0.13

334

1711

Intestinal stricture

597

4164

1.45

16.22

1.6

1.17

1.19

g/l

0.87

563

3966

Hypopituitarism

176

900

2.01

16.21

2.0

1.6

1.22

1.20

g/l

0.33

170

862

Amenorrhoea

188

984

1.96

16.19

2.3

2.0

1.13

1.18

g/l

1.13

181

937

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

892

6565

1.35

16.19

2.0

1.9

1.22

1.19

g/l

1.86

865

6320

Delirium, not induced by alcohol and other psychoactive substances

232

1291

1.82

16.19

1.8

1.5

1.14

1.17

g/l

0.68

220

1217

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

184

957

1.98

16.16

1.9

1.8

1.20

1.18

g/l

0.39

177

918

Multiple myeloma

260

2.98

16.07

1.6

1.7

1.15

g/l

0.08

245

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

260

2.98

16.07

1.6

1.7

1.15

g/l

0.08

245

Phobic anxiety disorders

316

1922

1.67

16.04

1.7

1.9

1.23

1.18

g/l

2.09

305

1845

Otitis externa

508

3447

1.50

16.03

1.9

1.8

1.21

1.19

g/l

0.45

488

3295

Other disorders of nervous system

158

782

2.08

15.99

1.5

1.6

1.19

g/l

0.00

150

747

Benign thyroid growths and nodules

669

4431

1.42

15.96

1.7

1.20

1.19

g/l

0.49

631

4217

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

397

2561

1.58

15.94

1.5

1.8

1.19

g/l

0.03

376

2456

Diabetic neuropathy

249

1422

1.79

15.92

1.3

1.5

1.22

1.26

g/l

0.80

240

1359

Viral meningitis, including avohilmo

110

473

2.43

15.91

3.0

1.8

1.15

1.20

g/l

1.03

104

446

Benign neoplasm: Stomach

214

1175

1.87

15.88

1.6

1.23

1.19

g/l

0.87

205

1122

Viral meningitis

106

449

2.46

15.87

3.0

1.8

1.16

1.20

g/l

0.97

100

426

Dislocation, sprain and strain of joints and ligaments at neck level

371

2361

1.60

15.85

1.6

1.9

1.23

1.19

g/l

2.56

359

2267

Scoliosis

197

1056

1.91

15.73

1.8

1.9

1.19

1.18

g/l

0.24

187

1012

Transport accidents

989

6232

1.33

15.73

1.8

1.19

g/l

0.35

945

6004

Otitis externa, unspecified

274

1621

1.73

15.70

1.8

1.20

1.19

g/l

0.36

263

1550

Diabetic retinopathy, strict definition

372

2101

1.60

15.68

1.3

1.6

1.18

1.29

g/l

8.89

357

2020

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

670

4803

1.41

15.68

1.4

1.8

1.39

1.18

g/l

60.20

645

4610

Glucagon-like peptide-1 (GLP-1) analogues

670

4803

1.41

15.68

1.4

1.8

1.39

1.18

g/l

60.20

645

4610

Thoracic aortic aneurysm

265

1552

1.74

15.66

1.5

1.17

1.18

g/l

0.21

252

1487

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

657

4694

1.42

15.65

1.8

1.19

g/l

0.01

629

4519

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

110

477

2.40

15.62

2.3

1.5

1.17

1.18

g/l

0.14

105

457

Plantar fascial fibromatosis

210

1151

1.86

15.61

1.9

1.7

1.24

1.20

g/l

1.46

199

1094

Acne

265

1547

1.74

15.58

2.3

2.0

1.13

1.17

g/l

1.60

249

1489

Procreative management

760

4565

1.39

15.56

1.9

1.8

1.18

1.21

g/l

1.88

717

4396

Ulcerative colitis (strict definition, require KELA)

371

2373

1.59

15.49

1.6

1.8

1.19

g/l

0.00

350

2272

COPD, hospital admissions 1, only main diagnosis

592

3562

1.44

15.41

1.6

1.5

1.18

g/l

0.01

569

3389

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

667

4736

1.41

15.40

2.1

1.9

1.18

g/l

0.02

640

4554

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

362

2307

1.60

15.37

1.6

1.8

1.19

g/l

0.11

341

2208

Overexertion and strenuous or repetitive movements

230

1304

1.81

15.35

1.7

1.25

1.19

g/l

1.66

222

1247

Barrett oesophagus

115

511

2.32

15.33

1.9

1.4

1.20

g/l

0.00

106

483

Autoimmune hyperthyroidism

121

548

2.26

15.31

1.7

1.3

1.18

1.23

g/l

1.12

112

521

Cardiac arrest

108

389

2.40

15.31

1.2

1.5

1.25

1.18

g/l

1.34

101

368

Open wound of ankle and foot

230

1305

1.80

15.27

1.8

1.6

1.18

1.19

g/l

0.09

217

1242

Chondrocostal junction syndrome [Tietze]

106

458

2.41

15.18

1.6

1.7

1.21

1.20

g/l

0.13

101

437

Trigger finger

287

1732

1.68

15.17

1.7

1.19

1.20

g/l

0.09

281

1649

Disorders of refraction and accommodation

649

4636

1.41

15.16

2.0

1.8

1.18

1.19

g/l

0.46

616

4455

conjunctival haemorrhage

167

859

2.00

15.15

1.8

1.6

1.18

g/l

0.14

160

823

Substance use, excluding alcohol

431

2865

1.53

15.08

1.9

1.8

1.22

1.19

g/l

1.10

412

2756

Otitis media, unspecified

265

1441

1.73

15.06

1.9

1.18

1.17

g/l

0.38

253

1386

Propionic acid derivatives

530

1801

1.49

15.04

1.5

1.9

1.20

1.14

g/l

3.23

508

1723

Myelodysplastic syndrome

104

4.20

14.89

1.6

1.4

1.03

1.10

g/l

0.61

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

378

2450

1.57

14.87

1.7

1.20

1.19

g/l

0.12

361

2332

Mental and behavioural disorders due to psychoactive substance use

1209

8695

1.28

14.81

1.7

1.21

1.19

g/l

1.25

1153

8369

Retinal vascular occlusion

220

1243

1.80

14.78

1.5

1.16

1.18

g/l

0.37

213

1172

Other and unspecified disorders of vitreous body

857

6299

1.34

14.77

1.7

1.18

1.20

g/l

0.99

814

6029

Substance abuse

1172

8524

1.29

14.74

1.7

1.21

1.19

g/l

1.25

1117

8204

Ascites

155

784

2.02

14.73

2.0

1.6

1.10

1.20

g/l

3.00

145

748

Thyrotoxicosis

548

3838

1.45

14.70

1.8

1.19

g/l

0.10

516

3661

Superficial injury of head

502

3453

1.47

14.68

1.7

1.19

g/l

0.10

482

3295

Retinal vascular disorders

221

1258

1.79

14.48

1.5

1.16

1.18

g/l

0.39

213

1187

Anogenital herpesviral [herpes simplex] infection

174

924

1.94

14.45

2.5

2.0

1.15

1.18

g/l

0.64

168

879

Alopecia areata

360

2.57

14.31

2.4

1.7

1.18

1.21

g/l

0.41

340

Anti-inflammatory and antirheumatic products, non-steroids

525

1802

1.48

14.21

1.5

1.9

1.19

1.15

g/l

2.75

501

1724

Dilated cardiomyopathy

222

1275

1.78

14.16

1.5

1.20

1.19

g/l

0.28

207

1214

Thyroiditis

184

1004

1.89

14.06

1.9

1.19

g/l

0.10

175

956

Insulin, fast-acting (human)

302

1884

1.63

14.06

1.5

1.8

1.13

1.18

g/l

2.86

288

1796

Other keratitis

258

1549

1.70

14.03

2.1

1.8

1.21

1.19

g/l

0.51

245

1477

Hernia of abdominal wall

898

6850

1.32

14.02

1.5

1.7

1.22

1.19

g/l

1.95

848

6566

Injuries to the shoulder and upper arm

1811

11514

1.22

13.98

1.7

1.19

g/l

0.27

1730

11037

Thyrotoxicosis, other and/or unspecified

429

2896

1.50

13.97

1.7

1.8

1.19

g/l

0.13

405

2767

Atrophic disorders of skin

328

2092

1.59

13.92

1.9

1.7

1.22

g/l

0.04

318

1999

Arthropathy in ulcerative colitis

169

3.39

13.87

2.1

1.4

1.19

1.20

g/l

0.13

163

Demyelinating diseases of the central nervous system

213

1219

1.79

13.87

2.0

1.18

1.19

g/l

0.13

205

1158

Other contact dermatitis

168

892

1.92

13.87

1.8

1.9

1.19

g/l

0.07

161

848

Exposure to other and unspecified inanimate mechanical forces

180

979

1.88

13.84

1.6

1.16

1.20

g/l

0.85

170

935

Unspecified misadventure during surgical and medical care

136

674

2.08

13.81

1.7

1.6

1.21

1.19

g/l

0.44

127

644

Other ulcerative colitis

141

708

2.05

13.79

1.5

1.7

1.21

1.20

g/l

0.25

129

675

Extreme obesity with alveolar hypoventilation

102

452

2.34

13.79

1.4

1.7

1.30

1.19

g/l

3.21

430

Colonic or urogenital fistula

546

3869

1.43

13.73

1.9

1.7

1.21

1.19

g/l

0.38

521

3706

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

245

2.89

13.68

2.6

1.5

1.12

1.19

g/l

1.01

235

Degeneration of macula and posterior pole

851

4963

1.33

13.66

1.8

1.5

1.16

1.19

g/l

2.49

809

4712

Lung diseases due to external agents

246

1467

1.70

13.64

1.8

1.5

1.22

1.17

g/l

1.58

236

1399

Gluteal tendinitis

110

507

2.24

13.50

1.6

1.18

1.20

g/l

0.20

102

483

Pyothorax

100

443

2.33

13.50

2.3

1.4

1.11

1.18

g/l

1.12

426

Paralytic strabismus

147

754

2.00

13.50

1.4

1.6

1.22

1.18

g/l

0.94

142

720

Fracture of foot, except ankle

542

3849

1.43

13.49

1.9

1.7

1.18

1.19

g/l

0.49

519

3698

Cardiac murmurs and other cardiac sounds

200

1118

1.80

13.43

2.0

1.7

1.20

1.18

g/l

0.39

193

1078

Olecranon bursitis

116

546

2.18

13.41

1.9

1.5

1.20

1.19

g/l

0.02

110

519

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1063

7219

1.29

13.39

2.1

1.9

1.23

1.19

g/l

4.82

1027

6909

Other noninflammatory disorders of vagina

189

1056

1.83

13.33

2.9

1.8

1.18

1.21

g/l

0.61

181

1000

Other condition

317

2030

1.59

13.27

1.9

1.8

1.20

g/l

0.01

303

1940

Oral lichen planus, including avohilmo , including avohilmo

169

915

1.90

13.25

1.7

1.19

g/l

0.07

163

873

Use of memantine

183

2586

0.56

13.24

1.4

1.5

1.15

1.16

g/l

0.06

170

2439

Use of other anti-dementia drugs

183

2586

0.56

13.24

1.4

1.5

1.15

1.16

g/l

0.06

170

2439

Chondropathies

332

2151

1.57

13.20

1.9

1.8

1.21

1.19

g/l

0.48

311

2058

Personality disorders

597

4334

1.39

13.07

1.8

1.9

1.22

1.19

g/l

1.63

568

4184

Benign neoplasm: Transverse colon

219

1285

1.74

13.02

1.8

1.6

1.19

g/l

0.05

208

1220

Corneal ulcer

388

2607

1.51

12.98

1.7

1.20

g/l

0.13

371

2496

Speech and linguistic disorders, excluding more controls

175

900

1.86

12.93

1.6

1.8

1.20

1.15

g/l

1.27

170

863

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

331

2154

1.56

12.88

1.8

1.7

1.19

g/l

0.10

315

2048

Achilles tendinitis

210

1221

1.75

12.87

1.7

1.23

1.20

g/l

0.63

202

1171

Speech disturbances, not elsewhere classified

178

987

1.84

12.85

1.8

1.6

1.20

1.18

g/l

0.47

166

938

Congenital malformations of the urinary system

141

728

1.99

12.79

1.7

1.14

1.19

g/l

1.06

141

691

Flat foot [pes planus] (acquired)

175

966

1.84

12.78

2.0

1.5

1.24

1.19

g/l

1.31

169

918

Strabismus

563

4053

1.40

12.75

1.7

1.8

1.20

1.19

g/l

0.68

532

3895

Periodontitis

2123

11395

1.19

12.67

1.8

1.7

1.21

1.19

g/l

1.61

2036

10912

Faecal incontinence

188

1065

1.80

12.64

2.2

1.6

1.14

1.19

g/l

1.53

175

1018

Other disorders of optic [2nd] nerve and visual pathways

152

808

1.93

12.64

1.9

1.6

1.22

1.19

g/l

0.89

145

768

Chronic periodontitis, including avohilmo

2119

11392

1.19

12.59

1.8

1.7

1.21

1.19

g/l

1.81

2031

10910

Acute myeloid leukaemia and myelodysplastic syndromes

216

2.90

12.54

1.5

1.7

1.11

1.15

g/l

0.37

209

Other (not insulin) diabetes medications

2064

10175

1.20

12.54

1.4

1.8

1.32

1.16

g/l

91.81

1980

9745

Benign neoplasm: Ascending colon

275

1728

1.62

12.51

1.6

1.21

1.19

g/l

0.42

265

1642

Vitamin B12 deficiency anaemia

187

1061

1.79

12.47

1.8

1.5

1.15

1.18

g/l

0.69

175

1009

Endometriosis ASRM stages 1,2

427

2953

1.47

12.44

1.7

2.0

1.18

1.19

g/l

0.24

407

2833

Lesion of lateral popliteal nerve

108

511

2.17

12.42

1.6

1.20

1.19

g/l

0.08

487

Other specified/unspecified bacterial intestinal infections

145

763

1.95

12.41

1.9

1.6

1.16

1.19

g/l

0.57

135

726

Gonarthrosis,primary

1760

8799

1.21

12.39

1.6

1.7

1.23

1.19

g/l

5.18

1681

8432

Other symptoms and signs involving the urinary system

200

1160

1.76

12.38

2.0

1.6

1.20

1.18

g/l

0.55

190

1110

Viral encephalitis, not elsewhere classified/unspecified

242

2.79

12.30

2.7

1.5

1.12

1.19

g/l

0.95

232

Hidradenitis suppurativa

105

495

2.20

12.27

1.6

2.0

1.23

1.18

g/l

0.85

100

469

Pneumothorax

131

668

2.00

12.24

1.8

1.5

1.14

1.20

g/l

1.30

126

637

Impetigo

119

588

2.09

12.24

2.7

1.7

1.18

1.19

g/l

0.09

112

559

Benign neoplasm: Sigmoid colon

357

2389

1.52

12.21

1.7

1.6

1.21

1.19

g/l

0.61

345

2273

Myeloproliferative diseases

164

902

1.86

12.21

1.4

1.6

1.12

1.19

g/l

2.46

155

858

Rapidly progressive nephritic syndrome

17.17

12.19

2.3

1.4

1.18

1.23

g/l

0.22

Erosion of teeth , including avohilmo

603

4439

1.37

12.15

1.9

1.8

1.17

1.19

g/l

1.27

588

4262

Pneumonia due to Streptococcus pneumoniae

394

2.32

12.04

1.8

1.5

1.18

1.19

g/l

0.09

375

Other noninflammatory disorders of vulva and perineum

227

1376

1.68

11.99

2.6

1.8

1.18

1.20

g/l

0.45

222

1307

Use of donepezil

115

2134

0.51

11.98

1.3

1.5

1.19

1.16

g/l

0.45

105

2015

Fentanyl

170

949

1.81

11.88

1.6

1.5

1.25

1.17

g/l

2.04

159

904

Umbilical hernia

527

3812

1.40

11.83

1.5

1.7

1.22

1.19

g/l

1.08

500

3665

Noninflammatory disorders of female genital tract

872

3357

1.31

11.82

2.1

1.8

1.17

1.19

g/l

1.66

847

3206

Use of anticholinesterases

276

3292

0.64

11.82

1.6

1.5

1.15

1.16

g/l

0.30

254

3121

N06DA Anticholinesterases

276

3292

0.64

11.82

1.6

1.5

1.15

1.16

g/l

0.30

254

3121

Other hearing loss

504

3501

1.41

11.80

1.8

1.6

1.18

g/l

0.12

475

3317

Visual impairment including blindness (binocular or monocular)

137

719

1.95

11.79

1.8

1.6

1.18

g/l

0.03

130

685

Use of pramipexole

423

2949

1.45

11.75

1.9

1.7

1.20

g/l

0.05

409

2797

Endometriosis of rectovaginal septum and vagina

175

995

1.80

11.72

1.5

1.8

1.19

1.20

g/l

0.06

166

936

Erythema intertrigo

230

2.76

11.70

1.7

1.31

1.18

g/l

2.42

223

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

13.66

11.61

1.5

1.2

1.23

1.12

g/l

0.56

Cryoglobulinemia

17.75

11.60

3.1

1.4

1.16

1.15

g/l

0.01

Injuries to unspecified part of trunk, limb or body region

216

1305

1.69

11.56

2.1

1.7

1.19

1.18

g/l

0.16

205

1244

Exclusions for E4_PCOS_CONSORTIUM

1635

8473

1.21

11.51

1.8

1.9

1.20

1.19

g/l

1.30

1572

8118

Hypoglycaemia, other or unspecified

147

797

1.89

11.50

1.8

1.6

1.12

1.19

g/l

2.25

138

758

Unspecific neurodegenerative disorder

373

3703

0.68

11.43

1.7

1.5

1.15

1.17

g/l

0.77

349

3517

Hypercalcemia

102

489

2.15

11.42

1.8

1.6

1.16

1.19

g/l

0.32

467

Tinnitus

474

3391

1.41

11.41

1.8

1.7

1.16

1.20

g/l

2.29

455

3246

Alzheimer disease, including avohilmo

306

3186

0.66

11.37

1.6

1.5

1.15

1.17

g/l

0.57

286

3018

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

158

881

1.84

11.32

1.6

1.8

1.23

1.19

g/l

0.82

147

838

Abnormal blood-pressure reading, without diagnosis

105

510

2.11

11.31

2.0

1.6

1.22

1.19

g/l

0.50

487

Other congenital malformations

205

1230

1.70

11.30

1.6

1.9

1.16

1.18

g/l

0.42

199

1171

Sensorineural hearing loss

1452

7968

1.22

11.25

1.6

1.7

1.19

1.20

g/l

0.60

1384

7631

Female infertility

640

2853

1.36

11.20

1.9

1.18

1.19

g/l

0.41

621

2722

Mononeuritis multiplex

11.11

11.16

2.8

1.5

1.11

1.20

g/l

0.60

Bipolar affective disorders

398

2772

1.45

11.15

2.0

1.9

1.21

1.18

g/l

1.40

385

2670

Disorders of tooth development and eruption

327

1771

1.52

11.14

2.3

1.7

1.17

1.18

g/l

0.14

315

1679

Secondary uncertain malignant neoplasm

239

1494

1.62

11.13

1.5

1.6

1.19

g/l

0.08

229

1412

Pleural plaque

143

776

1.87

11.09

1.8

1.3

1.10

1.18

g/l

1.99

135

742

L01XX Other antineoplastic agents

115

582

2.03

11.08

1.2

1.6

1.11

1.19

g/l

2.10

109

559

Ulcerative colitis (strict definition, all Crohn cases excluded)

302

1996

1.54

11.05

1.6

1.8

1.18

1.19

g/l

0.27

288

1909

Ulcer of oesophagus

121

623

1.98

11.05

1.5

1.4

1.17

1.19

g/l

0.34

109

591

Appendectomy

1389

10912

1.22

11.03

1.8

1.19

g/l

0.04

1325

10468

Familial hypercholesterolemia

244

1536

1.61

11.02

1.9

1.5

1.22

1.17

g/l

1.78

233

1464

Myeloproliferative diseases (CML excluded)

148

816

1.85

10.99

1.4

1.6

1.12

1.19

g/l

2.32

139

780

Acne vulgaris

198

1184

1.70

10.98

2.2

2.0

1.16

1.18

g/l

0.41

187

1137

Left bundle-branch block

126

659

1.95

10.96

1.7

1.5

1.18

1.21

g/l

0.48

116

623

Cholecystitis

256

1633

1.59

10.94

1.5

1.6

1.23

1.17

g/l

2.36

248

1552

Hallux rigidus

219

1345

1.65

10.94

1.6

1.5

1.20

g/l

0.03

213

1284

Mouth breathing

771

5960

1.30

10.94

1.7

1.23

1.19

g/l

3.51

739

5726

Bacterial, viral and other infectious agents, including avohilmo

196

1173

1.70

10.93

1.8

1.17

1.20

g/l

0.87

189

1116

Focal epilepsy

416

2930

1.44

10.93

2.2

1.7

1.19

1.18

g/l

0.05

397

2802

Intestinal adhesions without obstruction

161

912

1.80

10.89

1.7

1.6

1.14

1.20

g/l

1.75

149

865

Panniculitis affecting regions of neck and back

367

2.30

10.88

1.7

1.6

1.20

1.19

g/l

0.12

346

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.24

10.88

2.0

1.4

0.89

1.14

g/l

3.10

Pregnancy hypertension

950

6743

1.27

10.84

2.1

1.9

1.23

1.19

g/l

4.54

916

6456

D07AA Corticosteroids, weak (group I)

340

2308

1.49

10.84

1.6

1.9

1.24

1.18

g/l

3.24

325

2219

Any death

1178

6673

1.24

10.83

1.5

1.6

1.15

1.21

g/l

7.10

1115

6393

Emotional disorders starting during childhood or adolecense, excluding more controls

104

495

2.09

10.80

2.1

1.9

1.22

1.16

g/l

1.12

476

Degenerative macular diseases

211

1290

1.66

10.78

2.2

1.5

1.16

1.18

g/l

0.37

200

1211

Female infertility, cervical, vaginal, other or unspecified origin

587

2781

1.36

10.69

1.8

1.9

1.19

g/l

0.22

567

2651

Nail disorders

181

1067

1.73

10.69

2.2

1.7

1.19

g/l

0.01

176

1019

Other problems related to primary support group, including family circumstances

276

1754

1.56

10.67

2.3

1.9

1.17

g/l

0.13

265

1687

Other peripheral vertigo

190

1136

1.71

10.65

1.8

1.6

1.21

1.19

g/l

0.49

182

1086

Calculus of kidney and ureter

542

4008

1.37

10.64

1.7

1.6

1.20

1.19

g/l

0.76

518

3835

Cyst of kidney

140

768

1.86

10.59

1.4

1.5

1.20

1.19

g/l

0.15

134

728

Vulvovaginal ulceration/inflammation in other diseases

179

1057

1.73

10.57

1.7

2.1

1.15

1.18

g/l

0.48

173

1005

Sequelae of injuries, of poisoning and of other consequences of external causes

472

3422

1.40

10.53

1.6

1.7

1.23

1.20

g/l

1.65

456

3279

Adenomyosis (Endometriosis of uterus)

285

1878

1.54

10.52

1.9

1.7

1.21

1.20

g/l

0.19

276

1781

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

465

3365

1.40

10.52

2.6

1.9

1.15

1.19

g/l

1.72

443

3248

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

143

791

1.84

10.47

2.4

1.6

1.21

1.19

g/l

0.41

137

759

Specific personality disorders

505

3708

1.38

10.43

1.7

1.9

1.21

1.19

g/l

0.93

478

3574

Other disorders of glucose regulation and pancreatic internal secretion

171

999

1.75

10.43

1.8

1.7

1.12

1.19

g/l

1.84

161

953

Disorders of adult personality and behaviour

613

4634

1.34

10.42

1.8

1.9

1.21

1.19

g/l

1.01

581

4475

Benign neoplasm of other and unspecified endocrine glands

275

1807

1.55

10.40

1.5

1.7

1.24

1.20

g/l

1.13

253

1719

Cramp and spasm

112

577

2.00

10.33

1.8

1.7

1.21

1.19

g/l

0.23

105

544

Superficial injury of ankle and foot

285

1893

1.53

10.24

1.7

1.8

1.19

g/l

0.15

277

1817

Other predominantly sexually transmitted diseases, not elsewhere classified

389

2746

1.44

10.21

2.6

1.9

1.15

1.19

g/l

1.59

369

2646

Conductive and sensorineural hearing loss

1539

8541

1.20

10.19

1.6

1.7

1.19

1.20

g/l

0.80

1468

8186

Hypersplenism

5.26

10.11

2.3

1.9

1.08

1.16

g/l

0.61

Medial epicondylitis

392

2.20

10.10

1.5

1.8

1.24

1.20

g/l

0.45

370

Cardiomyopathy, Hypertrophic obstructive

151

3.04

10.09

1.5

1.4

1.19

1.17

g/l

0.12

145

Urolithiasis

574

4318

1.34

10.07

1.6

1.21

1.19

g/l

0.87

550

4130

Nontoxic goitre/thyroid nodule

569

4278

1.34

10.07

1.7

1.21

1.20

g/l

0.25

540

4066

Superficial injury of shoulder and upper arm

251

1629

1.57

10.04

1.5

1.7

1.23

1.19

g/l

1.39

242

1551

Acute gastritis

140

781

1.83

10.02

2.1

1.6

1.22

1.21

g/l

0.21

135

748

Other and unspecified mood [affective] disorders

165

967

1.74

9.99

1.8

2.1

1.21

1.18

g/l

0.72

158

927

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

257

1670

1.56

9.97

1.6

2.0

1.17

g/l

0.15

249

1597

Otalgia

193

1180

1.67

9.97

1.5

1.8

1.18

1.19

g/l

0.05

184

1123

Coxarthrosis, primary

1086

7326

1.24

9.95

1.6

1.21

1.19

g/l

1.57

1041

6995

Carbimazole or st.post thyroidectomy, condition for graves disease

443

3213

1.40

9.93

1.6

1.8

1.22

1.19

g/l

1.39

418

3076

Urethral stricture

100

501

2.04

9.91

1.6

1.3

1.20

1.17

g/l

0.51

478

Anogenital herpesviral [herpes simplex] infection, including avohilmo

271

1796

1.54

9.89

2.5

2.0

1.13

1.18

g/l

2.34

257

1725

Eating disorder

225

1429

1.60

9.88

2.0

2.2

1.13

1.16

g/l

0.84

218

1369

Poisoning by drugs, medicaments and biological substances

499

3690

1.37

9.88

1.6

1.9

1.22

1.19

g/l

1.24

471

3556

1096

7974

1.23

9.88

1.6

1.7

1.20

1.19

g/l

0.39

1039

7674

Thyrotoxicosis with diffuse goitre

297

2007

1.50

9.83

1.6

1.9

1.21

1.19

g/l

0.74

277

1922

Other abnormal uterine and vaginal bleeding

468

2444

1.39

9.83

1.9

1.8

1.20

g/l

0.02

438

2326

Alzheimer’s disease, strict definition

176

2324

0.61

9.81

1.7

1.5

1.15

1.16

g/l

0.17

158

2196

Heart failure and hypertrophic cardiomyopathy

188

2.79

9.76

1.7

1.4

1.19

1.18

g/l

0.08

180

Arthropathy in hypersensitivity reactions classified elsewhere

13.65

9.75

1.5

1.1

1.26

1.21

g/l

0.29

Sequelae of injuries of neck and trunk

334

2.29

9.72

1.5

1.6

1.29

1.19

g/l

1.78

317

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1302

8385

1.21

9.71

2.3

1.8

1.16

1.19

g/l

2.54

1250

8024

Dysplasia of cervi uteri

513

2667

1.37

9.68

2.6

1.8

1.16

1.20

g/l

1.77

485

2541

Event of undetermined intent

145

828

1.79

9.66

1.7

1.21

1.19

g/l

0.29

134

788

Arthropod-borne viral fevers and viral haemorrhagic fevers

186

1139

1.66

9.56

1.9

1.6

1.20

1.19

g/l

0.11

176

1087

Bell's palsy

228

1465

1.58

9.56

1.6

1.7

1.24

1.19

g/l

1.80

218

1394

Other secondary coxarthrosis

371

2.20

9.41

2.3

1.6

1.20

1.18

g/l

0.17

356

Right bundle-branch block

293

2.34

9.40

1.4

1.14

1.21

g/l

0.93

273

Alzheimer disease

263

2797

0.67

9.37

1.7

1.5

1.14

1.16

g/l

0.77

241

2645

Alcohol use disorder, Swedish definition

1018

7527

1.24

9.37

1.6

1.7

1.20

1.19

g/l

0.29

965

7241

Nontoxic multinodular goitre

356

2513

1.43

9.36

1.6

1.7

1.21

1.20

g/l

0.23

337

2389

Haemorrhage in early pregnancy

637

4778

1.31

9.33

1.9

2.0

1.19

1.18

g/l

0.49

609

4579

Ptosis of eyelid

209

1325

1.60

9.31

1.8

1.5

1.18

1.19

g/l

0.36

198

1260

Benign neoplasm: Small intestine

433

2.10

9.29

1.4

1.6

1.19

1.18

g/l

0.11

414

Amiodarone users

172

1040

1.68

9.28

1.4

1.5

1.14

1.18

g/l

0.83

163

989

Status post-ami

372

1996

1.43

9.21

1.8

1.5

1.17

g/l

0.02

356

1898

Other renal tubulo-interstitial diseases

272

2.41

9.21

1.7

1.9

1.21

1.18

g/l

0.25

261

Duodenal ulcer

175

1064

1.67

9.20

1.5

1.4

1.17

1.20

g/l

0.45

168

1019

Emotionally unstable personality disorder

284

1932

1.49

9.15

1.7

2.0

1.21

1.19

g/l

0.79

271

1858

Eating disorders

249

1647

1.53

9.14

1.9

2.1

1.14

1.17

g/l

0.88

241

1576

Superficial injury of abdomen, lower back and pelvis

319

2219

1.46

9.11

1.7

1.8

1.20

1.19

g/l

0.19

304

2114

Other congenital malformations, including avohilmo

282

1919

1.49

9.05

1.9

1.15

1.18

g/l

0.88

273

1838

Artificial joint operation, meniscal resection

1769

9671

1.17

9.03

1.7

1.22

1.19

g/l

2.93

1686

9256

Pre-eclampsia or eclampsia

480

3583

1.36

9.03

2.2

1.9

1.22

1.19

g/l

1.66

464

3435

Malignant neoplasm of breast, HER2-negative

569

4789

0.76

9.00

1.6

1.8

1.21

g/l

0.02

531

4567

Malignant neoplasm of breast

570

4795

0.76

8.99

1.6

1.8

1.21

g/l

0.05

532

4573

1150

8273

1.22

8.95

1.6

1.7

1.20

1.19

g/l

0.50

1093

7959

Superficial injury of hip and thigh

277

1881

1.49

8.94

1.9

1.6

1.20

1.18

g/l

0.27

265

1780

Cerebral aneurysm, nonruptured

173

1061

1.66

8.88

2.1

1.7

1.21

1.20

g/l

0.29

165

1015

Recurrent dislocation of patella

103

543

1.94

8.88

2.4

1.7

1.21

1.18

g/l

0.48

514

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

177

1092

1.65

8.87

2.0

1.7

1.20

1.19

g/l

0.22

170

1046

Congenital malformations of the circulatory system

300

2014

1.47

8.86

1.7

1.8

1.16

1.19

g/l

0.95

287

1926

Orchitis and epididymitis

154

915

1.71

8.86

1.5

1.4

1.24

1.18

g/l

1.72

145

879

Diseases of appendix

1541

11710

1.18

8.85

1.8

1.20

1.19

g/l

0.46

1473

11228

Striking against or struck by other objects

672

5254

1.29

8.83

1.9

1.8

1.19

g/l

0.13

638

5047

Amputation of thigh

239

2.45

8.83

1.6

1.3

1.23

1.15

g/l

0.86

229

Diabetic maculopathy

250

1576

1.52

8.80

1.4

1.6

1.20

1.29

g/l

3.98

242

1509

Diseases of male genital organs

817

3261

1.27

8.69

1.5

1.19

1.18

g/l

0.35

781

3146

Focal epilepsy, mode (most common among epilepsy diagnosis)

355

2539

1.41

8.68

2.2

1.7

1.18

g/l

0.08

344

2424

Excessive vomiting in pregnancy

201

1288

1.59

8.66

1.7

2.0

1.18

1.17

g/l

0.08

194

1235

Molar incisor enamel hypoplasia, with caries

132

3.11

8.65

2.6

1.4

1.01

1.14

g/l

1.67

126

Heterophoria

176

1092

1.64

8.64

1.8

1.9

1.18

g/l

0.10

166

1039

Poisoning by medicine

448

3331

1.36

8.64

1.7

1.8

1.22

1.19

g/l

1.10

423

3208

Malignant neoplasm, including Hilmo

1830

9160

1.17

8.64

1.8

1.7

1.20

g/l

0.24

1759

8774

Congenital malformations and deformations of the musculoskeletal system

203

1297

1.59

8.60

1.7

1.9

1.17

g/l

0.01

196

1243

Disorders of orbit

509

1.96

8.55

1.7

1.5

1.20

g/l

0.02

483

Early lumbar disc prolapse, operated

195

1242

1.59

8.54

1.9

1.23

1.19

g/l

1.44

186

1193

Endometriosis of ovary

356

2404

1.41

8.54

1.8

1.21

1.20

g/l

0.23

339

2288

Abscess of anal and rectal regions

164

1005

1.66

8.44

1.5

1.7

1.23

1.20

g/l

0.64

154

960

Injury of unspecified body region

158

960

1.68

8.44

2.1

1.6

1.20

1.18

g/l

0.31

148

913

Hypertrophic cardiomyopathy

456

2.01

8.42

1.7

1.6

1.21

1.19

g/l

0.27

435

Later onset COPD

417

2458

1.37

8.42

1.4

1.5

1.15

1.16

g/l

0.36

398

2322

Bacterial, viral and other infectious agents

171

1061

1.64

8.40

1.9

1.7

1.16

1.20

g/l

0.90

164

1010

Congenital malformations of heart and great arteries

266

1763

1.49

8.39

1.6

1.8

1.17

1.18

g/l

0.38

255

1691

Medicines for HER+ breast cancer

452

5584

0.75

8.38

1.6

1.8

1.22

1.20

g/l

0.72

422

5330

Aneurysms, operations, SAH

294

2048

1.45

8.37

2.0

1.7

1.21

1.20

g/l

0.30

279

1957

Other spirochaetal diseases, including avohilmo

676

5337

1.28

8.37

1.8

1.7

1.18

1.20

g/l

0.53

640

5110

Focal epilepsy, strict definition

370

2683

1.39

8.35

2.3

1.7

1.19

1.18

g/l

0.17

355

2561

Cystic kidney disease

390

2.09

8.34

1.3

1.6

1.13

1.20

g/l

1.37

372

Other and unspecified vascular occlusions

155

939

1.68

8.33

1.5

1.15

1.17

g/l

0.56

150

884

Smoking dependency

184

1165

1.61

8.33

1.9

1.7

1.20

1.19

g/l

0.11

177

1109

Other spirochaetal diseases

668

5270

1.28

8.33

1.8

1.18

1.20

g/l

0.63

633

5043

Ulcerative rectosigmoiditis

170

1056

1.64

8.32

1.5

1.8

1.19

g/l

0.13

162

1011

Calcific tendinitis of shoulder

111

613

1.85

8.32

1.8

1.7

1.21

1.19

g/l

0.26

105

582

Hypoplasia of dental enamel

141

2.99

8.31

2.5

1.4

1.03

1.14

g/l

1.28

135

Ventral hernia

440

3282

1.35

8.31

1.6

1.22

1.20

g/l

0.70

412

3138

Appendicitis, broad definition

1521

11654

1.18

8.29

1.8

1.20

1.19

g/l

0.41

1453

11174

Primary gonarthrosis, bilateral

936

6401

1.23

8.28

1.5

1.6

1.24

1.19

g/l

5.83

889

6128

Pre-eclampsia

446

3340

1.35

8.27

2.2

2.0

1.22

1.19

g/l

1.41

432

3203

Acne, including avohilmo

487

2974

1.34

8.26

2.2

2.0

1.13

1.17

g/l

2.36

462

2868

Fracture of lower leg, including ankle

1099

8975

1.21

8.23

1.8

1.7

1.23

1.19

g/l

5.24

1056

8582

Mental and behavioural disorders due to tobacco

184

1169

1.60

8.22

1.9

1.7

1.20

1.19

g/l

0.15

177

1113

Social phobias

179

1129

1.61

8.19

1.6

2.1

1.22

1.18

g/l

0.75

172

1082

Malignant neoplasm of breast, including Hilmo

593

4866

0.77

8.16

1.6

1.8

1.21

g/l

0.04

555

4639

Fracture at wrist and hand level

673

5308

1.27

8.16

1.8

1.7

1.17

1.19

g/l

1.25

644

5096

Malignant neoplasm of breast, HER2-negative, including Hilmo

593

4866

0.77

8.15

1.6

1.8

1.21

g/l

0.04

555

4639

Mental and behavioural disorders due to alcohol

944

7375

1.23

8.15

1.6

1.7

1.20

1.19

g/l

0.79

898

7099

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

566

4387

1.30

8.12

1.8

1.7

1.19

g/l

0.10

542

4196

Chronic periodontitis, complicated

1084

8795

1.21

8.07

1.7

1.21

1.20

g/l

0.87

1033

8426

Malignant neoplasm, wide definition

1824

9176

1.16

8.04

1.8

1.7

1.20

g/l

0.25

1753

8788

Aortic arch syndrome [Takayasu]

10.81

8.02

1.7

1.1

1.20

1.21

g/l

0.02

Degenerative diseases of the nervous system

324

3238

0.71

7.96

1.7

1.5

1.15

1.17

g/l

0.64

300

3065

Other degenerative diseases of the nervous system

449

2447

1.35

7.96

1.8

1.6

1.16

1.17

g/l

0.23

424

2338

Viral haemorrhagic fevers, not elsewhere classified/unspecified

150

914

1.67

7.95

2.0

1.6

1.18

1.19

g/l

0.13

141

875

Acute appendicitis, no complications

1148

9570

1.20

7.92

1.7

1.8

1.20

1.19

g/l

0.55

1097

9187

Ulcerative enterocolitis

357

2.11

7.90

1.8

1.7

1.19

1.20

g/l

0.09

343

Maternal care for other conditions predominantly related to pregnancy

496

3701

1.32

7.87

2.0

2.1

1.20

1.18

g/l

1.01

475

3561

Malignant neoplasm of skin, including Hilmo

991

5467

1.22

7.86

1.8

1.7

1.19

1.20

g/l

0.83

961

5213

Status epilepticus

344

2.11

7.83

1.4

1.6

1.10

1.16

g/l

0.68

326

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

270

1878

1.45

7.79

1.5

1.6

1.20

1.19

g/l

0.11

261

1783

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

192

1231

1.56

7.79

1.7

1.5

1.17

1.16

g/l

0.06

187

1155

Blepharochalasis

515

3967

1.31

7.78

1.6

1.21

1.20

g/l

0.24

495

3769

Other eating disorders

128

753

1.74

7.78

2.2

1.12

1.17

g/l

0.81

123

721

Pneumonitis due to solids and liquids

133

789

1.71

7.77

1.5

1.21

1.18

g/l

0.64

127

749

Hereditary angioödema type 2

28.05

7.76

2.5

1.4

1.33

1.34

g/l

—

Bitten or struck by other mammals

256

1767

1.47

7.75

2.1

1.9

1.19

g/l

0.01

242

1693

Sudden idiopathic hearing loss

187

1209

1.57

7.74

2.0

1.7

1.18

1.19

g/l

0.34

176

1153

Additional codes for the location of defect, injury or illness

122

711

1.75

7.68

1.5

1.7

1.23

1.20

g/l

0.60

115

672

Pre-eclampsia or poor fetal growth

680

5412

1.26

7.64

2.6

1.9

1.19

g/l

0.03

652

5196

Car occupant injured in other and unspecified transport accidents

379

2803

1.37

7.64

1.9

1.8

1.22

1.19

g/l

1.11

359

2691

Hordeolum and other deep inflammation of eyelid

128

757

1.73

7.63

2.3

1.6

1.16

1.20

g/l

0.97

121

721

Carcinoma in situ of skin of other and unspecified parts of face

139

839

1.68

7.63

2.2

1.5

1.15

1.17

g/l

0.19

133

796

Acute appendicitis

1424

11311

1.17

7.63

1.7

1.8

1.20

1.19

g/l

0.36

1359

10842

Ankylosing spondylitis, strict definition

530

1.88

7.61

1.6

1.7

1.23

1.20

g/l

0.57

505

338

2287

1.39

7.59

1.9

1.5

1.12

1.17

g/l

3.09

323

2155

Alcohol abuse, main dg, excluding more controls

265

1848

1.45

7.55

1.8

1.7

1.23

1.18

g/l

1.64

252

1777

Artificial joint re-operation

129

767

1.72

7.54

1.5

1.25

1.19

g/l

1.64

122

730

Spirochaetal infections, other/unspecified, including avohilmo

659

5257

1.26

7.53

1.8

1.18

1.20

g/l

0.67

625

5030

Hypertrophic disorders of skin

122

715

1.74

7.53

2.1

1.8

1.23

1.19

g/l

0.83

115

678

Alzheimer’s disease (Late onset)

164

2103

0.64

7.52

1.7

1.5

1.14

1.15

g/l

0.07

146

1983

Leisure time condition

350

2564

1.38

7.50

1.9

1.8

1.17

1.19

g/l

0.49

333

2442

Other benign neoplasms of skin

696

5589

1.25

7.49

2.0

1.7

1.19

g/l

0.10

662

5335

Gonarthrosis, primary, with knee surgery

1029

6667

1.21

7.49

1.6

1.24

1.19

g/l

6.92

980

6380

Disorders of breast

1086

8014

1.20

7.46

1.8

1.9

1.20

1.19

g/l

0.22

1037

7664

Early complications of trauma

491

1.90

7.42

1.8

1.5

1.30

1.20

g/l

1.90

468

!Aliquae complicationes praecoces traumatis

491

1.90

7.42

1.8

1.5

1.30

1.20

g/l

1.90

468

Other strabismus

439

3320

1.33

7.41

1.7

1.8

1.20

1.19

g/l

0.42

411

3180

Obsessive-compulsive disorder

144

885

1.65

7.39

2.2

2.1

1.13

1.17

g/l

0.90

136

854

Lyme disease

654

5232

1.26

7.31

1.8

1.18

1.20

g/l

0.73

620

5008

Lyme disease, including avohilmo

654

5232

1.26

7.31

1.8

1.18

1.20

g/l

0.73

620

5008

Total colectomy

473

1.91

7.28

1.5

1.6

1.26

1.19

g/l

1.30

448

Total colectomy operation

473

1.91

7.28

1.5

1.6

1.26

1.19

g/l

1.30

448

Vasomotor rhinitis (mode)

148

921

1.64

7.27

1.8

1.20

1.19

g/l

0.32

139

876

Carcinoma in situ of skin

146

906

1.64

7.23

2.5

1.5

1.12

1.18

g/l

1.58

138

863

Peritonsillar abscess

390

2923

1.35

7.20

1.6

1.9

1.19

1.18

g/l

0.38

382

2826

Primary hyperparathyroidism

208

1400

1.51

7.19

1.7

1.6

1.20

g/l

0.03

195

1336

Psoriasis (vulgaris), strict definition

385

2.00

7.13

1.5

1.4

1.28

1.22

g/l

1.01

369

Polycystic kidney disease

320

2.10

6.99

1.3

1.6

1.13

1.19

g/l

0.83

305

Deep endometriosis

208

1410

1.50

6.99

1.6

2.0

1.18

g/l

0.04

197

1343

Bronchitis, not specified as acute or chronic

145

906

1.62

6.97

2.0

1.7

1.20

1.18

g/l

0.36

135

861

Malignant neoplasm of breast, ER-positive, including Hilmo

420

4082

0.76

6.96

1.6

1.8

1.22

1.21

g/l

0.28

390

3891

Postprocedural musculoskeletal disorders, not elsewhere classified

135

831

1.65

6.95

1.6

1.26

1.18

g/l

2.10

130

797

Malignant neoplasm of breast, HER-positive

419

4077

0.76

6.94

1.6

1.8

1.22

1.21

g/l

0.26

389

3887

461

3046

1.31

6.93

1.8

1.5

1.13

1.17

g/l

2.59

439

2888

Myopia

277

1982

1.42

6.91

2.3

1.9

1.20

1.19

g/l

0.24

265

1899

Other salmonella infections, including avohilmo

503

1.85

6.90

2.3

1.6

1.20

1.19

g/l

0.02

474

Desensitization to allergens

128

780

1.68

6.89

1.6

2.0

1.15

1.18

g/l

0.85

128

742

Other secondary gonarthrosis

104

599

1.77

6.87

1.8

1.7

1.21

1.19

g/l

0.30

575

Septal defects

138

839

1.64

6.87

1.4

1.7

1.15

1.18

g/l

0.60

132

802

Astigmatism

131

802

1.66

6.85

1.9

1.6

1.19

1.18

g/l

0.05

125

762

Hypertrophy of breast in women and men

411

3133

1.33

6.82

1.9

1.25

1.20

g/l

3.10

389

2999

Fracture of shoulder and upper arm

659

5311

1.25

6.81

1.8

1.7

1.16

1.20

g/l

1.94

625

5061

Atopic conjunctivitis

564

1.79

6.80

1.7

2.0

1.26

1.18

g/l

1.48

536

Other and unspecified mononeuropathies, also in other diseases

290

2.13

6.74

2.0

1.6

1.17

1.20

g/l

0.21

277

Necrosis of pulp, including avohilmo

1217

10288

1.17

6.71

1.8

1.22

1.19

g/l

3.35

1167

9874

Familial hypercholesterolemia, with ischemic heart disease

134

831

1.63

6.66

1.8

1.5

1.22

1.17

g/l

1.09

128

784

Alcoholic liver disease

169

1107

1.55

6.66

1.4

1.5

1.14

1.21

g/l

1.91

158

1063

Mental and behavioural disorders due to alcohol, excluding acute intoxication

788

6437

1.22

6.64

1.5

1.7

1.20

1.19

g/l

0.52

748

6191

Fall on and from stairs and steps

497

3898

1.29

6.62

1.6

1.8

1.20

1.19

g/l

0.21

478

3718

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

605

4857

1.26

6.61

1.7

1.9

1.20

1.19

g/l

0.72

568

4684

Drug-induced neutropenia

139

875

1.62

6.57

2.3

1.7

1.15

1.18

g/l

0.51

132

841

Third [oculomotor] nerve palsy

209

2.34

6.55

1.1

1.4

1.23

1.18

g/l

0.59

200

Unspecified urinary incontinence

167

1097

1.55

6.52

1.8

1.7

1.17

1.20

g/l

0.61

157

1048

Salpingitis and oophoritis

348

2609

1.35

6.52

1.8

1.22

1.21

g/l

0.32

328

2498

Lactose intolerance

363

1.98

6.50

1.5

1.7

1.15

1.19

g/l

0.57

348

Benign neoplasm: Rectum, anus and anal canal

342

2559

1.35

6.46

1.5

1.6

1.19

g/l

0.12

326

2431

Other infective otitis externa

120

733

1.67

6.41

2.0

1.7

1.18

1.19

g/l

0.12

115

702

Open wound of head

1007

7995

1.19

6.39

1.6

1.7

1.19

g/l

0.10

969

7652

Other retinal artery occlusion

224

2.25

6.36

1.4

1.20

1.18

g/l

0.22

214

Benign neoplasm of meninges

194

1322

1.49

6.36

1.7

1.20

g/l

0.03

177

1268

Alcohol-induced chronic pancreatitis

114

690

1.68

6.31

1.4

1.5

1.23

1.20

g/l

0.36

108

663

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

857

4808

1.21

6.29

1.8

1.6

1.19

1.20

g/l

0.42

828

4581

Examination and encounter for administrative purposes

123

759

1.64

6.26

1.4

1.5

1.21

1.19

g/l

0.20

118

734

Benign neoplasm: Adrenal gland

149

965

1.57

6.25

1.4

1.6

1.25

1.19

g/l

1.17

135

927

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

176

2.44

6.24

1.9

1.5

1.23

1.19

g/l

0.32

169

L02BG Aromatase inhibitors

359

4641

0.76

6.23

1.6

1.7

1.23

1.21

g/l

0.64

339

4421

Disorders of psychological development

239

1573

1.42

6.21

1.7

1.9

1.19

1.17

g/l

0.58

232

1508

Abrasion of teeth

725

5976

1.22

6.20

2.0

1.8

1.17

1.20

g/l

1.84

699

5721

Ulcerative proctitis

125

781

1.63

6.12

1.7

1.8

1.19

g/l

0.01

118

742

Congenital malformations of cardiac septa

143

893

1.58

6.11

1.4

1.7

1.15

1.17

g/l

0.39

137

855

Pediculosis, acariasis and other infestations

121

751

1.64

6.09

2.0

1.6

1.17

1.20

g/l

0.61

115

708

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1108

6967

1.18

6.07

2.5

1.9

1.17

1.19

g/l

2.60

1063

6671

Personal history of other diseases and conditions

243

1735

1.41

6.04

2.0

1.20

1.17

g/l

1.01

233

1663

Monoamine oxidase A inhibitors

207

1443

1.45

6.03

1.6

1.7

1.20

1.19

g/l

0.28

200

1376

Chalazion

212

1486

1.44

6.01

1.9

1.7

1.21

1.20

g/l

0.17

206

1408

Unspecified event, undetermined intent

304

2.03

6.00

1.6

1.5

1.22

1.20

g/l

0.14

291

Malignant neoplasm

1736

8953

1.14

6.00

1.7

1.20

g/l

0.27

1668

8572

Benign neoplasm of mouth and pharynx

195

1348

1.47

5.96

2.2

1.7

1.21

1.19

g/l

0.49

187

1278

Speech and linguistic disorders

182

1190

1.49

5.92

1.6

1.8

1.20

1.17

g/l

0.85

177

1140

Chronic Coagulation defects

327

1.99

5.92

1.7

1.13

1.20

g/l

1.16

309

Injury of muscle and tendon at hip and thigh level

200

1393

1.46

5.89

1.9

1.7

1.21

1.20

g/l

0.31

194

1327

Benign neoplasm: Rectum

305

2279

1.35

5.87

1.5

1.6

1.19

g/l

0.10

289

2173

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

178

1216

1.49

5.85

1.9

2.1

1.28

1.18

g/l

4.46

170

1161

Corneal scars and opacities

307

2.01

5.84

2.5

1.6

1.15

1.20

g/l

0.46

293

Injury of muscle and tendon at lower leg level

275

2026

1.37

5.82

1.7

1.6

1.23

1.19

g/l

1.15

265

1941

Endometriosis ASRM stages 3,4

471

3737

1.27

5.80

1.7

1.9

1.20

1.19

g/l

0.23

450

3575

Injuries to the elbow and forearm

1463

10986

1.15

5.78

1.9

1.7

1.18

1.19

g/l

0.49

1394

10541

Torticollis

182

2.33

5.76

2.0

1.6

1.17

1.19

g/l

0.15

172

Postmenopausal atrophic vaginitis

493

2122

1.28

5.74

2.0

1.7

1.19

1.22

g/l

1.24

472

2014

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

134

865

1.57

5.72

2.0

1.8

1.21

1.20

g/l

0.12

125

824

Fall on same level involving ice and snow

1151

9935

1.16

5.71

1.9

1.7

1.21

1.19

g/l

1.34

1102

9526

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

330

2506

1.33

5.71

1.6

1.9

1.22

1.19

g/l

1.05

309

2414

In situ neoplasms

742

6182

1.21

5.70

2.1

1.7

1.17

1.18

g/l

0.99

704

5897

Drug-induced Cushing's syndrome

8.49

5.68

1.1

1.2

1.43

1.24

g/l

0.77

Basal cell carcinoma, including Hilmo

818

4634

1.20

5.67

1.8

1.6

1.19

1.20

g/l

0.51

786

4411

Any dementia

390

3464

0.77

5.67

1.9

1.5

1.15

1.17

g/l

0.97

362

3285

Gestational [pregnancy-induced] hypertension

555

4493

1.24

5.62

2.1

2.0

1.23

1.18

g/l

4.30

539

4300

Malignant neoplasm

1732

8973

1.13

5.61

1.7

1.20

g/l

0.25

1665

8590

Endometriosis diagnosis and infertility diagnosis occurring together

243

1769

1.39

5.61

1.7

2.1

1.19

1.18

g/l

0.10

232

1688

Benign neoplasm: Cerebral meninges

175

1201

1.48

5.60

1.6

1.7

1.19

1.20

g/l

0.07

162

1151

Stenosis and insufficiency of lacrimal passages

164

1112

1.49

5.57

1.6

1.17

1.19

g/l

0.59

159

1059

Mixed and other personality disorders

165

1122

1.49

5.55

1.8

1.9

1.24

1.20

g/l

0.76

158

1073

Eustachian salpingitis and obstruction

167

1139

1.49

5.53

1.6

2.0

1.20

1.18

g/l

0.26

160

1090

Postmenopausal bleeding

489

2028

1.27

5.52

1.8

1.6

1.21

1.22

g/l

0.07

467

1927

Other menopausal disorders

539

2412

1.26

5.51

1.8

1.7

1.16

1.20

g/l

2.43

524

2297

Other and unspecified injuries of ankle and foot

555

1.71

5.50

1.5

1.7

1.15

1.20

g/l

0.85

522

Alcohol use disorder, ICD-based

723

6031

1.21

5.49

1.5

1.7

1.21

1.19

g/l

0.63

686

5799

Follicular cysts of skin and subcutaneous tissue

327

2495

1.32

5.47

1.4

1.7

1.21

1.20

g/l

0.41

306

2388

Benign neoplasm: Duodenum

280

2.02

5.47

1.4

1.5

1.17

1.19

g/l

0.25

268

Perforation of tympanic membrane

177

1223

1.47

5.46

1.8

1.7

1.18

g/l

0.02

169

1167

Other congenital malformations of skin, including avohilmo

166

1134

1.49

5.46

1.9

1.18

1.19

g/l

0.09

161

1072

Thiazolidinediones

179

1241

1.46

5.42

1.4

1.5

1.30

1.16

g/l

7.35

174

1184

Fracture of femur

413

2931

1.28

5.32

1.8

1.5

1.15

1.18

g/l

1.18

393

2776

Dislocation, sprain and strain of joints and ligaments of knee

1246

9828

1.15

5.32

1.8

1.20

1.19

g/l

1.19

1204

9431

Superficial injury of thorax

272

2031

1.35

5.31

2.0

1.7

1.20

1.19

g/l

0.04

259

1932

Anomalies of dental arch relationship, including avohilmo

407

2898

1.28

5.30

1.7

1.9

1.19

1.18

g/l

0.01

383

2785

Hyperplasia of prostate

520

2351

1.25

5.29

1.6

1.5

1.17

1.19

g/l

0.35

495

2265

Coxarthrosis, primary, with hip surgery

779

6082

1.19

5.29

1.7

1.6

1.21

1.19

g/l

1.04

749

5799

MS-disease / Multiple Sclerosis

153

1036

1.50

5.29

1.8

1.9

1.18

1.19

g/l

0.25

147

981

Hypertrophic scar

105

654

1.63

5.27

2.1

1.8

1.24

1.19

g/l

0.99

100

620

Psychotic depression

109

685

1.61

5.25

1.7

1.8

1.19

1.18

g/l

0.15

100

653

Pediculosis, acariasis and other infestations, including avohilmo

348

2695

1.30

5.24

1.8

1.9

1.17

1.19

g/l

0.36

331

2588

Bursitis of shoulder

230

2.09

5.19

2.2

1.7

1.20

1.24

g/l

0.41

214

Oral lichen planus and hypothyroidism or thyroxine medication

238

2.09

5.18

2.2

1.8

1.16

1.21

g/l

0.62

226

Periapical abscess

893

7630

1.18

5.17

1.7

1.8

1.23

1.19

g/l

3.81

857

7318

Other nonautoimmune haemolytic anaemias

6.97

5.17

2.1

1.5

1.05

1.18

g/l

0.75

Special screening examination for neoplasms

104

649

1.62

5.15

1.7

1.4

1.20

1.22

g/l

0.16

104

618

Female infertility, associated with anovulation

168

1164

1.46

5.15

2.0

1.18

1.17

g/l

0.06

163

1114

Anankastic personality disorder

528

1.70

5.15

1.8

1.9

1.20

1.19

g/l

0.07

502

Lichen sclerosus et atrophicus

198

1414

1.42

5.12

1.8

1.7

1.23

1.22

g/l

0.22

193

1345

Other papulosquamous disorders

135

2.48

5.10

1.5

1.6

1.22

1.18

g/l

0.45

129

Other/unspecified disorders of vestibular function

461

1.75

5.10

1.6

1.19

g/l

0.05

436

Benign intracranial hypertension

142

2.44

5.06

1.9

1.8

1.28

1.18

g/l

0.94

137

Other primary thrombocytopenia

3.63

5.05

1.8

2.0

1.18

1.19

g/l

0.06

Dementia, including avohilmo

511

4280

0.81

5.05

1.9

1.5

1.17

1.18

g/l

0.51

485

4059

Anaemia due to enzyme disorders

14.09

5.05

2.4

1.3

1.01

1.19

g/l

—

Scabies

592

1.65

5.04

1.8

1.7

1.17

1.19

g/l

0.28

561

Complications predominantly related to the puerperium

552

4532

1.23

5.04

2.2

2.0

1.18

1.19

g/l

0.19

526

4351

Presence of other devices

380

2941

1.28

5.04

1.8

1.6

1.14

1.18

g/l

1.51

363

2776

Biguanides

1897

10258

1.12

5.04

1.4

1.8

1.33

1.16

g/l

93.89

1820

9823

Hypertrophy of breast

362

2839

1.29

4.99

1.9

1.26

1.20

g/l

3.95

342

2718

Dementia in Alzheimer disease

126

1579

0.66

4.98

1.8

1.4

1.18

1.15

g/l

0.39

117

1493

Inflammatory diseases of prostate (prostatitis)

185

1312

1.42

4.97

1.4

1.5

1.17

1.18

g/l

0.10

176

1263

Infectious mononucleosis, including avohilmo

173

1214

1.44

4.97

1.9

2.0

1.19

1.18

g/l

0.28

167

1167

Infectious mononucleosis

173

1214

1.44

4.97

1.9

2.0

1.19

1.18

g/l

0.28

167

1167

Any event in cancer register

1903

9962

1.12

4.97

1.8

1.19

g/l

0.03

1816

9551

Redundant prepuce, phimosis and paraphimosis

313

2373

1.31

4.89

1.4

1.5

1.23

1.19

g/l

1.52

294

2287

Suicide or other Intentional self-harm

461

3727

1.25

4.88

1.7

1.8

1.22

1.19

g/l

1.20

430

3590

Acrodermatitis chronica atrophicans

7.17

4.86

1.1

1.2

1.22

1.14

g/l

0.29

All dysplastic lesions of the cervix uteri, vagina or vulva

640

5224

1.20

4.78

2.6

2.0

1.16

1.19

g/l

1.26

611

5013

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

176

1250

1.43

4.77

1.8

2.0

1.22

1.20

g/l

0.58

171

1187

Retinal detachment with retinal break

209

1527

1.38

4.75

1.6

1.16

1.19

g/l

0.86

198

1456

Organ-limited amyloidosis

4.56

4.75

2.9

1.3

1.16

1.12

g/l

0.18

Malignant neoplasm of skin

893

5182

1.17

4.72

1.7

1.19

1.20

g/l

0.57

869

4942

Open wound of forearm

168

1184

1.43

4.72

1.7

1.19

g/l

0.08

161

1129

Non-neuropathic heredofamilial amyloidosis

11.72

4.72

1.6

1.4

1.08

1.12

g/l

—

Other maternal disorders predominantly related to pregnancy

1221

6699

1.15

4.71

2.0

1.22

1.19

g/l

2.98

1166

6420

Emotional disorders and disorders of social functioning with onset specific to childhood

110

698

1.57

4.69

2.2

2.0

1.20

1.16

g/l

0.97

104

670

Ulcerative ileocolitis

458

1.71

4.68

1.5

1.8

1.19

g/l

0.04

436

Dementia

472

3959

0.81

4.66

1.8

1.5

1.16

1.18

g/l

0.46

445

3759

Injury of muscle and tendon at shoulder and upper arm level

608

5079

1.20

4.64

1.7

1.6

1.19

1.20

g/l

0.22

580

4862

Other acute viral hepatitis

161

2.26

4.61

1.7

1.5

1.23

1.20

g/l

0.15

152

Other endocrine disorders

110

686

1.56

4.61

2.5

1.8

1.15

1.17

g/l

0.21

104

655

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

151

1050

1.45

4.57

1.4

1.5

1.26

1.18

g/l

2.32

145

994

Hypertrophy of (infrapatellar) fat pad

2.68

4.56

1.7

1.3

1.12

1.27

g/l

1.43

Glucosamine medication

760

5162

1.18

4.55

1.5

1.6

1.20

1.19

g/l

0.13

717

4920

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

182

2.15

4.50

1.4

1.13

1.14

g/l

0.06

176

L02BA Anti-estrogens

182

2492

0.72

4.47

1.5

1.8

1.21

g/l

0.01

165

2381

Mental disorders, not otherwise specified

167

1190

1.42

4.46

1.8

2.0

1.21

1.18

g/l

0.47

155

1136

Primary coxarthrosis, bilateral

458

3742

1.23

4.42

1.5

1.6

1.23

1.19

g/l

2.21

434

3562

Chronic inflammatory disorders of orbit

4.59

4.41

1.6

1.39

1.17

g/l

1.45

Malignant neoplasm of heart, mediastinum and pleura

138

2.32

4.40

1.3

1.13

1.12

g/l

0.04

133

Sequelae of injuries of head

598

1.60

4.39

1.6

1.23

1.20

g/l

0.33

566

Haemangioma, any site

160

1138

1.42

4.33

1.7

1.8

1.18

1.19

g/l

0.18

151

1084

Presbycusis

191

1381

1.38

4.29

1.6

1.5

1.15

1.16

g/l

0.29

181

1299

Other disorders of breast

278

2157

1.30

4.25

1.7

1.9

1.19

g/l

0.14

271

2063

Scabies, including avohilmo

296

2314

1.29

4.25

1.7

1.9

1.18

1.19

g/l

0.11

282

2221

Coronary artery bypass grafting

324

1887

1.28

4.24

1.5

1.17

g/l

0.04

312

1797

Malignant melanoma

250

1913

1.32

4.21

1.9

1.6

1.19

g/l

0.02

242

1814

Other and/or unspecified nontoxic goitre

145

1019

1.44

4.21

1.7

1.8

1.23

1.19

g/l

0.95

140

973

Benign neoplasm: Skin of lower limb, including hip

337

1.79

4.20

2.9

1.6

1.18

1.19

g/l

0.09

319

Impacted teeth

405

2816

1.24

4.19

2.3

2.0

1.16

1.18

g/l

0.50

397

2708

LSIL lesion of the cervix uteri, vagina or vulva

308

2427

1.28

4.18

3.0

2.0

1.14

1.18

g/l

1.73

295

2327

Traumatic subdural haemorrhage

173

1170

1.39

4.17

2.0

1.5

1.17

g/l

0.01

164

1110

Other and unspecified injuries of lower leg

154

1096

1.42

4.17

1.8

1.9

1.20

1.19

g/l

0.18

148

1045

Unspecified protein-energy malnutrition

3.02

4.17

1.3

1.4

1.25

1.16

g/l

0.54

Malnutrition

258

1.91

4.16

1.4

1.5

1.14

1.17

g/l

0.28

248

Ménière disease

156

1113

1.42

4.16

2.1

1.6

1.19

1.18

g/l

0.15

151

1063

Retinal breaks without detachment

273

2119

1.30

4.15

1.5

1.6

1.16

1.20

g/l

1.40

263

2017

Assault by bodily force

148

1047

1.43

4.14

1.7

1.8

1.15

1.20

g/l

0.91

141

1001

Embedded and impacted teeth

546

3700

1.20

4.14

2.2

2.0

1.17

g/l

0.08

530

3559

Benign neoplasm: Liver

310

1.82

4.11

1.7

1.5

1.30

1.20

g/l

1.35

294

Outcome of delivery

232

1867

0.76

4.10

1.8

2.1

1.15

1.21

g/l

2.20

222

1794

Lethal midline granuloma

16.53

4.06

17.8

1.0

1.15

1.24

g/l

—

Malignant neoplasm of kidney, except renal pelvis

133

926

1.45

4.05

1.5

1.25

1.18

g/l

1.61

127

876

Iridocyclitis in diseases classified elsewhere

211

2.00

4.04

1.8

1.6

1.18

g/l

0.07

200

Bacterial meningitis

386

1.72

4.03

2.5

1.6

1.20

g/l

0.06

368

Other acquired deformities of musculoskeletal system and connective tissue

509

1.62

4.02

1.6

1.18

1.20

g/l

0.22

482

Malignant melanoma, including Hilmo

276

2156

1.29

4.00

1.8

1.6

1.19

g/l

0.01

267

2045

Other specified/unspecified hearing loss

141

996

1.43

3.98

1.6

1.24

1.19

g/l

0.99

133

945

Single delivery by forceps and vacuum extractor

234

1819

0.76

3.96

2.2

2.3

1.14

1.19

g/l

1.94

222

1742

Lack of expected normal physiological development

178

2.01

3.96

1.9

1.7

1.04

1.12

g/l

1.06

169

Any dementia, excluding more controls

367

3113

0.81

3.96

2.0

1.5

1.15

1.17

g/l

0.79

340

2954

Myocardial infarction, with ST-elevation

234

1794

1.31

3.91

1.7

1.5

1.22

1.17

g/l

1.51

219

1703

Other malignant neoplasms of skin (=non-melanoma skin cancer)

784

4595

1.16

3.87

1.7

1.6

1.19

1.20

g/l

0.48

757

4377

Other noninflammatory disorders of uterus, except cervix

377

2035

1.24

3.85

1.8

1.7

1.21

g/l

0.06

367

1929

Other puerperal infections

175

1293

1.37

3.83

2.4

2.1

1.19

1.17

g/l

0.40

167

1239

Benign neoplasm: Pituitary gland, craniopharyngeal duct

645

1.53

3.78

1.5

1.8

1.26

1.19

g/l

1.87

611

Drug phototoxic response

9.55

3.77

1.4

1.3

1.21

1.16

g/l

—

Nontraumatic intracranial haemmorrhage

288

2279

1.27

3.76

1.9

1.5

1.21

1.18

g/l

0.70

274

2164

Perineal laceration during delivery

258

2652

0.78

3.76

2.1

2.2

1.18

1.17

g/l

0.10

250

2543

Emotional disorders starting during childhood or adolescence

106

712

1.50

3.76

2.1

2.0

1.22

1.16

g/l

1.17

100

684

Macular pucker

243

1885

1.30

3.75

1.8

1.5

1.18

g/l

0.04

230

1781

Iliotibial band syndrome

109

2.37

3.75

1.2

1.8

1.21

1.19

g/l

0.09

102

Malignant neoplasm of digestive organs

453

4162

0.83

3.75

1.6

1.18

1.20

g/l

0.57

433

3965

Impacted cerumen

183

1365

1.35

3.74

1.4

1.6

1.24

1.18

g/l

1.60

174

1302

Heberden's nodes [with arthropathy]

110

2.38

3.72

1.2

1.4

1.20

1.24

g/l

0.28

105

Mandibular retrognathia

132

933

1.43

3.71

1.5

1.9

1.19

g/l

0.06

125

890

Assault

241

1872

1.30

3.70

1.7

1.9

1.15

1.20

g/l

1.34

228

1800

Atrial septal defect

526

1.58

3.68

1.4

1.7

1.12

1.18

g/l

1.35

504

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

12.23

3.68

1.7

1.2

1.02

1.17

g/l

—

Other and unspecified injuries of head

128

904

1.43

3.66

1.9

1.6

1.20

1.19

g/l

0.15

120

857

Polyp of the female genital tract

556

2655

1.19

3.64

1.8

1.7

1.20

g/l

0.07

534

2524

Vestibular neuronitis

149

1082

1.39

3.64

1.6

1.22

1.19

g/l

0.69

139

1032

Uterine polyps

523

2565

1.20

3.63

1.8

1.7

1.20

g/l

0.04

497

2438

124

2.26

3.63

1.8

1.7

1.17

1.16

g/l

0.02

118

Traumatic subarachnoid haemorrhage

284

1.78

3.63

1.5

1.6

1.25

1.17

g/l

0.95

271

Autonomic dysreflexia

12.70

3.60

1.3

2.0

1.33

1.22

g/l

—

Other specified and unspecified personality disorders

169

1255

1.36

3.59

1.8

1.9

1.20

1.19

g/l

0.18

160

1199

Alcohol abuse, main dg

265

2092

1.28

3.58

1.8

1.7

1.23

1.19

g/l

1.13

252

2011

Sequelae of injuries of lower limb

166

1230

1.36

3.58

1.8

1.7

1.25

1.20

g/l

1.03

160

1169

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

253

3105

0.78

3.57

1.3

1.6

1.23

1.19

g/l

0.97

234

2953

Superficial injury of forearm

188

1420

1.34

3.56

1.9

1.8

1.20

1.18

g/l

0.28

179

1355

Fracture of forearm

1064

8500

1.13

3.55

1.9

1.7

1.18

1.19

g/l

0.74

1015

8142

Persons encountering health services in circumstances related to reproduction

1114

6645

1.13

3.55

1.9

1.7

1.19

1.21

g/l

1.63

1065

6390

Glaucoma

953

7151

1.14

3.51

1.6

1.19

g/l

0.07

914

6818

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

4.08

3.51

1.3

1.7

1.14

1.18

g/l

0.14

Malignant neoplasm of urinary organs, including Hilmo

164

1216

1.36

3.51

1.4

1.5

1.25

1.18

g/l

2.16

157

1151

Other specific arthropathies

5.53

3.49

1.1

1.26

1.25

g/l

—

Failure in dosage during surgical and medical care

6.55

3.49

2.0

1.7

1.21

1.20

g/l

—

Benign neoplasm: Liver/bile ducts

349

1.70

3.49

1.7

1.5

1.29

1.20

g/l

1.19

331

Neuralgic amyotrophy

5.50

3.49

2.1

1.4

1.03

1.29

g/l

—

Febrile neutrophilic dermatosis [Sweet]

6.50

3.48

2.0

1.4

1.06

1.20

g/l

—

Fitting and adjustment of other devices

563

4224

1.18

3.47

1.7

1.6

1.17

1.19

g/l

0.79

542

4004

Contact with and exposure to communicable diseases

620

5310

1.17

3.46

2.1

1.9

1.18

g/l

0.02

596

5125

Malignant neoplasm of urinary organs

142

1032

1.39

3.45

1.5

1.24

1.18

g/l

1.49

135

979

HSIL lesion of the cervix uteri, vagina or vulva

426

3555

1.21

3.45

2.7

2.0

1.17

1.18

g/l

0.63

406

3428

Basal cell carcinoma

754

4470

1.15

3.45

1.8

1.6

1.19

1.20

g/l

0.41

726

4256

Dislocation, sprain and strain of joints and ligaments of thorax

412

1.63

3.43

2.0

1.6

1.20

g/l

0.04

391

Hereditary factor VIII deficiency

3.98

3.43

2.0

1.5

1.05

1.13

g/l

0.55

Other acantholytic disorders

4.70

3.41

1.4

1.3

1.18

1.21

g/l

—

Tooth eruption problems

292

2265

1.25

3.41

2.1

2.0

1.18

1.17

g/l

0.16

281

2173

Excessive earwax

1158

9405

1.12

3.39

1.8

1.7

1.19

g/l

0.04

1113

8998

Haemangioma and lymphangioma, any site

165

1234

1.35

3.38

1.8

1.17

1.19

g/l

0.33

156

1175

Sequelae of infectious and parasitic diseases

121

860

1.42

3.37

1.5

1.7

1.15

1.19

g/l

0.98

116

820

Dermatitis herpetiformis

204

1.91

3.37

2.3

1.5

1.14

1.19

g/l

0.57

195

Benign lipomatous neoplasm

498

4223

1.19

3.35

1.9

1.7

1.21

1.19

g/l

0.42

477

4031

Injury of nerves at hip and thigh level

3.22

3.34

2.0

1.7

1.16

1.14

g/l

0.06

Open wound of wrist and hand

823

6994

1.14

3.34

1.7

1.20

1.19

g/l

0.37

794

6724

Pemphigus foliaceus

7.40

3.33

1.6

1.1

1.24

1.22

g/l

—

Injury of muscle and tendon at wrist and hand level

223

1741

1.29

3.33

1.5

1.7

1.21

1.20

g/l

0.16

214

1666

Sequelae of infectious and parasitic diseases, including avohilmo

123

879

1.41

3.33

1.5

1.7

1.15

1.19

g/l

0.88

118

839

Pityriasis lichenoides et varioliformis acuta

6.04

3.33

1.3

1.01

1.22

g/l

—

Lactose intolerance, other/unspecified

316

1.71

3.30

1.4

1.7

1.15

1.19

g/l

0.52

301

Benign neoplasm: Skin of other and unspecified parts of face

169

1273

1.34

3.29

1.8

1.7

1.18

1.19

g/l

0.16

161

1212

Lesion of femoral nerve

2.60

3.28

1.3

1.4

1.22

1.20

g/l

0.10

Malignant melanoma of skin, including Hilmo

225

1763

1.29

3.27

1.5

1.6

1.19

g/l

0.01

217

1669

Chronic suppurative otitis media, including avohilmo

131

950

1.39

3.27

1.5

1.7

1.21

1.18

g/l

0.49

126

906

Inflammatory disorders of breast

136

994

1.39

3.26

2.1

1.17

1.18

g/l

0.20

130

942

Other otitis externa (chronic)

117

833

1.42

3.26

1.7

1.26

1.18

g/l

1.41

111

792

Mucinosis of skin

5.96

3.24

1.4

1.3

1.15

1.28

g/l

—

Other and unspecified injuries of wrist and hand

506

1.55

3.23

2.1

1.7

1.18

1.19

g/l

0.09

478

Complications of other internal prosthetic devices, implants and grafts

458

1.57

3.23

1.8

1.6

1.19

1.17

g/l

0.13

437

All dysplastic lesions of the cervix uteri

551

4659

1.17

3.19

2.6

2.0

1.16

1.18

g/l

1.35

523

4474

Other and unspecified heterotropia

3.95

3.19

1.9

1.6

1.17

1.22

g/l

0.14

Sweet's syndrome

5.67

3.19

2.0

1.3

1.06

1.17

g/l

—

Benign neoplasm: Long bones of lower limb

405

1.61

3.18

2.3

1.7

1.15

1.20

g/l

0.71

385

282

1.74

3.18

2.4

1.7

1.10

1.19

g/l

1.25

262

Benign neoplasm: Other and unspecified parts of small intestine

187

1.93

3.17

1.3

1.6

1.26

1.18

g/l

0.85

178

Malignant melanoma of skin

185

1422

1.31

3.14

1.3

1.6

1.19

g/l

0.12

179

1345

Cicatricial pemphigoid

4.69

3.10

2.1

1.3

1.09

1.18

g/l

—

Mesothelioma, including Hilmo

119

2.16

3.10

1.4

1.11

1.12

g/l

0.02

114

Intracerebral haemorrhage

169

1285

1.32

3.09

2.0

1.5

1.21

1.17

g/l

0.66

163

1215

Disorders in reading

196

1.88

3.08

1.5

1.7

1.20

1.19

g/l

0.06

181

Fasciculation

154

2.01

3.07

2.2

1.6

1.18

g/l

0.03

147

Brain meningioma, including Hilmo

610

1.48

3.07

1.5

1.7

1.23

1.19

g/l

0.52

580

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

4.12

3.06

1.2

1.7

1.26

1.11

g/l

—

All dysplastic lesions of the vulva

611

1.48

3.06

4.2

2.0

1.15

1.19

g/l

0.61

581

Primary ovarian failure

286

1.72

3.06

3.2

1.8

1.19

g/l

0.05

270

Certain conditions originating in the perinatal period

164

1106

1.33

3.00

1.8

1.9

1.17

1.16

g/l

0.19

157

1064

Sulfonylureas

460

3102

1.18

3.00

1.3

1.6

1.23

1.15

g/l

6.78

438

2941

Early lumbar disc prolapse operation

200

1565

1.29

2.99

1.9

1.23

1.20

g/l

1.03

191

1497

Crushed, pushed or stepped on by crowd or human stampede

136

1009

1.36

2.98

2.0

1.8

1.24

1.19

g/l

1.04

126

959

Sequelae of other and unspecified infectious and parasitic diseases

697

1.44

2.98

1.6

1.8

1.14

1.19

g/l

0.90

662

Acne varioliformis

4.40

2.96

2.7

1.5

1.02

1.16

g/l

—

Other secondary gout

3.95

2.96

1.3

1.8

1.24

1.12

g/l

—

Nystagmus and other irregular eye movements

186

1.88

2.90

2.0

1.6

1.23

1.17

g/l

0.58

180

Graves disease, strict definition

195

1529

1.29

2.89

1.5

1.9

1.23

1.18

g/l

1.31

184

1455

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

703

1.43

2.85

1.6

1.8

1.14

1.19

g/l

0.92

668

Effects of foreign body entering through natural orifice

407

3449

1.19

2.83

1.6

1.8

1.17

1.19

g/l

0.47

396

3311

Type 1 diabetes, strict (exclude DM2)

171

1320

1.30

2.80

2.0

1.10

1.16

g/l

2.69

158

1263

Brain meningioma

598

1.46

2.79

1.5

1.7

1.23

1.19

g/l

0.59

568

Monocytic leukaemia

3.21

2.78

7.3

1.3

1.31

1.16

g/l

1.09

Tuberculosis of nervous system, including avohilmo

6.60

2.78

1.3

1.1

1.19

1.21

g/l

—

Tuberculosis of nervous system

6.60

2.78

1.3

1.1

1.19

1.21

g/l

—

Type 1 diabetes, definitions combined

172

1331

1.30

2.77

2.0

1.10

1.17

g/l

2.53

159

1273

LSIL lesion of the cervix uteri

237

1917

1.25

2.72

2.6

2.0

1.14

1.18

g/l

1.01

225

1837

Transient synovitis

2.40

2.70

1.6

1.4

1.18

1.21

g/l

0.13

Other benign neoplasms of connective and other soft tissue

163

1262

1.30

2.69

1.9

1.8

1.19

g/l

0.04

155

1205

Other and unspecified disorders of lacrimal system

5.02

2.66

2.9

1.4

1.17

1.19

g/l

—

Cauda equina syndrome

163

1.89

2.63

1.7

1.4

1.35

1.18

g/l

2.07

156

Hypergammalglobulinemia, unspecified

8.02

2.63

3.0

1.4

1.27

0.99

g/l

—

Embedded teeth, including avohilmo

172

1346

1.29

2.62

1.9

2.0

1.20

1.18

g/l

0.37

164

1291

Burns and corrosions

235

1907

1.24

2.62

1.7

1.8

1.20

1.19

g/l

0.19

223

1827

Other and unspecified mononeuropathies of lower limb

291

1.64

2.61

2.4

1.6

1.23

1.20

g/l

0.24

275

Use of antiglaucoma preparations and miotics

106

774

1.38

2.60

1.5

1.18

g/l

0.01

101

735

Contraceptive management

792

4934

1.13

2.60

2.1

1.8

1.19

1.22

g/l

2.17

761

4761

Injury of other and unspecified intrathoracic organs

690

1.41

2.60

1.9

1.5

1.16

1.19

g/l

0.39

660

Benign neoplasm of middle ear and respiratory system

114

843

1.36

2.60

1.5

1.6

1.20

1.19

g/l

0.13

107

799

Erythema in diseases classified elsewhere

3.77

2.57

2.8

1.4

1.10

1.18

g/l

—

Medullary cystic kidney disease, nephronophthisis

4.23

2.56

1.5

1.4

1.14

1.24

g/l

—

Drug-induced gout

3.37

2.56

1.1

1.7

1.41

1.14

g/l

—

Deep bite

215

1519

1.25

2.56

1.8

1.9

1.16

1.18

g/l

0.33

205

1461

Fracture of skull and facial bones

353

2985

1.19

2.56

2.0

1.7

1.17

1.19

g/l

0.50

342

2861

Erythema annulare centrifugum

4.19

2.56

2.4

1.4

1.16

1.26

g/l

—

Inflammation of lacrimal passages (acute and unspecified)

194

1.79

2.55

2.0

1.6

1.15

1.19

g/l

0.42

187

HSIL lesion of the vulva

225

1.73

2.52

6.1

1.7

1.17

1.22

g/l

0.29

213

Other disorders of the genitourinary system

209

1684

1.25

2.51

1.8

1.7

1.20

1.19

g/l

0.15

198

1597

Colectomy operation

249

2045

1.22

2.49

1.7

1.6

1.21

1.19

g/l

0.76

241

1940

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

5.54

2.48

1.3

1.1

1.21

1.25

g/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

168

1322

1.28

2.46

1.7

1.5

1.18

1.17

g/l

0.13

156

1251

Other superficial mycoses, including avohilmo

193

1545

1.26

2.46

1.7

1.9

1.21

1.18

g/l

0.75

185

1478

Palmar fascial fibromatosis [Dupuytren]

185

1473

1.26

2.45

1.3

1.5

1.15

1.18

g/l

0.83

178

1400

Use of rivastigmine

122

1599

0.76

2.44

1.9

1.4

1.13

1.17

g/l

0.64

113

1496

Single spontaneous delivery

629

3759

0.88

2.44

1.8

1.9

1.18

1.20

g/l

0.71

594

3594

Glaucoma suspect

596

5258

1.14

2.44

1.7

1.6

1.20

1.19

g/l

0.32

574

5008

Nontoxic single thyroid nodule

124

940

1.33

2.43

2.0

1.8

1.16

1.19

g/l

0.66

114

895

Hypermetropia

124

939

1.33

2.43

2.0

1.8

1.14

1.19

g/l

1.13

111

896

Pityriasis lichenoides chronica

2.75

2.42

1.4

2.0

1.20

1.17

g/l

0.26

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

268

1.64

2.37

2.4

1.7

1.14

1.17

g/l

0.32

255

Kyphosis

140

1.90

2.36

1.8

1.7

1.23

1.17

g/l

0.49

132

Hypoplasia of dental enamel, prenatal , including avohilmo

2.35

2.36

1.6

1.2

1.08

1.17

g/l

0.54

Endovascular or surgical operations to intracerebral aneurysms

661

1.39

2.35

2.1

1.6

1.16

1.19

g/l

0.66

633

Chronic drug-induced interstitial lung disorders

5.04

2.34

2.5

1.1

1.12

1.14

g/l

—

Erythrasma

3.71

2.33

1.9

1.7

1.07

1.22

g/l

—

Transient acantholytic dermatosis [Grover]

4.92

2.32

1.0

1.5

1.30

1.19

g/l

—

Contact with heat and hot substances

672

1.38

2.31

1.4

1.6

1.18

1.19

g/l

0.08

635

Injury of eye and orbit

235

1936

1.22

2.31

1.5

1.8

1.20

1.19

g/l

0.25

227

1852

Family history of other conditions

201

1.73

2.29

1.6

1.8

1.22

g/l

0.00

193

Mixed conductive and sensorineural hearing loss

181

1452

1.25

2.29

1.7

1.6

1.19

1.20

g/l

0.08

173

1379

Medical abortion

1296

6447

1.09

2.29

1.8

1.9

1.20

1.19

g/l

0.71

1217

6186

Interstitial myositis

6.21

2.29

1.2

1.16

1.35

g/l

—

Nonpyogenic thrombosis of intracranial venous system

128

1.94

2.27

2.5

1.6

1.29

1.19

g/l

0.53

121

Malignant neoplasm of digestive organs, including Hilmo

540

4497

0.88

2.24

1.7

1.6

1.18

1.20

g/l

0.43

515

4283

Other bursal cyst

150

1.84

2.24

1.7

1.8

1.12

1.20

g/l

0.84

141

Retinal haemorrhage

280

1.60

2.23

1.9

1.4

1.17

1.21

g/l

0.46

266

Acute alcohol intoxication

398

3444

1.16

2.21

1.7

1.22

1.19

g/l

1.51

378

3312

Liver disorders in diseases classified elsewhere

2.79

2.21

3.6

1.4

1.30

1.17

g/l

0.73

Diphtheria

4.65

2.21

2.8

1.8

1.17

1.12

g/l

—

Other and unspecified corneal deformities and disorders

369

1.51

2.21

1.6

1.24

1.21

g/l

0.37

349

Generalized epilepsy

543

1.42

2.20

1.7

1.14

1.19

g/l

0.57

514

Explicit viral Sepsis

6.09

2.19

1.8

1.5

1.06

1.12

g/l

—

Other fall from one level to another

384

3316

1.16

2.19

1.7

1.8

1.21

1.18

g/l

1.15

369

3174

Peroneal tendinitis

182

1.73

2.15

1.9

1.8

1.22

1.21

g/l

0.10

171

LSIL lesion of the vulva

389

1.49

2.13

3.9

1.9

1.13

1.21

g/l

1.38

368

Benign neoplasm: Pancreas

316

1.54

2.12

1.6

1.15

1.18

g/l

0.21

301

Hypertension, portal

3.05

2.12

2.2

1.4

1.12

1.22

g/l

—

Actinomycosis

2.82

2.11

1.5

1.4

1.24

1.21

g/l

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

3.76

2.11

1.1

1.8

1.28

1.20

g/l

—

Acute alcohol intoxication, ICD10

326

2792

1.17

2.10

1.6

1.8

1.22

1.19

g/l

1.15

312

2678

Subclinical iodine-deficiency hypothyroidism

4.35

2.10

1.3

1.1

1.20

1.32

g/l

—

Hyposplenism

4.31

2.09

2.5

1.5

1.22

1.18

g/l

—

Endometriosis in cutaneous scar

2.63

2.07

5.3

1.6

1.14

1.18

g/l

0.17

Malignant neoplasm of other and ill-defined sites

4.14

2.06

1.0

1.5

1.36

0.98

g/l

—

Environmental-pollution-related condition

3.76

2.06

1.1

1.5

1.24

1.21

g/l

—

Malignant neoplasm of endocrine gland, including Hilmo

139

1098

1.28

2.05

1.5

1.8

1.19

g/l

0.02

129

1031

Preterm labour and delivery

491

4341

1.14

2.04

2.2

1.9

1.19

1.20

g/l

0.43

474

4154

Benign neoplasm of eye and adnexa

164

1322

1.25

2.03

1.6

1.7

1.18

1.19

g/l

0.12

154

1258

Ankylosis of teeth

3.19

2.03

1.0

1.4

1.03

1.21

g/l

—

Intermittent heterotropia

103

782

1.33

2.03

1.6

1.7

1.19

1.17

g/l

0.28

743

Fibrosis and sclerosis of liver

4.29

2.03

1.7

1.4

1.28

1.14

g/l

—

Delivery

642

3774

0.89

2.02

1.9

1.18

1.20

g/l

0.56

609

3608

Inguinal hernia

947

5747

1.10

2.02

1.5

1.6

1.15

1.19

g/l

3.37

906

5505

Alcohol dependence

403

3520

1.15

2.01

1.5

1.6

1.21

1.19

g/l

0.81

382

3381

Benign neoplasm of bone and articular cartilage

145

1155

1.27

2.01

2.1

1.8

1.16

1.19

g/l

0.54

134

1102

Female genital prolapse

501

2456

1.14

2.00

1.8

1.7

1.20

g/l

0.22

476

2338

Cystic fibrosis with pulmonary manifestations

4.12

2.00

2.3

1.4

1.03

1.16

g/l

—

Cholera

4.93

1.99

1.0

1.3

1.05

1.16

g/l

—

Ovarian dysfunction

158

1273

1.25

1.99

2.3

2.1

1.25

1.17

g/l

2.50

151

1217

Lens-induced iridocyclitis

4.02

1.98

3.7

1.7

1.37

1.09

g/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

197

2379

0.82

1.97

1.3

1.6

1.16

1.19

g/l

0.71

188

2263

Spontaneous abortion

939

5752

1.10

1.96

1.9

2.0

1.18

1.19

g/l

0.62

897

5529

Pemphigus vulgaris

3.39

1.93

1.3

1.1

0.99

1.26

g/l

—

Solid cancers, including Hilmo

1653

9006

1.07

1.92

1.8

1.7

1.21

1.20

g/l

0.72

1588

8624

Explicit viral Sepsis, including avohilmo

4.87

1.91

1.8

1.5

1.06

1.12

g/l

—

Sequelae of tuberculosis, including avohilmo

128

1.82

1.91

1.3

1.15

g/l

0.01

123

Thyrotoxicosis with toxic multinodular goitre

722

1.33

1.91

1.4

1.6

1.16

1.19

g/l

0.45

686

HSIL lesion of the cervix uteri

376

3288

1.15

1.89

2.7

2.1

1.16

1.18

g/l

0.68

357

3171

Kissing spine

3.75

1.88

1.3

1.27

1.12

g/l

—

Memory loss

125

987

1.28

1.88

1.8

1.5

1.21

1.18

g/l

0.42

111

935

Other inflammation of vagina/vulva

552

1.38

1.87

1.6

2.1

1.17

1.19

g/l

0.27

521

Burns and corrosions of external body surface, specified by site

176

1445

1.23

1.87

1.4

1.8

1.18

1.19

g/l

0.08

166

1383

Complications following myocardial infarction

2.25

1.86

1.4

1.13

1.12

g/l

0.04

Colorectal cancer

254

2860

0.85

1.85

1.6

1.18

1.19

g/l

0.21

242

2710

Sickle-cell disorders

2.91

1.83

1.0

1.9

1.25

1.19

g/l

—

Lordosis

3.19

1.83

2.3

1.6

1.14

1.20

g/l

—

Myeloid leukaemia

295

1.51

1.82

1.5

1.6

1.20

1.17

g/l

0.27

278

Acquired keratosis [keratoderma] palmaris et plantaris

2.43

1.82

2.0

1.5

1.17

1.20

g/l

0.09

Microcephaly

4.55

1.81

2.6

1.3

1.15

1.14

g/l

—

Divergent concomitant strabismus

126

1002

1.27

1.80

1.5

1.8

1.27

1.19

g/l

1.99

116

951

Drug-induced fever

3.56

1.79

1.0

1.3

1.18

1.27

g/l

—

Diphtheria, including avohilmo

3.56

1.79

2.8

1.6

1.17

1.16

g/l

—

Rickettsioses

3.56

1.79

1.2

1.4

1.25

1.04

g/l

—

Hyperchylomicronaemia

3.53

1.78

1.5

1.6

1.17

1.16

g/l

—

Other disorders of skin and subcutaneous tissue related to radiation

3.16

1.78

2.0

1.4

1.28

1.16

g/l

—

Linear scleroderma

4.27

1.77

2.4

1.2

1.30

1.14

g/l

—

Drug-induced interstitial lung disorders, unspecified

3.12

1.77

1.3

1.33

1.15

g/l

—

Rickettsioses, including avohilmo

3.09

1.76

1.1

1.5

1.37

1.04

g/l

—

Scleritis and episcleritis in diseases classified elsewhere

4.18

1.76

3.8

1.2

1.20

1.17

g/l

—

Inguinal hernia, bilateral

142

1148

1.24

1.76

1.4

1.5

1.15

1.19

g/l

0.80

136

1102

Hip and thigh

3.06

1.76

2.0

1.7

1.24

1.17

g/l

—

Colorectal cancer, including Hilmo

295

3171

0.86

1.73

1.7

1.6

1.18

1.19

g/l

0.26

281

3011

Calcific tendinitis

1.95

1.73

1.6

1.2

1.23

g/l

0.00

False labour

635

3564

1.11

1.72

1.6

2.1

1.17

1.19

g/l

1.04

614

3424

Malignant neoplasm of bladder, including Hilmo

139

1109

1.24

1.72

1.3

1.5

1.15

1.16

g/l

0.17

128

1050

Transepidermal elimination disorders

3.42

1.71

2.7

1.8

1.07

1.19

g/l

—

Hereditary lymphedema

3.39

1.71

2.8

1.2

1.21

1.15

g/l

—

Wet age-related macular degeneration

217

1768

1.19

1.70

1.7

1.5

1.16

g/l

0.11

206

1663

Otorrhoea

2.59

1.70

2.1

1.5

1.33

1.22

g/l

—

Malignant neoplasm of thyroid gland, including Hilmo

123

984

1.26

1.69

1.6

1.8

1.20

1.19

g/l

0.06

115

921

Other osteochondropathies

113

895

1.27

1.69

2.1

1.7

1.20

g/l

0.01

103

852

Interstitial cystitis (chronic), drug-induced

2.57

1.69

1.4

1.3

1.35

1.20

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

182

1517

1.21

1.69

2.1

1.8

1.15

1.19

g/l

0.93

172

1448

Benign neoplasm: Skin of eyelid, including canthus

236

2013

1.18

1.68

1.9

1.7

1.22

1.19

g/l

0.67

223

1918

Dementia due to Parkinson's disease

227

0.48

1.68

1.1

1.3

1.15

1.14

g/l

0.04

217

Other acute disseminated demyelination

150

1.71

1.68

3.0

1.7

1.09

1.19

g/l

0.93

143

Other sideroblastic anaemias

2.89

1.67

1.1

1.3

1.06

1.16

g/l

—

Perioral dermatitis, drug-induced

3.93

1.67

2.8

1.8

1.18

1.11

g/l

—

UC patients in KELA-register (code 208), prior to 1994

478

1.37

1.66

1.5

1.6

1.16

1.20

g/l

0.57

454

Fitting and adjustment of external prosthetic device

2.50

1.66

1.7

1.6

1.15

1.12

g/l

—

Malignant neoplasm of thyroid gland

112

889

1.27

1.66

1.6

1.8

1.19

g/l

0.06

104

839

Fourth [trochlear] nerve palsy

253

1.53

1.66

1.4

1.17

1.19

g/l

0.18

244

Pregnancy examination and test

335

1813

1.15

1.65

2.1

1.19

1.20

g/l

0.47

316

1748

Disorders of lacrimal system and orbit in diseases classified elsewhere

294

1.48

1.65

1.6

1.17

1.19

g/l

0.15

280

Hydrocele

137

1113

1.24

1.64

1.6

1.4

1.15

1.17

g/l

0.17

132

1068

Lipomatosis, not elsewhere classified

2.62

1.63

1.4

1.5

1.27

1.11

g/l

—

Inguinal or femoral hernia, bilateral

144

1178

1.23

1.62

1.4

1.5

1.15

1.19

g/l

0.86

138

1129

Other sexually transmitted chlamydial diseases, including avohilmo

179

1498

1.20

1.61

1.8

2.0

1.15

1.18

g/l

0.66

168

1439

247

1.52

1.60

1.7

2.0

1.13

1.18

g/l

0.77

235

Malignant neoplasm of vulva

114

1.80

1.60

3.2

1.9

1.07

1.17

g/l

0.50

109

Sequelae of tuberculosis

121

1.76

1.59

1.4

1.3

1.13

1.15

g/l

0.12

116

Secondary malignant neoplasm of respiratory and digestive organs

175

0.45

1.59

1.4

1.5

0.93

1.14

g/l

—

167

Other sexually transmitted chlamydial diseases

112

895

1.26

1.58

1.9

2.0

1.13

1.18

g/l

1.31

103

853

Malignant neoplasm of endocrine gland

119

958

1.25

1.58

1.6

1.8

1.20

1.19

g/l

0.07

111

900

Alzheimer’s disease (Late onset), excluding more controls

122

982

0.80

1.57

1.8

1.5

1.15

1.17

g/l

0.27

109

925

Adenocarcinoma and Papillary adenocarcinoma of kidney

115

1.78

1.55

2.0

1.4

1.25

1.17

g/l

0.52

108

Cystic fibrosis, other manifestations/unspecified

3.06

1.55

2.3

2.0

0.92

1.19

g/l

—

Drug-induced thyroiditis

2.71

1.54

1.4

1.6

1.27

1.17

g/l

—

Disorders of aromatic amino-acid metabolism

2.69

1.54

1.3

1.4

1.24

1.14

g/l

—

Non-small cell lung cancer, adenocarcinoma

641

1.30

1.54

1.6

1.13

1.17

g/l

0.52

605

Unspecified lump in breast

271

2357

1.16

1.53

1.7

1.8

1.18

1.20

g/l

0.53

257

2244

Glaucoma secondary to eye inflammation

1.90

1.53

2.8

1.6

1.17

1.15

g/l

0.13

Combinations of oral blood glucose lowering drugs

413

3690

1.12

1.53

1.3

1.7

1.30

1.16

g/l

15.87

394

3523

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

217

1858

1.17

1.51

2.2

1.7

1.19

1.20

g/l

0.26

205

1769

Other and unspecified disease of Bartholin gland

342

1.42

1.51

1.4

1.7

1.20

g/l

0.05

327

Open bite

102

812

1.27

1.51

1.8

1.9

1.13

1.18

g/l

0.91

774

Diastasis of muscle

1.85

1.50

2.6

1.5

1.23

1.20

g/l

0.16

Von Willebrand disease

171

1.61

1.49

1.4

1.5

1.09

1.24

g/l

1.90

166

Benign neoplasm: Eye, unspecified

2.20

1.48

1.3

1.4

1.14

1.12

g/l

0.08

Nutritional marasmus

2.87

1.46

1.7

1.1

1.18

g/l

—

Injury of blood vessels at shoulder and upper arm level

3.28

1.46

1.4

1.6

1.31

1.21

g/l

—

Cyst of spleen

3.28

1.46

2.2

1.6

1.04

1.20

g/l

—

Foreign body in respiratory tract

649

1.29

1.43

1.4

1.7

1.18

1.20

g/l

0.22

614

Malignant neoplasm of breast, HER-negative

256

2815

0.87

1.43

1.4

1.7

1.18

1.21

g/l

0.94

245

2671

Subarachnoid haemorrhage

136

1124

1.22

1.42

1.8

1.6

1.20

1.19

g/l

0.16

128

1074

Melanoma in situ of other and unspecified parts of face

134

1.67

1.42

1.4

1.3

1.20

1.15

g/l

0.33

129

Ectopic pregnancy

320

2835

1.13

1.41

1.7

1.9

1.21

1.19

g/l

0.53

305

2728

Combined immunodeficiency, unspecified

3.22

1.40

3.2

1.5

1.08

1.13

g/l

—

Congenital retinoschisis

2.74

1.39

2.0

1.6

1.28

1.18

g/l

—

Gestational diabetes (for exclusion)

675

5043

0.92

1.39

1.7

2.1

1.27

1.17

g/l

13.75

645

4851

Phantom limb syndrome

2.70

1.39

1.7

1.4

1.18

1.14

g/l

—

Complications of the puerperium, not elsewhere classified

635

1.29

1.38

1.9

2.1

1.18

1.19

g/l

0.12

600

Antenatal screening

387

2419

0.89

1.38

2.1

2.0

1.19

1.21

g/l

0.54

375

2332

Alcohol-induced acute pancreatitis

391

1.37

1.38

1.2

1.4

1.29

1.20

g/l

1.24

375

Delivery, wide proxy

526

3069

0.91

1.37

2.0

1.9

1.18

1.19

g/l

0.23

499

2926

Papillary adenocarcinoma of thyroid gland

662

1.28

1.37

1.6

1.9

1.22

1.18

g/l

0.53

627

Other appendicitis

133

1103

1.21

1.37

1.9

1.8

1.18

1.19

g/l

0.10

127

1061

Malignant neoplasm of prostate

281

1891

0.88

1.35

1.2

1.4

1.20

1.18

g/l

0.22

270

1813

Vitreous prolapse

2.18

1.33

1.2

1.5

1.05

1.21

g/l

—

Drug-induced acute pancreatitis

2.64

1.33

1.2

1.6

1.29

1.21

g/l

—

Other respiratory conditions originating in the perinatal period

2.67

1.33

2.2

1.3

1.05

1.14

g/l

—

Sequelae of intentional self-harm, assault and events of undetermined intent

1.89

1.32

1.6

1.7

1.19

1.20

g/l

0.06

Inflammatory disease of cervix uteri

100

809

1.25

1.32

2.2

1.9

1.17

1.20

g/l

0.57

772

Benign neoplasm: Rectosigmoid junction

429

1.34

1.31

1.8

1.6

1.13

1.18

g/l

0.51

408

Cutaneous autosensitization

2.95

1.31

1.8

1.3

1.28

g/l

—

Abnormal findings in peritoneal fluid saliva

2.43

1.31

1.0

1.6

1.36

1.09

g/l

—

Alport

2.94

1.31

1.4

1.5

0.85

1.17

g/l

—

Actinomycosis, including avohilmo

2.15

1.30

1.5

1.3

1.24

1.20

g/l

—

Other complications of labour and delivery, not elsewhere classified

194

1991

0.86

1.30

2.1

2.3

1.16

1.17

g/l

0.12

186

1910

Injury of blood vessels of thorax

2.36

1.29

1.3

1.2

1.20

1.18

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

659

1.27

1.29

1.6

1.5

1.13

1.18

g/l

0.64

631

Puerperal sepsis

216

1878

1.16

1.29

1.9

1.8

1.21

1.22

g/l

0.16

208

1789

Attention to artificial openings

388

1.35

1.27

1.4

1.5

1.25

1.18

g/l

1.04

367

Transient retinal artery occlusion

2.51

1.27

1.7

2.1

1.12

1.19

g/l

—

Malignant neoplasm of colon

145

1714

0.84

1.26

1.8

1.6

1.18

1.19

g/l

0.02

139

1619

Intentional self-harm by sharp object

329

1.38

1.26

1.4

1.8

1.26

1.18

g/l

0.67

314

Other disorders of cornea

148

1251

1.19

1.26

1.7

1.21

1.19

g/l

0.39

140

1195

Parkinson's disease, strict definition, excluding more controls

142

1114

1.19

1.25

1.5

1.14

1.18

g/l

0.98

136

1053

Malignant neoplasm of head and neck

103

841

1.23

1.25

2.1

1.6

1.16

1.18

g/l

0.29

792

Carcinoma in situ of breast, intraductal

1166

0.81

1.25

1.3

1.8

1.17

1.21

g/l

0.68

1108

Cytomegaloviral hepatitis

2.26

1.25

4.1

1.4

1.14

1.20

g/l

—

Tarsal tunnel syndrome

108

1.70

1.24

1.6

1.5

1.18

g/l

0.00

103

Other and unspecified disorders of sclera

2.79

1.24

1.2

1.20

g/l

—

malignant neoplasm of male genital organs

295

2000

0.89

1.24

1.4

1.21

1.19

g/l

0.50

284

1919

Unspecified visual impairment (binocular)

188

1.51

1.23

1.6

1.5

1.13

1.15

g/l

0.18

177

Parkinson's disease, excluding more controls

154

1203

1.18

1.22

1.5

1.15

1.18

g/l

0.79

148

1138

Other and unspecified disorders of globe

2.42

1.21

1.7

1.3

1.20

1.14

g/l

—

Phantom limb syndrome with pain

2.39

1.20

1.7

1.1

1.18

1.15

g/l

—

Circumscribed brain atrophy

225

0.57

1.20

1.0

1.6

1.26

1.19

g/l

0.38

215

Foreign body or object entering through skin

765

1.24

1.20

1.3

1.6

1.21

1.19

g/l

0.17

729

Other disorders of penis

124

1037

1.20

1.18

1.4

1.5

1.21

1.18

g/l

0.64

119

998

Solar urticaria

2.65

1.18

1.2

1.5

1.54

1.21

g/l

—

187

1623

1.16

1.17

1.9

2.2

1.19

1.16

g/l

0.70

178

1564

Benign mammary dysplasia

223

1959

1.14

1.17

1.6

1.8

1.17

1.20

g/l

1.02

214

1855

Acute and transient psychotic disorders

135

1592

0.84

1.17

2.1

1.8

1.20

g/l

0.10

128

1528

Congenital mitral valve regurgitation

2.49

1.16

1.1

1.3

0.97

1.28

g/l

—

Hypothyroidism due to medicaments and other exogenous substances

126

1.61

1.16

1.2

1.5

1.29

1.19

g/l

0.80

119

Habitual aborter

283

1.39

1.16

2.4

2.2

1.15

1.19

g/l

0.31

263

Oesophagitis, drug-induced

2.45

1.15

1.9

1.2

1.52

1.17

g/l

—

Colorectal adenocarcinoma

209

2348

0.88

1.13

1.6

1.19

g/l

0.11

200

2220

Schizophrenia or delusion

438

4785

0.91

1.12

1.7

1.8

1.22

1.19

g/l

1.17

418

4600

Thyrotropin deficiency

160

1.53

1.12

3.0

1.6

1.21

1.19

g/l

0.16

155

Schizophrenia, schizotypal and delusional disorders

440

4803

0.91

1.11

1.7

1.8

1.22

1.19

g/l

1.17

420

4619

Cholera, including avohilmo

2.47

1.11

1.0

1.5

1.05

1.19

g/l

—

Presbyopia

128

1084

1.19

1.10

1.8

1.15

1.20

g/l

1.33

121

1034

Type1 diabetes, definitions combined, early onset

109

906

1.21

1.10

2.1

1.9

1.07

1.18

g/l

4.57

103

868

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

320

2369

1.11

1.10

1.6

1.14

1.19

g/l

1.37

303

2247

Pneumoconiosis due to dust containing silica

2.25

1.10

2.4

1.5

1.19

1.12

g/l

—

Other mosquito-borne viral fevers

2.22

1.08

1.3

1.04

1.19

g/l

—

Retained placenta and membranes, without haemorrhage

212

1869

1.14

1.08

1.6

1.9

1.17

1.20

g/l

1.10

203

1789

Graves ophthalmopathy

313

1.36

1.08

1.4

1.8

1.18

1.19

g/l

0.09

298

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

326

0.67

1.08

1.4

1.8

1.13

1.19

g/l

0.51

307

Supervision of high-risk pregnancy

417

2286

1.10

1.08

2.6

2.0

1.16

1.21

g/l

2.73

403

2201

Acquired pure red cell aplasia [erythroblastopenia]

2.06

1.07

1.9

1.2

1.25

1.13

g/l

—

Malignant neoplasm of colon, including Hilmo

188

2135

0.87

1.07

1.8

1.6

1.19

1.18

g/l

0.21

179

2018

Gonococcal infection

375

1.32

1.06

1.7

1.6

1.18

1.22

g/l

0.39

358

Congenital absence, atresia and stenosis of large intestine

2.40

1.05

4.6

1.3

1.06

1.17

g/l

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

179

1.48

1.05

3.3

1.7

1.17

1.22

g/l

0.47

174

Unspecified severe protein-energy malnutrition

2.36

1.05

1.0

1.3

0.98

1.29

g/l

—

Pregnancy with abortive outcome

1312

6495

1.05

1.04

1.8

1.9

1.20

1.19

g/l

0.45

1244

6233

Poor fetal growth

244

2178

1.13

1.03

3.4

2.0

1.12

1.17

g/l

2.03

232

2097

Malignant neoplasm of breast, ER-negative, including Hilmo

291

3016

0.90

1.03

1.4

1.7

1.18

1.21

g/l

1.23

279

2862

2.06

1.02

1.1

1.6

1.13

1.22

g/l

—

Gonococcal infection, including avohilmo

413

1.29

1.01

1.6

1.7

1.19

1.22

g/l

0.28

394

Congenital retinoschisis

2.01

0.99

1.9

1.6

1.29

1.18

g/l

—

Factitial dermatitis

1.79

0.99

1.3

1.6

1.21

1.16

g/l

0.25

Malignant neoplasm of head and neck, including Hilmo

124

1059

1.18

0.99

2.2

1.5

1.17

1.19

g/l

0.32

119

1004

Rheumatic fever without mention of heart involvement

2.00

0.99

2.7

1.9

1.05

1.17

g/l

—

Labyrinthitis

2.00

0.98

2.4

1.4

1.16

1.19

g/l

—

Benign neoplasm: Scapula and long bones of upper limb

124

1.56

0.98

2.3

1.6

1.10

1.19

g/l

0.57

119

Acute thyroiditis

1.85

0.98

1.4

1.7

1.28

1.14

g/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

132

1.53

0.98

2.0

1.8

1.20

1.25

g/l

0.25

126

Rheumatic fever with heart involvement

1.84

0.98

1.4

1.5

1.24

1.10

g/l

—

Calcaneal spur

124

1.55

0.98

1.3

1.5

1.25

1.24

g/l

0.02

115

Malignant neoplasm of bladder

576

1.24

0.96

1.2

1.4

1.16

1.14

g/l

0.14

544

Motorcycle rider injured in other and unspecified transport accidents

714

1.21

0.95

1.7

1.6

1.23

1.21

g/l

0.32

689

Crushing injury of lower leg

2.30

0.95

1.2

1.29

1.24

g/l

—

Aphakia

125

1.53

0.94

2.1

1.3

1.18

g/l

0.00

120

Congenital malformations of eye, ear, face and neck

104

881

1.19

0.93

1.6

1.9

1.14

1.18

g/l

0.79

837

Accidental poisoning by and exposure to pesticides

2.22

0.93

1.3

1.21

1.23

g/l

—

Nosocomial condition (hospital)

1.76

0.93

3.9

1.5

1.16

1.15

g/l

—

Labour and delivery complicated by fetal stress [distress]

437

3077

0.92

0.93

2.3

2.2

1.17

g/l

0.16

417

2954

Malignant neoplasm of prostate, including Hilmo

297

1930

0.91

1.3

1.4

1.20

1.19

g/l

0.26

286

1851

Foreign body in genitourinary tract

136

1.50

0.88

1.9

1.6

1.19

1.18

g/l

0.04

131

Supervision of normal pregnancy

378

2344

0.92

0.88

1.6

2.1

1.20

1.21

g/l

0.32

356

2259

Primary open-angle glaucoma, strict

352

3224

1.09

0.88

1.5

1.19

1.18

g/l

0.29

334

3046

Certain zoonotic bacterial diseases, including avohilmo

360

1.29

0.88

1.2

1.5

1.24

1.20

g/l

0.44

343

Other disorders originating in the perinatal period

162

1.45

0.86

1.7

1.6

1.13

1.14

g/l

0.05

154

Benign neoplasm: other/unspecified salivary gland

273

1.33

0.86

1.3

1.5

1.23

1.19

g/l

0.44

263

Drug-induced obesity

137

1.49

0.86

1.2

1.5

1.39

1.18

g/l

2.46

131

Non-small cell lung cancer

122

1044

1.16

0.85

1.6

1.5

1.15

1.17

g/l

0.30

115

984

Prominent ears

138

0.57

0.85

1.3

1.9

1.02

1.19

g/l

—

130

Venous complications and haemorrhoids in pregnancy

301

1.31

0.84

1.6

1.9

1.08

1.17

g/l

1.81

285

Trichomoniasis, including avohilmo

113

1.53

0.84

1.9

1.13

1.23

g/l

0.54

107

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

209

0.65

0.83

1.9

1.4

1.18

1.14

g/l

0.29

202

Trichomoniasis

1.58

0.83

2.0

1.7

1.08

1.22

g/l

0.81

Abscess of external ear

164

1.42

0.81

1.3

1.5

1.31

1.18

g/l

1.01

156

Long labour

417

3800

0.93

0.80

2.0

2.1

1.18

g/l

0.08

402

3651

Hypospadias with an incomplete glans penis

0.00

0.80

0.0

1.2

—

1.16

—

Single delivery by caesarean section

345

2136

0.92

0.80

2.3

2.2

1.21

1.20

g/l

0.39

329

2052

Restrictive cardiomyopathy

1.86

0.80

1.2

1.4

1.08

1.09

g/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

151

0.59

0.80

2.0

1.7

1.09

1.20

g/l

—

142

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.80

0.0

1.4

—

1.22

—

Solid cancers

1554

8761

1.04

0.80

1.7

1.20

g/l

0.48

1493

8385

Traumatic cerebral oedema

0.00

0.79

0.0

2.2

—

1.09

—

Acute myeloid leukaemia, including Hilmo

140

1.45

0.78

1.4

1.5

1.29

1.14

g/l

1.03

134

Acute myeloid leukaemia

140

1.45

0.78

1.4

1.5

1.29

1.14

g/l

1.03

134

Acute myeloid leukaemia, helper endpoint

140

1.45

0.78

1.4

1.5

1.29

1.14

g/l

1.03

134

malignant neoplasm of male genital organs, including Hilmo

311

2033

0.92

0.78

1.4

1.21

1.19

g/l

0.53

300

1951

Dislocation, sprain and strain of joints and ligaments of elbow

101

871

1.17

0.77

1.7

1.8

1.17

1.18

g/l

0.16

827

Sequelae of hyperalimentation

2.17

0.76

1.0

1.8

1.50

1.09

g/l

—

Other congenital malformations of respiratory system

2.17

0.76

1.8

1.3

1.17

1.07

g/l

—

Other abnormal products of conception

664

4116

1.06

0.75

2.1

1.17

1.19

g/l

0.75

644

3971

Type 1 diabetes, strict definition

124

1086

1.14

0.74

1.7

2.0

1.09

1.17

g/l

3.06

116

1037

Fall involving playground equipment

100

1.53

0.74

2.5

1.4

1.12

1.16

g/l

0.36

Acute disseminated encephalitis/encephalomyelitis

2.08

0.74

1.8

1.4

1.10

1.17

g/l

—

Dementia due to Parkinsons disease, excluding more controls

172

0.64

0.74

1.1

1.6

1.15

1.10

g/l

0.29

161

Other congenital malformations of digestive system

2.05

0.74

2.0

1.4

1.46

1.21

g/l

—

Exposure to sunlight

2.05

0.74

2.8

1.2

1.11

1.24

g/l

—

Small plaque parapsoriasis

2.05

0.74

1.6

1.5

1.13

1.20

g/l

—

Polycystic ovarian syndrome, broad definition

214

1943

1.11

0.73

1.8

2.2

1.20

1.16

g/l

0.81

205

1873

Contusion of toe(s) with damage to nail

142

1.43

0.73

2.0

1.6

1.19

g/l

0.00

137

Glaucoma secondary to drugs

1.79

0.72

1.3

1.2

1.44

1.15

g/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.79

0.72

1.3

1.25

1.10

g/l

—

Antepartum haemorrhage, not elsewhere classified

166

1489

1.12

0.72

2.2

1.17

1.18

g/l

0.19

161

1433

Toxic effect of carbon monoxide

194

1.35

0.72

1.3

1.5

1.15

1.18

g/l

0.23

186

Type 1 diabetes, strict definition, subgroup 1

117

1025

1.14

0.71

1.7

2.0

1.08

1.17

g/l

3.35

111

978

Degenerative macular diseases, drug-induced

1.96

0.71

1.6

1.3

0.99

1.12

g/l

—

Onychogryphosis

1.90

0.69

5.4

1.2

1.22

1.17

g/l

—

Benign neoplasm: Connective and other soft tissue of pelvis

1.90

0.69

1.8

1.9

1.18

1.15

g/l

—

Drug-induced myopathy

1.89

0.69

1.0

1.2

1.09

1.21

g/l

—

Acquired atrophy of ovary and fallopian tube

1.67

0.68

2.3

1.3

1.21

1.18

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

733

1.16

0.68

1.8

1.6

1.25

1.19

g/l

1.02

697

Primary open-angle glaucoma

423

3814

1.07

0.67

1.5

1.19

1.18

g/l

0.26

403

3608

Non-small cell lung cancer, including Hilmo

183

1554

1.11

0.67

1.6

1.16

1.18

g/l

0.38

173

1469

Acute drug-induced interstitial lung disorder

1.54

0.67

1.6

1.4

1.21

1.16

g/l

0.13

Benign leiomyoma with endometriosis

241

2213

1.09

0.67

1.6

1.8

1.19

1.21

g/l

0.49

229

2108

Malignant neoplasm of other and unspecified female genital organs

179

0.66

0.67

1.5

1.8

1.09

1.17

g/l

0.46

169

Vascular dementia (undefined)

283

1.26

0.65

1.3

1.12

1.15

g/l

0.18

265

Secondary sideroblastic anaemia

1.76

0.64

1.6

1.7

1.25

1.09

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

271

2079

1.08

0.63

1.7

1.6

1.14

1.19

g/l

1.62

257

1971

Glaucoma secondary to eye trauma

1.61

0.63

1.3

1.15

g/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

397

1.22

0.62

1.8

1.7

1.14

1.19

g/l

0.44

378

Familial benign pemphigus (Hailey-Hailey disease)

1.71

0.62

1.0

1.3

1.21

g/l

—

Personal history of malignant neoplasm

130

1163

1.12

0.62

1.7

1.8

1.20

g/l

0.02

125

1104

Vertical strabismus

407

1.21

0.61

1.4

1.6

1.19

1.20

g/l

0.09

385

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.60

0.61

1.4

1.04

1.20

g/l

—

Arteriovenous malformation of cerebral vessels

140

0.63

0.61

1.1

1.5

1.03

1.20

g/l

—

134

Medullary carcinoma of thyroid gland, including Hilmo

0.00

0.61

0.0

1.4

—

1.11

—

Social disorders starting during childhood or adolecense, excluding more controls

1.46

0.60

1.9

1.4

1.18

1.20

g/l

0.18

Syndactyly

0.00

0.59

0.0

1.9

—

1.18

—

Other and unspecified injuries of neck

112

0.62

0.59

1.7

1.18

1.21

g/l

—

105

Malignant neoplasm of ureter

0.00

0.59

0.0

1.3

—

1.06

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

214

0.72

0.58

1.8

1.4

1.17

1.14

g/l

0.28

207

Adenocarcinoma and papillary adenocarcinoma of stomach

242

0.74

0.58

1.8

1.5

1.11

1.15

g/l

0.25

232

Oesophageal obstruction

337

1.22

0.57

1.2

1.5

1.21

1.20

g/l

0.08

322

Cervical polyps

151

1370

1.11

0.57

1.7

1.19

1.21

g/l

0.45

144

1296

Neurofibromatosis, type 1

0.57

1.8

1.5

1.10

1.17

g/l

—

Malignant neoplasm of oesophagus

241

0.74

0.57

1.2

1.6

1.23

1.16

g/l

0.38

227

Malignant neoplasm of ureter, including Hilmo

0.57

1.0

1.4

1.00

1.07

g/l

—

Venous complications and haemorrhoids in the puerperium

150

1.35

0.57

1.6

1.5

1.16

1.21

g/l

0.29

144

Eclampsia

1.66

0.56

1.0

1.7

1.28

1.16

g/l

—

Generalized pustular psoriasis

1.65

0.56

1.3

1.4

1.17

1.11

g/l

—

Malignant neoplasm of other and unspecified parts of tongue

159

1.33

0.56

1.8

1.5

1.23

1.16

g/l

0.73

153

Other benign neoplasm of uterus: Corpus uteri

123

0.64

0.56

1.6

2.0

1.15

1.20

g/l

—

117

Mandibular retrognathia AND surgery (BSSO)

348

1.22

0.55

1.3

1.8

1.16

1.21

g/l

0.45

331

Mandibular prognathia

228

0.74

0.55

3.1

1.6

1.09

1.18

g/l

0.65

217

Maternal care for known or suspected abnormality of pelvic organs

499

3196

1.06

0.55

2.2

2.1

1.14

1.19

g/l

3.34

481

3068

Personal history of risk-factors, not elsewhere classified

177

1.31

0.55

1.4

1.7

1.33

1.21

g/l

0.99

170

Pedestrian injured in other and unspecified transport accidents

142

1.35

0.55

2.5

1.6

1.11

1.18

g/l

0.47

135

Benign neoplasm of other and unspecified sites

376

1.20

0.55

2.0

1.6

1.13

1.20

g/l

0.75

358

Deaf mutism, not elsewhere classified

1.47

0.54

2.8

1.8

1.03

1.16

g/l

—

Bilateral sagittal split ramus osteotomy operation

460

1.18

0.54

1.3

1.8

1.17

1.20

g/l

0.30

439

Drug-induced dystonia

1.57

0.54

1.3

1.4

1.12

1.18

g/l

—

Disorders of puberty, all

223

1.27

0.53

4.0

1.7

1.14

1.17

g/l

0.22

212

Other disorders of Eustachian tube

387

1.20

0.53

1.8

1.6

1.12

1.18

g/l

0.93

368

Congenital vesicoureteral reflux

1.47

0.53

1.2

1.8

1.21

1.18

g/l

0.18

Benign neoplasm: Carotid body

1.53

0.52

1.8

1.6

1.14

1.15

g/l

—

Alzheimer disease, excluding more controls

172

1213

0.92

0.52

1.9

1.4

1.15

1.18

g/l

0.77

159

1150

Premature rupture of membranes

378

2845

0.94

0.51

2.0

2.1

1.14

1.19

g/l

2.33

363

2736

Malignant neoplasm of tongue

215

1.27

0.51

2.0

1.5

1.24

1.19

g/l

0.57

206

Obstructed labour due to maternal pelvic abnormality

247

2306

1.07

0.51

1.7

1.8

1.23

1.22

g/l

0.21

241

2204

Non-small cell lung cancer, squamous, helper endpoint

412

0.82

0.50

1.5

1.4

1.15

1.16

g/l

0.02

397

Malignant neoplasm of rectum

1062

0.89

0.50

1.4

1.5

1.17

1.19

g/l

0.30

1007

Leiomyosarcoma, including Hilmo

107

0.65

0.49

1.4

1.5

1.16

g/l

—

102

Isolated growth hormone deficiency

1.42

0.49

2.3

1.3

1.24

1.19

g/l

0.23

Scissor bite

396

1.18

0.48

1.8

1.7

1.08

1.15

g/l

0.96

381

Measles

128

1.34

0.48

1.5

1.25

g/l

0.02

120

Other mosquito-borne viral fevers, including avohilmo

102

1.39

0.48

1.6

1.4

1.06

1.20

g/l

0.67

Myocardial infarction, unclassifiable

239

1994

1.07

0.48

1.6

1.4

1.19

1.16

g/l

0.82

226

1887

Complications of labour and delivery

1146

6563

0.97

0.48

2.0

1.9

1.18

1.20

g/l

0.57

1102

6279

Foreign object accidentally left in body during surgical and medical care

1.48

0.47

2.3

1.5

1.18

1.16

g/l

—

Unspecified mental disorder

674

6479

1.04

0.47

1.7

1.8

1.21

1.19

g/l

1.28

641

6224

Pedestrian injured in collision with pedal cycle

346

1.19

0.47

2.4

1.5

1.17

1.20

g/l

0.31

331

Disorders of puberty

191

1.27

0.47

4.0

1.7

1.10

1.18

g/l

0.70

181

Postdysenteric arthropathy

120

1.35

0.47

3.1

1.5

1.31

1.17

g/l

0.90

115

Unspecified dementia

873

0.89

0.47

1.4

1.11

1.15

g/l

0.50

824

Unspecified maternal hypertension

187

0.74

0.46

1.6

2.0

1.36

1.19

g/l

1.34

177

Parkinson's disease

154

1671

0.92

0.46

1.5

1.15

1.17

g/l

0.59

148

1591

Malignant neoplasm of oesophagus, including Hilmo

320

0.81

0.46

1.5

1.7

1.17

g/l

0.01

300

Other osteochondrodysplasias, including avohilmo

156

1.29

0.46

1.4

1.6

1.23

1.20

g/l

0.17

149

Familial erythrocytosis

1.42

0.45

2.3

1.3

1.30

1.17

g/l

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

183

1.27

0.45

1.3

1.6

1.18

g/l

0.01

175

Postpartum haemorrhage

462

3988

0.95

0.45

2.0

2.1

1.17

1.18

g/l

0.43

441

3826

Pedal cyclist injured in noncollision transport accidents

150

1626

0.92

0.45

1.7

1.8

1.17

1.20

g/l

0.61

145

1550

Viral infections of central nervous system, not elsewhere classified/unspecified

139

1.31

0.44

1.3

1.6

1.23

1.17

g/l

0.38

132

Benign neoplasm of ovary

259

2438

1.06

0.44

1.7

1.8

1.22

1.21

g/l

0.32

250

2308

Postprocedural disorders of eye and adnexa, not elsewhere classified

1.64

0.43

1.2

1.5

1.20

1.10

g/l

—

conjunctival scars

1.61

0.43

1.6

1.4

1.27

1.21

g/l

—

Parkinson's disease, strict definition

142

1540

0.92

0.43

1.5

1.14

1.17

g/l

0.90

136

1466

Dependent personality disorder

239

1.22

0.43

1.6

1.7

1.26

1.21

g/l

0.28

227

Failure of sterile precautions during surgical operation

1.59

0.43

1.0

1.3

1.34

1.15

g/l

—

Malignant neoplasm of meninges, including Hilmo

1.58

0.42

2.0

1.6

1.07

1.09

g/l

—

Abnormalities of forces of labour

181

1686

1.08

0.42

1.8

2.0

1.20

g/l

0.03

173

1618

Use of cabergoline

173

0.75

0.42

1.2

1.6

1.42

1.18

g/l

1.79

164

Forearm

0.00

0.42

0.0

1.1

—

1.24

—

Fusion of the labia, including avohilmo

0.00

0.42

0.0

1.1

—

1.23

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.42

0.0

1.4

—

1.29

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.42

0.0

1.2

—

1.14

—

Traumatic amputation of shoulder and upper arm

0.00

0.42

0.0

1.5

—

1.14

—

Urethral discharge

0.00

0.42

0.0

1.8

—

1.23

—

Other and unspecified water transport accidents

1.53

0.42

1.4

1.8

1.23

1.11

g/l

—

Traumatic secondary and recurrent haemorrhage

0.00

0.41

0.0

1.3

—

1.08

—

Congenital deformities of hip, including avohilmo

295

1.19

0.41

1.6

1.10

1.18

g/l

0.93

280

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.41

0.0

1.6

—

1.14

—

Precocious central puberty

1.41

0.41

2.0

1.5

1.21

g/l

0.00

Crossbite

118

995

1.09

0.41

1.8

1.9

1.24

1.17

g/l

1.65

112

955

Schizophrenia or delusion, excluding more controls

438

4138

1.05

0.41

1.7

1.22

1.18

g/l

1.70

418

3967

Other congenital malformations of integument, including avohilmo

1.49

0.41

6.0

2.1

1.11

1.14

g/l

—

Malignant neoplasm of corpus uteri

992

0.90

0.40

1.5

1.7

1.30

1.20

g/l

2.11

937

Sexual dysfunction

223

1.22

0.40

2.0

1.5

1.23

1.18

g/l

0.44

214

Benign neoplasm: Heart

1.45

0.40

1.8

1.5

1.16

1.09

g/l

—

Laparoscopic left hemicolectomy

204

0.78

0.39

1.4

1.26

1.20

g/l

0.48

197

Measles, including avohilmo

133

1.29

0.39

1.5

1.25

1.24

g/l

0.01

125

Postpartum haemorrhage due to retained placenta

193

2057

0.94

0.39

2.2

2.1

1.17

1.19

g/l

0.33

182

1979

Other and unspecified disorders of psychological development

155

1.26

0.39

1.3

1.6

1.27

1.16

g/l

0.93

149

Mental and behavioural disorders associated with the puerperium

170

0.76

0.39

1.4

1.6

1.10

1.18

g/l

0.56

161

Mental and behavioural disorders of puerperium, not classified elsewhere

170

0.76

0.39

1.4

1.6

1.10

1.20

g/l

0.72

163

Convergent concomitant strabismus

751

1.11

0.38

1.7

2.0

1.19

1.18

g/l

0.05

709

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

192

0.78

0.38

1.8

1.25

1.16

g/l

0.59

182

Accidental poisoning by and exposure to other gases and vapours

1.34

0.38

1.8

1.4

1.14

g/l

—

severe traumatic brain injury, does not include concussion

284

2696

1.05

0.38

1.7

1.5

1.18

g/l

0.01

269

2569

Benign neoplasm of breast

183

1715

1.07

0.38

2.3

1.9

1.19

1.20

g/l

0.19

174

1628

Contact with machinery

115

1248

0.92

0.37

1.4

1.5

1.22

1.21

g/l

0.29

110

1200

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

101

1102

0.91

0.37

1.4

1.5

1.18

1.19

g/l

0.16

1044

Other abnormal auditory perceptions

152

1.26

0.37

1.9

1.6

1.05

1.22

g/l

2.54

142

Clubfoot

134

1.28

0.37

1.2

1.5

1.10

1.19

g/l

0.66

128

LeFortI or BSSO operation

544

1.13

0.37

1.3

1.8

1.15

1.20

g/l

0.58

516

Medical treatment for female infertility

407

3867

1.04

0.36

1.9

2.1

1.14

1.18

g/l

1.67

392

3712

Maternal care for other known or suspected fetal problems

480

2895

1.04

0.36

2.4

2.1

1.16

1.18

g/l

0.99

459

2780

Use of dimethyl fumarate

121

0.74

0.36

1.3

1.7

1.06

1.19

g/l

—

115

Pedal cyclist injured in other and unspecified transport accidents

161

1507

1.07

0.35

1.7

1.8

1.16

1.19

g/l

0.71

154

1441

Maternal care related to the fetus and amniotic cavity and possible delivery problems

862

4910

1.03

0.35

2.0

1.19

1.20

g/l

0.31

833

4723

Maternal care for known or suspected malpresentation of fetus

372

2540

1.05

0.35

2.0

2.1

1.15

1.18

g/l

1.50

355

2441

Leiomyoma of uterus

1197

6555

1.02

0.34

1.7

1.8

1.20

1.19

g/l

0.66

1142

6264

Other hypertrichosis

1.35

0.34

2.5

1.5

1.15

g/l

—

Malignant neoplasm of bone and articular cartilage

118

1.28

0.34

1.8

1.5

1.15

1.18

g/l

0.13

111

Benign neoplasm of male genital organs

191

1.21

0.33

1.2

1.4

1.15

1.16

g/l

0.09

184

Foreign body in ear

256

1.18

0.33

1.7

1.6

1.18

1.19

g/l

0.03

242

Malignant neoplasm of cervix uteri

238

1.18

0.33

2.0

1.7

1.27

1.19

g/l

0.72

227

Other and unspecified nonorganic psychotic disorders

276

2891

0.95

0.32

1.7

1.9

1.24

1.19

g/l

1.95

263

2784

Toxic effect of other and unspecified substances

154

0.77

0.32

4.1

1.6

1.10

1.22

g/l

0.71

144

Social disorders starting during childhood or adolescence

110

1.29

0.32

1.9

1.8

1.18

1.17

g/l

0.00

105

Acute appendicitis, with complications

276

2636

1.05

0.32

2.0

1.7

1.18

1.20

g/l

0.38

262

2522

Organic, including symptomatic, mental disorders

746

5101

1.03

0.31

1.9

1.5

1.17

1.18

g/l

0.68

707

4856

Use of levodopa decarboxylase inhibitor

140

1493

0.94

0.31

1.3

1.5

1.14

1.17

g/l

0.71

128

1420

Malignant neoplasm of corpus uteri, including Hilmo

103

1110

0.93

0.31

1.5

1.7

1.29

1.20

g/l

2.05

1046

Perforation of oesophagus

1.31

0.31

1.3

1.2

1.05

1.20

g/l

—

Postpartum hemorraghe, all women as controls

462

4660

0.97

0.30

2.0

2.1

1.17

1.18

g/l

0.29

441

4470

Polycystic ovarian syndrome

918

1.08

0.30

1.5

2.2

1.26

1.16

g/l

2.24

878

Other specified and unspecified strabismus

157

1.22

0.30

2.2

1.4

1.30

1.19

g/l

0.89

150

Other/unspecified mastoiditis and related conditions

1.26

0.30

3.1

1.5

1.13

1.16

g/l

—

Liveborn infants according to place of birth

129

1.23

0.29

1.9

1.4

1.18

g/l

0.01

123

Parkinson's disease, including avohilmo

166

1752

0.95

0.28

1.5

1.14

1.17

g/l

0.78

158

1666

Carcinoma in situ of cervix uteri

178

1690

1.06

0.28

2.4

2.1

1.14

1.17

g/l

0.84

165

1620

Marfan's syndrome

1.24

0.27

1.1

1.4

1.07

1.17

g/l

—

Valgus deformity, not elsewhere classified

1.24

0.27

2.1

1.3

1.19

1.23

g/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

159

1.20

0.27

1.4

1.6

1.10

1.20

g/l

0.75

152

Maternal care for known or suspected fetal abnormality and damage

302

2463

1.04

0.26

2.7

2.1

1.16

1.18

g/l

0.70

292

2374

Crushing injury of wrist and hand

170

0.82

0.25

1.3

1.5

1.24

1.16

g/l

0.34

164

Feeding problems of newborn

1.18

0.25

1.6

1.8

1.14

1.15

g/l

—

Benign neoplasm: Other/unspecified site

189

1.17

0.24

2.2

1.5

1.11

1.20

g/l

0.83

183

Ductal carcinoma of pancreas

0.71

0.24

1.8

1.4

1.08

1.17

g/l

—

Congenital malformations of lung, including avohilmo

1.33

0.23

1.4

1.06

1.13

g/l

—

Exposure to other specified electric current

296

0.88

0.23

2.0

1.5

1.23

1.20

g/l

0.22

282

Benign neoplasm: Peripheral nerves and autonomic nervous system

200

0.85

0.23

1.3

1.4

1.10

1.20

g/l

0.59

191

Intracranial and intraspinal phlebitis and thrombophlebitis

0.00

0.22

0.0

1.1

—

1.12

—

Malignant neoplasm of meninges

0.00

0.22

0.0

1.2

—

1.03

—

Use of apomorphine

0.00

0.22

0.0

1.5

—

1.30

—

Traumatic amputation of forearm

0.00

0.22

0.0

1.5

—

1.32

—

Hyperalimentation, other specified

0.00

0.22

0.0

1.4

—

1.06

—

Medullary carcinoma of thyroid gland

0.00

0.22

0.0

1.1

—

1.16

—

Retained (old) intraocular foreign body

0.00

0.22

0.0

1.5

—

1.20

—

Sclerosis of liver

0.00

0.22

0.0

1.3

—

1.25

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

229

1.14

0.22

2.2

1.6

1.23

1.15

g/l

0.64

218

Alcoholic myopathy

0.00

0.22

0.0

1.5

—

1.26

—

Unspecified drowning and submersion

0.00

0.22

0.0

1.3

—

1.28

—

Brucellosis, including avohilmo

0.00

0.22

0.0

1.3

—

1.17

—

Fusion of the labia

0.00

0.21

0.0

1.2

—

1.25

—

Carcinoma in situ of bronchus and lung

0.00

0.21

0.0

1.5

—

1.19

—

Exposure to noise

0.00

0.21

0.0

1.8

—

1.16

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.21

0.0

1.3

—

1.05

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

0.21

0.0

1.3

—

0.87

—

Disorders of optic chiasm

0.00

0.21

0.0

1.5

—

1.15

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.21

0.0

1.2

—

1.09

—

Other hypertrophic osteoarthropathy

0.00

0.21

0.0

2.3

—

1.20

—

Labyrinthine dysfunction

0.00

0.21

0.0

1.3

—

1.18

—

Myiasis, including avohilmo

0.00

0.21

0.0

1.4

—

1.11

—

Indeterminate sex and pseudohermaphroditism

0.00

0.21

0.0

1.5

—

1.25

—

Benign lipomatous neoplasm of spermatic cord

0.00

0.21

0.0

1.5

—

1.28

—

Malignant neoplasm of rectum, including Hilmo

127

1335

0.95

0.21

1.6

1.5

1.16

1.19

g/l

0.51

120

1269

Malignant neoplasm of nasopharynx, including Hilmo

1.17

0.21

3.8

1.7

1.12

1.09

g/l

—

Drowning to ice

0.00

0.21

0.0

1.3

—

1.20

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.21

0.0

1.4

—

1.32

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.21

0.0

1.3

—

1.30

—

Other osteochondrodysplasias

117

1.21

0.21

1.4

1.6

1.22

1.21

g/l

0.03

112

Pedal cyclist injured in transport accident

330

3398

0.97

0.20

1.7

1.8

1.16

1.20

g/l

1.43

318

3262

Café au lait spots

0.00

0.20

0.0

1.3

—

1.22

—

Malignant neoplasm of oropharyng

0.00

0.20

0.0

1.3

—

1.02

—

Use of pergolide

0.00

0.20

0.0

1.4

—

1.12

—

Undefined dementia

861

0.94

0.20

1.4

1.11

1.15

g/l

0.52

811

Guttate psoriasis

193

1.15

0.20

1.4

1.5

1.29

1.21

g/l

0.78

183

Benign neoplasm: Bones of skull and face

133

0.82

0.19

2.7

1.6

1.23

1.20

g/l

0.14

127

Use of disulfiram, acamprosate or naltrexone

116

1104

1.05

0.19

1.3

1.7

1.22

1.21

g/l

0.20

110

1062

Senility

1.18

0.19

1.0

1.5

1.08

1.17

g/l

—

Mild mental retardation

322

0.90

0.19

2.0

1.6

1.20

g/l

0.01

311

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

175

0.85

0.19

1.5

1.12

1.18

g/l

0.19

166

Pervasive developmental disorders excl. Autism + Asperger

183

0.86

0.19

2.1

1.6

1.21

1.16

g/l

0.26

177

Adenocarcinoma and papilloma adenocarcinoma of rectum

100

1053

0.95

0.19

1.4

1.5

1.19

g/l

0.05

999

Non-small cell lung cancer, squamous

374

0.91

0.19

1.5

1.6

1.15

g/l

0.03

349

Hereditary retinal dystrophy

156

1.16

0.19

2.6

1.5

1.13

1.21

g/l

0.65

149

Dementia in other diseases classified elsewhere

463

1.08

0.18

4.0

1.5

1.14

1.18

g/l

0.35

445

Fall on and from ladder

804

1.06

0.18

1.6

1.5

1.24

1.19

g/l

0.97

767

Other maltreatment syndromes

349

1.09

0.17

1.8

1.4

1.21

g/l

0.01

334

Horner syndrome

158

1.14

0.16

1.6

1.5

1.24

1.18

g/l

0.42

152

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.75

0.16

1.3

1.12

1.16

g/l

—

Tick-borne viral encephalitis, including avohilmo

1.16

0.15

1.2

1.4

0.97

1.15

g/l

—

Kela-code for severe mental illness

552

5619

0.98

0.15

1.6

1.8

1.22

1.19

g/l

1.42

527

5395

Other bursitis, not elsewhere classified

1.21

0.15

1.1

1.2

1.10

1.24

g/l

—

Malignant neoplasm of bronchus and lung

209

1800

0.97

0.15

1.6

1.5

1.15

1.18

g/l

0.79

197

1703

Pneumoconiosis due to asbestos and other mineral fibres

140

1.15

0.15

1.3

1.4

1.17

1.10

g/l

0.40

135

Infections specific to the perinatal period

169

1.13

0.14

1.4

1.5

1.17

1.13

g/l

0.41

162

Malignant neoplasm of oropharynx

160

0.87

0.14

1.7

1.5

1.23

1.17

g/l

0.40

153

Slow fetal growth and fetal malnutrition

102

1.18

0.14

2.5

1.5

1.18

1.17

g/l

0.07

Poisoning by medicine, drug-induced

159

0.88

0.13

2.8

1.7

1.23

1.20

g/l

0.10

154

Malignant neoplasm of bronchus and lung, including Hilmo

253

2059

1.02

0.13

1.5

1.6

1.16

1.19

g/l

0.69

238

1948

Malignant neoplasm of bone and articular cartilage, including Hilmo

209

1.10

0.13

1.6

1.5

1.15

1.16

g/l

0.08

197

Malignant neoplasm of oropharynx, including Hilmo

190

0.89

0.13

2.0

1.5

1.23

1.17

g/l

0.41

182

Phakomatoses, not elsewhere classified

142

1.13

0.13

1.4

1.6

1.08

1.20

g/l

0.77

132

Benign neoplasm: Tonsil

142

1.13

0.13

2.6

1.6

1.19

1.20

g/l

0.06

136

Femoral hernia

462

1.06

0.13

1.4

1.6

1.14

1.19

g/l

0.48

443

Use of rotigotine

127

0.86

0.12

1.5

1.4

1.30

1.20

g/l

0.38

122

Pyogenic granuloma

200

1.10

0.12

2.2

1.5

1.19

1.22

g/l

0.22

189

Benign neoplasm: Conjunctiva

365

1.07

0.12

1.8

1.5

1.17

1.20

g/l

0.35

348

Donors of organs and tissues

181

1.11

0.12

1.2

1.6

1.09

1.20

g/l

1.85

172

malignant neoplasm of female genital organs, including Hilmo

258

2405

1.02

0.12

1.6

1.7

1.23

1.21

g/l

0.58

250

2275

Malignant neoplasm of tongue, including Hilmo

269

1.08

0.11

2.1

1.7

1.22

1.18

g/l

0.30

258

Congenital ovarian cysts

669

0.96

0.11

1.3

2.1

1.13

1.19

g/l

1.07

626

Personality and behavioural disorders due to brain disease, damage and dysfunction

153

1.11

0.11

2.9

1.5

1.14

1.18

g/l

0.28

148

Abnormal findings on antenatal screening of mother

149

1451

1.03

0.10

2.1

2.2

1.15

g/l

0.02

142

1400

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

176

0.91

0.09

3.9

1.7

1.26

1.21

g/l

0.29

167

Reduction defects of upper limb, including avohilmo

1.04

0.09

1.0

1.9

1.24

1.19

g/l

—

malignant neoplasm of female genital organs

211

2104

0.98

0.09

1.7

1.8

1.24

1.21

g/l

0.68

204

1986

Otosclerosis

862

1.03

0.09

1.7

1.6

1.16

1.18

g/l

0.46

825

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

214

0.92

0.09

1.7

1.5

1.18

1.12

g/l

0.58

206

Congenital deformities of hip

272

1.07

0.08

1.7

1.6

1.13

1.19

g/l

0.55

257

Noise effects on inner ear

410

0.95

0.08

1.5

1.4

1.27

1.17

g/l

0.95

395

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

224

1.07

0.08

1.8

1.7

1.26

1.18

g/l

0.75

214

Postpartum haemorrhage due to anatomy

175

1716

1.02

0.08

2.1

1.17

g/l

0.03

169

1648

Postpartum care and examination

253

1613

0.98

0.08

2.6

2.2

1.15

1.20

g/l

1.66

242

1556

Other diseases caused by chlamydiae

166

1.09

0.08

1.3

1.8

1.12

1.21

g/l

1.12

158

Congenital nasolacrimal duct obstruction or stenosis

0.85

0.08

1.3

1.12

1.16

g/l

—

Constitutional tall stature

0.85

0.08

3.3

1.7

0.98

1.18

g/l

—

Acute poliomyelitis, including avohilmo

143

0.91

0.07

1.0

1.4

1.25

1.16

g/l

0.34

136

Other acquired deformities of ankle and foot

1.05

0.07

1.3

1.2

1.16

1.22

g/l

—

Congenital malformations of oesophagus, including avohilmo

1.04

0.07

1.1

1.6

1.38

1.16

g/l

—

Aggressive periodontitis

265

1.06

0.07

1.5

1.6

1.21

1.19

g/l

0.17

252

Fetus and newborn affected by maternal complications of pregnancy

101

0.89

0.06

2.0

1.5

1.13

1.16

g/l

—

Delayed milestone in childhood

247

1.06

0.06

2.1

1.6

1.06

1.14

g/l

0.69

240

Malignant neoplasm of other and ill-defined sites, including Hilmo

148

1.08

0.06

1.4

1.5

1.28

1.14

g/l

1.17

141

Acute poliomyelitis

141

0.92

0.05

1.0

1.5

1.25

1.16

g/l

0.33

134

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

149

1.08

0.05

1.8

1.5

1.16

g/l

0.01

140

Family history of malignant neoplasm

168

1657

1.01

0.05

1.7

1.8

1.16

1.20

g/l

0.80

158

1583

Pregnancy, childbirth and the puerperium

481

2529

0.99

0.05

1.9

1.18

1.19

g/l

0.19

453

2415

Perichondritis of external ear

209

1.05

0.04

1.2

1.6

1.31

1.19

g/l

1.21

199

Mumps, including avohilmo

298

1.04

0.04

1.5

1.24

1.21

g/l

0.20

283

Vascular dementia

796

1.02

0.03

1.3

1.4

1.15

1.14

g/l

0.13

747

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

139

0.93

0.03

1.4

1.9

1.10

1.19

g/l

0.63

130

Motorcycle rider injured in noncollision transport accidents

349

1.03

0.03

2.2

1.6

1.20

1.19

g/l

0.09

334

Malignant neoplasm of tonsil

149

0.94

0.03

1.7

1.5

1.23

1.17

g/l

0.40

142

Malignant neoplasm of testis, including Hilmo

149

0.94

0.03

5.0

1.4

1.31

1.17

g/l

0.85

141

Previous suicide attempt

151

1.06

0.03

1.6

1.7

1.25

1.23

g/l

0.08

146

Laparoscopic right hemicolectomy

602

0.98

0.03

1.7

1.5

1.16

1.18

g/l

0.25

576

Generalized epilepsy, strict definition

290

1.04

0.03

1.4

1.6

1.11

1.18

g/l

0.47

276

Diabetes mellitus in pregnancy

633

4038

1.00

0.03

1.8

2.2

1.26

1.17

g/l

10.25

606

3873

Vascular dementia (mixed)

148

0.95

0.02

1.4

1.3

1.12

1.13

g/l

0.05

140

Malignant neoplasm of tonsil, including Hilmo

168

0.95

0.02

2.1

1.5

1.23

1.17

g/l

0.41

160

Obstructed labour due to malposition and malpresentation of fetus

420

3872

1.00

0.02

2.2

2.0

1.20

1.19

g/l

0.35

403

3714

Crowding of teeth, including avohilmo

143

1174

1.01

0.02

1.6

1.9

1.14

1.18

g/l

0.63

137

1134

Use of galantamine

699

0.99

0.01

1.4

1.5

1.15

g/l

0.02

662

Malignant neoplasm of testis

133

1.05

0.01

5.0

1.4

1.31

1.16

g/l

0.95

126

Postpartum hemorraghe, parous women as controls

462

3874

1.00

0.01

2.0

1.17

1.18

g/l

0.26

441

3726

Other obstructed labour

116

1151

1.01

0.01

1.7

2.0

1.24

1.19

g/l

0.92

109

1096

Mumps

293

1.02

0.01

1.5

1.4

1.27

1.21

g/l

0.48

278

Family history of other specific disorders

184

1.03

0.00

1.1

1.5

1.16

1.19

g/l

0.22

174

Malignant neoplasm of tonsil and base of tongue

194

1.03

0.00

2.0

1.5

1.25

1.15

g/l

0.85

184

Open wound of shoulder and upper arm

236

1.02

0.00

2.3

1.6

1.27

1.18

g/l

0.67

223

Injury of nerves and spinal cord at neck level

266

1.02

0.00

3.1

1.6

1.25

1.19

g/l

0.45

253

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

158

1.01

0.00

2.2

1.4

1.27

1.19

g/l

0.46

153

Use of fingolimod

129

1.01

0.00

1.2

1.6

1.06

1.20

g/l

1.65

123

Congenital malformations of ovaries, fallopian tubes and broad ligaments

872

1.00

0.00

1.4

2.1

1.16

1.19

g/l

0.51

826

Other disorders of amniotic fluid and membranes

247

2382

1.00

0.00

2.2

2.1

1.20

1.19

g/l

0.40

240

2295

Burn and corrosion of shoulder and upper limb, except wrist and hand

253

0.99

0.00

1.4

1.5

1.13

1.20

g/l

0.57

241

Pedestrian injured in collision with car, pick-up truck or van

295

1.02

0.00

1.3

1.5

1.15

1.21

g/l

0.50

282

Transient global amnesia

108

1077

1.00

0.00

1.8

1.6

1.17

1.19

g/l

0.32

103

1022

Diseases caused by chlamydiae

155

1.03

0.00

1.3

1.8

1.11

1.22

g/l

1.16

147

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

104

0.96

0.00

1.5

1.12

1.16

g/l

—

Enophthalmos

0.00

0.0

1.0

—

1.21

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.2

—

1.32

—

Carcinoma in situ of oral cavity, oesophagus and stomach

1.00

0.00

1.3

1.4

1.25

1.17

g/l

—

Choroidal degeneration

0.00

0.0

1.4

—

1.29

—

Taeniasis

0.00

0.0

1.2

—

1.17

—

Defects in post-translational modification of lysosomal enzymes

0.00

0.0

1.3

—

1.07

—

Myiasis

0.00

0.0

1.5

—

1.13

—

Other transitory neonatal endocrine disorders

0.00

0.0

1.4

—

1.27

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

0.0

1.4

—

0.90

—

Refsum disease

0.00

0.0

1.5

—

1.03

—

R07AX Other respiratory system products

0.00

0.0

1.2

—

1.22

—

Lichen ruber moniliformis

0.00

0.0

1.2

—

1.19

—

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

0.00

0.0

1.2

—

1.15

—

Carcinoma in situ of stomach

0.00

0.0

1.4

—

1.11

—

Toxic effect of metals

0.00

0.0

1.5

—

1.44

—

Miliaria rubra

0.00

0.0

1.4

—

1.29

—

Congenital viral diseases

0.00

0.0

1.0

—

1.41

—

Unspecified effects of radiation

0.00

0.0

1.0

—

1.13

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

1.2

—

1.08

—

Pseudosarcomatous fibromatosis

0.00

-0.00

0.0

2.0

—

1.15

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

1.2

—

1.17

—

Disorders of glycosaminoglycan metabolism

0.00

-0.00

0.0

1.0

—

1.21

—

Malignant neoplasm of trachea

0.00

-0.00

0.0

1.6

—

0.95

—

Follicular adenocarcinoma of thyroid gland

1.01

-0.00

1.1

1.8

1.09

1.14

g/l

—

Diastrofic dysplasy

0.00

-0.00

0.0

1.8

—

1.05

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

1.2

—

1.15

—

Nephropathy induced by unspecified drug, medicament or biological substance

0.00

-0.00

0.0

3.5

—

1.10

—

Epiphyseal arrest

0.00

-0.00

0.0

1.2

—

1.25

—

Use of benzatropine

0.00

-0.00

0.0

1.4

—

1.23

—

Intrauterine hypoxia

0.00

-0.00

0.0

1.3

—

1.22

—

Other neonatal haemorrhages

0.00

-0.00

0.0

1.0

—

1.49

—

Other transepidermal elimination disorders

0.00

-0.00

0.0

1.7

—

1.17

—

Use of etanautine orphenadrine

0.00

-0.00

0.0

1.4

—

0.95

—

Toxic effect of aflatoxin and other mycotoxin food contaminants

0.00

-0.00

0.0

1.2

—

1.28

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

1.0

—

1.15

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.6

—

1.17

—

Meckel's diverticulum

0.92

-0.00

1.0

1.6

1.48

1.15

g/l

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

-0.00

0.0

1.1

—

1.11

—

Air embolism (traumatic)

0.00

-0.00

0.0

1.8

—

1.22

—

Benign neoplasm: Ureter

0.00

-0.00

0.0

1.2

—

1.19

—

Reduction defects of unspecified limb

0.00

-0.00

0.0

1.8

—

1.15

—

Carcinoma in situ of other/unspecified female genital organs

0.00

-0.00

0.0

1.3

—

1.08

—

Malignant neoplasm of bone and articular cartilage of limbs

1.02

-0.00

1.8

1.7

1.06

1.14

g/l

—

Nail disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

1.14

—

Other specified air transport accidents

0.00

-0.00

0.0

1.2

—

1.20

—

Methaemoglobinaemia

0.00

-0.00

0.0

1.2

—

1.22

—

Crushing injury of neck

0.00

-0.00

0.0

1.6

—

1.35

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

-0.00

0.0

1.5

—

1.05

—

Intracranial injury with prolonged coma

0.00

-0.00

0.0

1.3

—

1.15

—

Congenital malformations of oesophagus

0.92

-0.00

1.0

1.5

1.48

1.18

g/l

—

Taeniasis, including avohilmo

0.00

-0.00

0.0

1.3

—

1.17

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

2.0

—

1.20

—

Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

1.26

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.3

—

1.14

—

Brucellosis

0.00

-0.00

0.0

1.4

—

1.19

—

Compression of brain

0.00

-0.00

0.0

2.3

—

1.25

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.4

—

1.04

—

Disorders of sulfur-bearing amino-acid metabolism

0.00

-0.00

0.0

1.3

—

1.19

—

Mosquito-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

1.2

—

1.20

—

Myxoedema coma

0.00

-0.00

0.0

1.8

—

1.15

—

Pedal cyclist injured in collision with train or tram

0.00

-0.00

0.0

1.4

—

1.28

—

Echinococcosis

0.00

-0.00

0.0

1.2

—

1.17

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

2.0

—

1.30

—

Echinococcosis, including avohilmo

0.00

-0.00

0.0

1.2

—

1.17

—

Disorders of glycine metabolism

0.00

-0.00

0.0

1.4

—

1.18

—

Anhidrosis

0.00

-0.00

0.0

1.6

—

1.28

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C3 [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS